1. hobbies and interests
2. inventors and patents

THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
APPENDIX X
STATUTORY AND GENERAL INFORMATION
1.
FURTHER INFORMATION ABOUT THE COMPANY
A.
Incorporation
Shanghai Pharmaceuticals Holdings Co., Ltd was established by way of subscription on January 18,
1994 under the name of Shanghai No.4 Pharmaceutical Co., Ltd. as a joint stock limited company in
the PRC, with Shanghai Pharmaceutical (Group) Corporation (上海醫藥(集團)總公司), the predecessor
of Shanghai Pharmaceutical (Group) as the sole promoter and the issuance of 15,000,000 ordinary
shares to the public. The Company has established a place of business in Hong Kong at 8th Floor,
Gloucester Tower, The Landmark, 15 Queen’s Road Central, Hong Kong, and was registered with the
Registrar of Companies in Hong Kong as a non-Hong Kong company under Part XI of the Companies
Ordinance on [●]. LU Mingfang/HAN Min, the authorized representatives of the Company for the
purposes of Part XI of the Companies Ordinance whose correspondence address is Room 20E, No. 1,
Lane 123, Yanping Road, Shanghai, PRC, has been appointed as the Company’s agents for the
acceptance of service of process in Hong Kong. As the Company is established in the PRC, its
corporate structure and the Articles of Association are subject to the relevant laws and regulations
of the PRC. Summaries of the relevant laws and regulations of the PRC and of the Articles of
Association are set out in Appendices VII and VIII to this Document.
B.
Change in the Registered Capital of the Company
At our establishment, the Company’s initial registered capital was RMB57,966,600, divided into
57,966,600 Domestic Shares of par value RMB1.00 each, all of which were held and fully paid up or
credited as fully paid up by the promoters.
In March 1997, the Company issued 17,389,980 domestic shares through placing to all its
shareholders on the basis of 3 shares for every 10 shares. As a result, the total share capital of the
Company was enlarged from 57,966,600 shares to 75,356,580 shares.
In June 1997, the Company issued share dividends to shareholders. As a result, the total share capital
of the Company was further enlarged from 75,356,580 shares to 113,034,870 shares.
In 1998, the Company conducted an asset restructuring and a follow-on offering in respect of the
Company. As a result, the total share capital of the Company was enlarged from 113,034,870 shares
to 153,034,870 shares.
In May 1999, the Company issued share dividends to shareholders. As a result, the Company further
enlarged its share capital to 229,552,305 shares.
In 2001, the Company issued share dividends to shareholders. As a result, the Company’s share
capital was further enlarged to 316,207,158 shares.
In June 2003, the Company issued share dividends to shareholders. As a result, the total share capital
of the Company amounted to 474,310,737 shares.
In June 2007, the Company issued share dividends to shareholders. As a result, the Company further
enlarged its share capital to 569,172,884 shares.
In October 2009, the Company conducted the 2009 Restructuring. As a result, the total number of
shares of the Company increased by 1,423,470,454 shares to 1,992,643,338 shares.
– X-1 –
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
APPENDIX X
STATUTORY AND GENERAL INFORMATION
Save as aforesaid, there has been no alteration in the registered capital of the Company since its
establishment as a joint stock limited company.
2 . THE RESTRUCTURING
Shareholders of the Company and the Company itself underwent the 2009 Restructuring, details of
which are set out in the section headed “History, Restructuring and Corporate Structure — The
Restructuring” in this Document. As confirmed by Grandall Legal Group, Shanghai Office, our legal
advisers as to PRC law, our 2009 Restructuring complies with all applicable PRC laws and regulations,
and all necessary approvals from relevant PRC regulatory authorities required for the implementation
of the 2009 Restructuring have been obtained.
3.
SUBSIDIARIES AND INTERESTS IN OTHER COMPANIES
A. Principal subsidiaries, jointly controlled entities and associates
The Company’s principal subsidiaries, jointly controlled entities and associates are referred to in Note
40 to the Accountant’s Report, the text of which is set out in Appendix I to this Document.
B. Changes in the share capital of subsidiaries
Save as disclosed below, there has been no alteration in the share capital of any of the subsidiaries
of the Company within the two years preceding the date of this Document:
1.
On June 29, 2010, the registered capital of Shanghai Pharmaceutical Distribution Co. was
increased from RMB400,000,000 to RMB908,471,109.41. On September 29, 2010, the
registered capital of Shanghai Pharmaceutical Distribution Co. was further increased from
RMB908,471,109.41 to RMB1,816,867,958.07;
2.
On June 28, 2010, the registered capital of Huashi Pharmacy was increased from
RMB90,000,000 to RMB99,570,000;
3.
On November 11, 2008, the registered capital of Sine Pharmaceutical was increased from
RMB51,067,000 to RMB220,000,000. On May 15, 2009, the registered capital of Sine
Pharmaceutical was further increased from RMB220,000,000 to RMB660,000,000;
4.
On April 15, 2009, the registered capital of Shanghai Traditional Chinese Medicine Co., Ltd. was
increased from RMB45,420,000 to RMB463,690,000;
5.
On August 19, 2009, the registered capital of Zhonghua Pharmaceutical was increased from
RMB40,000,000 to RMB63,641,789;
6.
On July 24, 2009, the registered capital of Changzhou Pharmaceutical Factory Co., Ltd. was
increased from RMB72,000,000 to RMB108,000,000;
7.
On October 23, 2009, the company structure of Shanghai Pharmaceutical Material Supply and
Marketing Co. was changed from a state-owned enterprise to a one-person limited liability
corporate with a registered capital of RMB71,390,000; and
8.
On June 17, 2009, the registered capital of SPIE was increased from RMB10,000,000 to
RMB19,400,000. On October 26, 2009, the company structure of SPIE was changed from a
people-owned enterprise to a one-person limited liability corporate with a registered capital
increased to RMB90,140,000.
– X-2 –
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
APPENDIX X
STATUTORY AND GENERAL INFORMATION
C. Interests in listed companies
As of the Latest Practicable Date, the Company owns the following interests in the listed companies
as detailed below:
Name
[●] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
[●] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.
Place of listing
Attributable equity
interests (%)
[●]
[●]
[●]
[●]
FURTHER INFORMATION ABOUT THE BUSINESS
A. Summary of material contracts
The following contracts (not being contracts entered into in the ordinary course of business) have
been entered into by the Company or its subsidiaries within the two years preceding the date of this
Document and are or may be material:
(i)
a debt settlement agreement dated March 21, 2008 entered into among Zhongxi
Pharmaceutical, Shenzhen Kondarl and Shenzhen Kondarl (Group) Real Estate Development
Co., Ltd. (深圳康達爾（集團）房地產開發有限公司) regarding the settlement of Shenzhen
Kondarl’s debt of RMB12,486,719.93 to Zhongxi Pharmaceutical;
(ii)
a patent license agreement dated April 2008 entered into between Shanghai Institute of
Pharmaceutical Industry and Shanghai Zhongxi Pharmaceutical Co., Ltd. (上海中西製藥有限公司)
regarding a patent license effective from September 2006 to October 2013;
(iii)
a technology transfer agreement dated August 28, 2008 entered into between Shanghai New
Asiatic and Xinhualian Pharmaceutical Factory regarding a technology transfer of a chemical
drug;
(iv)
a technology transfer agreement dated March 2, 2009 entered into between Shanghai Zhongxi
Pharmaceutical Co., Ltd. (上海中西製藥有限公司) and Chongqing Pharmaceutical Research
Institute Co. Ltd. (重慶醫藥工業研究院有限責任公司) regarding a technology of chemical drugs;
(v)
a registered capital increase agreement dated March 26, 2009 entered into between Shanghai
Pharmaceutical (Group) as the sole shareholder and Shanghai Pharmaceutical (Group) as the
registered capital increase subscriber regarding the registered capital increase of Shanghai
Medical Material Co. from RMB45.42 million to RMB463.69 million;
(vi)
a cooperation agreement dated June 2, 2009 entered into between Shanghai Medical
Instruments Co. Ltd. (上海醫療器械股份有限公司) and Shanghai Kang Tai Medical Instruments
Factory (上海康泰醫療器械廠) regarding commissioning manufacture by Shanghai Medical
Instruments Co. Ltd. (上海醫療器械股份有限公司) to Shanghai Kang Tai Medical Instruments
Factory (上海康泰醫療器械廠);
(vii) an equity transfer agreement dated June 29, 2009 entered into between Shanghai Industrial
Medical Health Products Co., Ltd. (上實醫藥健康產品有限責任公司) and World Honest
Investments Limited (運誠投資有限公司) regarding the disposal of 51.007% equity interest in
Huqingyutang Pharmaceutical by Shanghai Industrial Medical Health Products Co., Ltd. (上實醫
藥健康產品有限責任公司) to World Honest Investments Limited (運誠投資有限公司) with a
consideration of HK$203,955,916.07;
(viii) an equity transfer agreement dated June 29, 2009 entered into between (上實醫藥健康產品有
限責任公司) and World Honest Investments Limited (運誠投資有限公司) regarding the disposal of
55% equity interest in Chiata Qingchunbao with a consideration of HK$70,389,029.25;
– X-3 –
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
APPENDIX X
STATUTORY AND GENERAL INFORMATION
(ix)
an equity transfer agreement dated June 29, 2009 entered into between (上實醫藥健康產品有
限責任公司) and World Honest Investments Limited (運誠投資有限公司) regarding the disposal of
61% equity interest in Xiamen Traditional Chinese Medicine Co., Ltd. by (上實醫藥健康產品有
限責任公司) to World Honest Investments Limited (運誠投資有限公司) with a consideration of
HK$114,055,970.7;
(x)
a technology program agreement dated July 27, 2009 entered into between Xiamen Traditional
Chinese Medicine Co., Ltd. and Xiamen Science and Technology Bureau (廈門市科學技術局)
regarding a technology project;
(xi)
an amended joint venture agreement related to the incorporation of Xiamen Traditional Chinese
Medicine Co. dated August 2, 2009 entered into by and among Xiamen Light Industry (Group)
Co., Ltd. (廈門輕工集團有限公司), World Honest Investments Limited (運誠投資有限公司) and
Rocal Health Limited (羅克健康有限公司);
(xii) an equity swap and merger agreement dated October 15, 2009 entered into by and among the
predecessor of the Company, Shanghai Industrial Pharma and Zhongxi Pharmaceutical regarding
the merger of Shanghai Industrial Pharma and Zhongxi Pharmaceutical by the predecessor of the
Company;
(xiii) an equity transfer agreement dated October 22, 2009 entered into between Shanghai
Pharmaceutical (Group) and the employee stock ownership meeting regarding the equity
transfer of Shanghai Sunve Co.;
(xiv) A Framework Daily Transactions Agreement dated October 14, 2009 entered into by and
between Shanghai Pharmaceutical (Group) and Shanghai Pharmaceutical Co., Ltd. (the name
formerly used by the Company) regarding the rules of connected transactions between the two
parties thereof.
(xv) two Non-Compete Deeds dated December 22, 2009 from Shanghai Pharmaceutical (Group) and
SIIC to the Company;
(xvi) a registered capital increase agreement dated November 18, 2009 entered into by and among
Huashi Pharmacy, the Company and Shanghai Huashi Asset Management Co., Ltd. regarding
the registered capital increase of Shanghai Huashi Pharmacy Distribution Co. subscribed by the
predecessor of the Company with an amount of RMB9,570,000;
(xvii) a technology transfer agreement dated December 28, 2009 entered into between Shanghai
Zhongxi Pharmaceutical Co., Ltd. (上海中西製藥有限公司) and Beijing Dezhong Wanquan
Medicines Technological Development Co., Ltd. (北京德眾萬全藥物技術開發有限公司) regarding
a technology of chemical drugs;
(xviii) an equity transfer agreement dated January 18, 2010 entered into between Shanghai
Pharmaceutical (Group) and the Company regarding the disposal of 48% equity interest in
Sunve Pharmaceutical by Shanghai Pharmaceutical (Group) to the Company;
(xix) an equity transfer agreement dated January 18, 2010 entered into between the Shanghai
Pharmaceutical (Group) and our Company regarding the disposal of 100% equity interest in
Shanghai No.1 Biochemical by our Company to Shanghai Pharmaceutical Distribution Co. at a
consideration of RMB808,900,000;
(xx) an equity transfer agreement dated January 18, 2010 entered into between Shanghai
Pharmaceutical (Group) and our Company regarding the disposal of 100% equity interest in
Shanghai Sunve Co. by Shanghai Pharmaceutical (Group) to the Company with a consideration
of RMB743,324,843;
– X-4 –
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
APPENDIX X
STATUTORY AND GENERAL INFORMATION
(xxi) a restructuring agreement dated April 12, 2010 entered into among the predecessor of our
Company, Shanghai Huashi Asset Management Co., Ltd, Guangzhou Zhongda Industry Group
Co., Ltd. (廣州中大產業集團有限公司), Shenzhen Tongfu Investment Co., Ltd. (深圳市同富投資有
限公司), Guangzhou Guanghong Medicine Company (廣州廣弘醫藥有限公司) and four
individuals (namely, Tab Lining, Chen Yaoming, Zhangze and Zhang Yuan) regarding the
restructuring of Guangzhou Z.S.Y Pharmaceuticals Co.;
(xxii) a joint venture agreement dated April 15, 2010 entered into by and among Fujian Overseas
Chinese Industrial (Group) Corp. (福建省華僑實業集團有限責任公司), the predecessor of our
Company and Fujian Medicinal Materials Company (福建省藥材公司) regarding the
incorporation of Fujian Pharmaceutical;
(xxiii) a technology transfer agreement dated May 7, 2010 entered into between Shanghai Zhongxi
Pharmaceutical Co., Ltd. (上海中西製藥有限公司) and Tianjin Hang Kang Pharmaceutical
Bio-Tech Co. Ltd. (天津市漢康醫藥生物技術有限公司) regarding a technology of chemical drugs;
(xxiv) a property and land use right transfer agreement dated May 12, 2010 entered into between
Qingdao Growful and (青島市南區人民政府江蘇路街道辦事處) regarding the transfer of property
and the land use right from Qingdao Growful to (青島市南區人民政府江蘇路街道辦事處) with a
consideration of RMB15,900,000;
(xxv) an equity transfer agreement dated May 31, 2010 entered into between Shanghai Ruijing Real
Estate Management and Cooperation Company (上海瑞景物業管理合作公司) and Shanghai
Industrial United Holdings Pharmaceutical Co., Ltd. (上海實業聯合集團藥業有限公司) regarding
the disposal of 0.5% equity interest in Shanghai Medical Instruments Co. Ltd. (上海醫療器械股
份有限公司) by Shanghai Ruijing Real Estate Management and Cooperation Company (上海瑞景
物業管理合作公司) to Shanghai Industrial United Holdings Pharmaceutical Co., Ltd. (上海實業聯
合集團藥業有限公司) for a consideration of RMB1,090,000;
(xxvi) a trademark license agreement dated June 29, 2010 entered into between Shanghai Zhongxi
Pharmaceutical Co., Ltd. (上海中西製藥有限公司) and Zhongxi Pharmaceutical regarding a
trademark license (Registered Number 32441111 of Class 5) by Zhongxi Pharmaceutical to
Shanghai Zhongxi Pharmaceutical Co., Ltd. (上海中西製藥有限公司);
(xxvii) a trademark license agreement dated July 1, 2010 entered into between Zhongxi
Pharmaceutical and Zhongxi Sunve regarding a trademark license (Registered Number
32441111 of Class 5) by Zhongxi Pharmaceutical to Zhongxi Sunve;
(xxviii) a real estate development agreement dated July 6, 2010 entered into by and among Zhongxi
Pharmaceutical, Shanghai Mingrun Real Estate Co., Ltd. and Shanghai Pharmaceutical (Group)
regarding a real estate development project;
(xxix) a registered capital increase agreement dated July 9, 2010 entered into between our Company
and Shanghai Pharmaceutical Distribution Co. regarding the registered capital increase of
Shanghai
Pharmaceutical
Distribution
Co.
from
RMB0908,471,109.41
to
RMB1,816,867,958.07;
(xxx) a technology transfer agreement dated July 13, 2010 entered into between Zhongxi Sunve and
Chongqing Pharmaceutical Research Institute Co. Ltd. (重慶醫藥工業研究院有限責任公司)
regarding a technology of chemical drugs;
(xxxi) a technology development contract dated July 15, 2010 entered into between Zhongxi
Pharmaceutical and Jiangsu Provincial Institute of Materia Medica Co., Ltd. (江蘇省藥物研究所
有限公司) regarding a research and development project of an injection;
– X-5 –
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
APPENDIX X
STATUTORY AND GENERAL INFORMATION
(xxxii) an incorporation agreement dated August 20, 2010 entered into by and among the Company
and Shanghai Pharmaceutical Distribution Co. regarding the incorporation of Shanghai
Pharmaceutical Distribution Co., according to which four of the branch companies of the
predecessor of the Company (namely, Xinyao Branch Company, East Yang’an Road Branch
Company, Huxi Branch Company and Hudong Branch Company) will be merged into Shanghai
Pharmaceutical Distribution Co., and the operational assets, creditor’s rights and liabilities of the
predecessor of the Company will also be transferred to Shanghai Pharmaceutical Distribution
Co.;
(xxxiii) a restructuring agreement dated November 12, 2010 entered into between Shanghai
Pharmaceutical Distribution Co. and three individuals (namely, Dong Quchen, Lin Peng and Wu
Gang) regarding the restructuring of Beijing Aixin Weiye;
(xxxiv) A Consulting Service and Research Report Agreement dated November 17, 2010 between the
Company and Guangzhou Biaodian Medical Information Co., Ltd.;
(xxxv) A Share Purchase Agreement dated November 29, 2010 entered into by and among Northern
Light Venture Capital II, Ltd., and the Company and SIIC Medical Science and Technology,
regarding the disposal of 2.63354% of the issued and outstanding share capital of CHS by
Northern Light Venture Capital II, Ltd. to the Company at a cash consideration of
RMB93,989,068.9, with SIIC Medical Science and Technology as the acquisition vehicle;
(xxxvi) an equity transfer agreement entered into by Shanghai Pharmaceutical Group, Shanghai New
Asiatic, Shanghai Huakang and the Company dated December 13, 2010, regarding the
acquisition of 96.9% equity interest in Shanghai New Asiatic and 100% equity interest in
Shanghai Huakang, with an aggregate cash consideration of approximately RMB1.49 billion;
(xxxvii) An Entrustment Agreement dated December 13, 2010 entered into by and between Shanghai
New Asiatic and Shanghai Pharmaceutical (Group) regarding the entrustment of the equity
interests in and assets of Shanghai Asia Pioneer from Shanghai Pharmaceutical (Group) to
Shanghai New Asiatic;
(xxxviii) A Share Purchase Agreement dated December 14, 2010 entered into by and among Sagamore
Bioventures LLC and the Company and SIIC Medical Science and Technology, regarding the
disposal of approximately 3% of the issued and outstanding share capital of CHS by Sagamore
Bioventures LLC to the Company at a cash consideration of RMB114,057,500, with SIIC Medical
Science and Technology as the acquisition vehicle;
Note:
Such amount of purchase consideration is based on the condition that no right of first refusal is exercised by
preferred shareholders.
(xxxix) A Share Purchase Agreement dated December 14, 2010 entered into by and among Bioveda
China Fund II, L.P., Lilly Asian Ventures, Eli Lilly and Company, New Enterprise Associates 12,
Limited Partnership, NEA Ventures 2008, Limited Partnership, and the Company and SIIC
Medical Science and Technology, regarding the disposal of 35.89% of the issued and
outstanding share capital of CHS at a cash consideration of RMB1.28088287 billion to the
Company, with SIIC Medical Science and Technology as the acquisition vehicle;
Note:
(xl)
Such amounts of purchase consideration are based on the condition that no right of first refusal is exercised.
A Share Purchase Agreement dated December 14, 2010 entered into by and among Biomedical
Sciences Investment Fund Pte. Ltd. and the Company and SIIC Medical Science and Technology,
regarding the disposal of 3.4% of the issued and outstanding share capital of CHS by
Biomedical Sciences Investment Fund Pte. Ltd. to the Company at a cash consideration of
RMB140,983,605.5, with SIIC Medical Science and Technology as the acquisition vehicle;
Note:
Such amount of purchase consideration is based on the condition that no right of first refusal is exercised by
Biomedical Sciences Investment Fund Pte. Ltd..
– X-6 –
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
APPENDIX X
STATUTORY AND GENERAL INFORMATION
(xli) A Share Purchase Agreement dated December 14, 2010 entered into and among Bioveda China,
L.P., the Company and SIIC Medical Science and Technology, regarding the disposal of 19.57%
of issued and outstanding share capital of CHS by Bioveda China, L.P. to the Company at a cash
consideration of RMB698,474,357.1, with SIIC Medical Science and Technology as the
acquisition vehicle;
Note:
Such amount of purchase consideration is based on the condition that no right of first refusal or co-sale right
(as defined in the agreement) is exercised by preferred shareholders.
(xlii) an equity transfer agreement dated December 24, 2010 entered into between 44 individuals
(collectively as the seller) and Shanghai Pharmaceutical Distribution Co. regarding the disposal
of 37.87% equity interest in Shanghai Yutiancheng Pharmaceutical Co., Ltd. (上海余天成醫藥有
限公司) by the 44 individuals to Shanghai Pharmaceutical Distribution Co. for a consideration of
RMB40,896,000;
(xliii) a registered capital increase agreement dated December 25, 2010 entered into by and among
Shanghai Songjiang Commercial Development Co., Ltd. (上海松江商業發展有限公司), Shanghai
Pharmaceutical Distribution Co. and 29 individuals regarding the registered capital increase of
RMB28,946,880 in Shanghai Yutiancheng Pharmaceutical Co., Ltd. (上海余天成醫藥有限公司);
and
(xliv) an equity transfer agreement entered into by Shanghai Pharmaceutical Distribution Co. and
eight individuals dated December 31, 2010 regarding the acquisition of 53% equity interest in
Taizhou Medicine Co., Ltd. for a cash consideration of RMB150 million;
(xlv) an Share Purchase Agreement dated February 1, 2011, entered into and among Qiming Venture
Partners II, L.P., Qiming Venture Partners II-C, L.P., Qiming Managing Directors Fund II, L.P., First
Prosper Holdings Limited, FV Investment Alpha Four Limited, the Company and SIIC Medical
Science and Technology (Group) Limited regarding the disposal of 34.76% of issued and
outstanding share capital of China Health System Ltd. with a consideration of RMB1.24053249
billion in total, with SIIC Medical Science and Technology as the acquisition vehicle; and
(xlvi) a strategic cooperation framework contract entered into by and among the Company, Shanghai
Pharmaceutical Distribution Co. and China Post Logistics Co., Ltd. dated April 20, 2011
regarding the establishment of a nationwide pharmaceutical delivery network.
– X-7 –
Patents
Registered Patents:
(i)
(a)
A ground mixture of letrozole and its
preparing method and
pharmaceutical compositions
contained therein (一種來曲唑共研磨
物及其製備方法和含其藥物組合物)
A Clofarabine and the preparing
methods of its intermediate
compounds (一種氯法拉濱及其中間體
化合物的製備方法)
Packaging box
Levalbuterol hydrochloride aerosol and
its preparing process (鹽酸左旋沙丁胺
醇氣霧劑及製備工藝)
Eye drop of tobramycin and sodium
hyaluronate and its preparing
process (妥布黴素透明質酸鈉滴眼液及
製備方法)
Oral disintegrating tablet containing
tramadol hydrochloride and
acetaminopher, and its preparing
method (含有鹽酸曲馬多和對乙醯氨基
酚的口崩片及其製備方法)
Medicinal preparation containing
lactobacillus acidophilus and
preparing method thereof (含嗜酸乳
桿菌的藥物製劑及製備方法)
1
– X-8 –
7
6
5
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Shanghai Pharmaceuticals
Holding Co., Ltd.
Shanghai Pharmaceuticals
Holding Co., Ltd.
Patent Owner
ZL00125469.3
ZL200510023352.X
ZL03115684.3
ZL02314579.X
ZL02111473.0
201010234571.3
201010230687.X
Patent Number
Invention
Invention
Invention
Design
Invention
Invention
Invention
Type
20 years
20 years
10 years
20 years
20 years
20 years
Term of
the patent
September 28, 2000 20 years
January 14, 2005
March 6, 2003
May 17, 2002
April 24, 2002
July 23, 2010
July 20, 2010
Application date
Remarks
APPENDIX X
3
4
2
Patent
No.
As of the Latest Practicable Date, the following patents were registered in the name of the relevant member of our Company:
Intellectual property rights
B.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-9 –
14
13
12
11
10
ZL200410053608.7
ZL95111600.2
Shanghai Yan’an
Pharmaceutical Laboratories
(上海延安製藥廠) (Closed and
incorporated into Sine
Pharmaceutical Laboratories)
ZL95111698.3
Shanghai Yan’an
Pharmaceutical Laboratories
(上海延安製藥廠) and
Shanghai Wuzhou
Pharmaceutical Co., Ltd.
(上海五洲葯業股份有限公司)
(Closed and incorporated
into Sine Pharmaceutical
Laboratories)
Shanghai Sine Kangjie
Pharmaceutical Co., Ltd.
ZL200530035865.3
ZL96116239.2
Sine Pharmaceutical
Shanghai Sine Kangjie
Pharmaceutical Co., Ltd.
ZL02145079.X
ZL92100660.8
Patent Number
Sine Pharmaceutical
Sine Pharmaceutical
Patent Owner
April 18, 1995
July 19, 1995
Invention
August 10, 2004
April 27, 2005
February 2, 1996
November 6, 2002
January 27, 1992
Application date
Invention
Invention
Design
Invention
Invention
Invention
Type
20 years
20 years
20 years
10 years
20 years
20 years
20 years
Term of
the patent
Remarks
APPENDIX X
Lisinopril synthesis (賴諾普利合成方法)
Cholecalciferol-cholesterol emulsion
and its preparing method (膽維丁乳
液及其製備方法）
Preparation containing Cetirizine
Hydrochloride and hydrochloric
pseudoephedrine and its preparing
method (含有鹽酸西替利嗪和鹽酸偽麻
黃堿的製劑及其製備方法)
Triazazole nucleoside aerosol and its
preparing method (三氮唑核苷氣霧劑
及其製備方法）
Packaging box (Compound
Norethisterone Tablets) (包裝盒（誼可
婷）)
Process for preparing formulation
containing infinitesimal medicine (含
極微量藥物的製劑生產工藝）
Process for preparing controlled-release
tablet of diltiazem hydrochloride (鹽
酸地爾品 控釋片的製備方法)
8
9
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-10 –
21
20
Invention
Invention
GB2338244
Invention
Invention
Invention
Invention
Invention
Type
US6368591B2
CN2,333,205
AUST760398
ZL 98 1 10623.4
ZL 93 1 12373.9
ZL03128948.7
Patent Number
January 20, 1999
May 15, 1998
May 14, 1999
May 14, 1998
January 20, 1998
March 20, 1993
May 30, 2003
Application date
20 years
20 years
20 years
20 years
20 years
20 years
20 years
Term of
the patent
Remarks
APPENDIX X
19
18
17
Instant polyvitamine fodder additive
and preparing method thereof (速溶
多維飼料添加劑及其製備方法)
Preparing method for preparing live
triple bifidobacteria (雙歧三聯活菌製
劑製備方法)
Beneficial microbe composition new
protective materials for the microbes,
method to prepare the same and
uses thereof (雙歧三聯活菌製劑及製
備方法)
Beneficial microbe composition new
Sine Pharmaceutical
protective materials for the microbes,
method to prepare the same and
uses thereof (雙歧三聯活菌製劑及製
備方法)
Beneficial microbe composition new
Sine Pharmaceutical
protective materials for the microbes,
method to prepare the same and
uses thereof (雙歧三聯活菌製劑及製
備方法)
Sine Pharmaceutical
Beneficial microbe composition new
protective materials for the microbes,
method to prepare the same and
uses thereof (雙歧三聯活菌製劑及製
備方法)
16
Shanghai Yanan Wanxiang
Pharmaceutical Co., Ltd.
(上海延安萬象葯業股份
有限公司)
Shanghai Yan’an
Pharmaceutical Laboratories
(上海延安製藥廠)
Shanghai Sine Pharmaceutical
Co., Ltd. (上海信誼藥業有限
公司)
Sine Pharmaceutical
Synthesis of benzoxazine
monohydrochlorate compound (一種
苯並惡嗪單鹽酸鹽化合物的合成方法)
15
Patent Owner
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Beneficial microbe composition new
protective materials for the microbes,
method to prepare the same and
uses thereof (雙歧三聯活菌製劑及製
備方法)
Beneficial microbe composition new
protective materials for the microbes,
method to prepare the same and
uses thereof (雙歧三聯活菌製劑及製
備方法)
Compound preparation containing
rifampicin and isoniazid and its
preparing method (一種含有利福平異
煙肼的複方製劑及其製備方法)
Method for determining impurities for
paracetamol and tramadol
hydrochloride preparation (對乙醯氨
基酚和鹽酸曲馬多製劑中雜質的測定方
法)
Compound famotidine chewing tablet
preparing method (複方法莫替丁咀嚼
片製備方法)
Decoloring method and decoloring
agent for quinolone injection ( 諾酮
類注射液的脫色方法和脫色劑)
Packaging box (Ofloxacin Eye Drops) (包
裝盒（氧氟沙星滴眼液）)
Compound non-carrier antibacterial
eye drops containing practofren and
its production (含普拉洛芬的複方非載
體抗菌眼用製劑及其製備方法)
22
– X-11 –
29
28
27
26
ZL 2008 3 0064037.6
200510111463.6
Sine Pharmaceutical
ZL 2005 1 0025535.5
ZL 2003 1 0122940.X
ZL 2006 1 0024109.4
ZL 02 1 36930.5
ZL98110623.4
SGP77351
Patent Number
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Patent Owner
Invention
Design
Invention
Invention
Invention
Invention
Invention
Invention
Type
20 years
20 years
Term of
the patent
December 14, 2005
June 11, 2008
April 29, 2005
December 31, 2003
February 23, 2006
20 years
10 years
20 years
20 years
20 years
September 10, 2002 20 years
January 20, 1998
May 14, 1999
Application date
Remarks
APPENDIX X
25
24
23
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-12 –
38
37
36
35
Trichosanthes peel injection and its
preparing method（瓜蔞皮注射液及
製備方法）
Pericarpium Trichosanthis or
Pericarpium Trichosanthis injection
liquid chromatography fingerprint
test method（瓜蔞皮或瓜蔞皮注射液
的液相色譜指紋圖譜測試方法）
Method for preparing dimefline
hydrochloride (一種鹽酸二甲弗林的製
備方法)
Therapy for primary and metastatic
cancers（原發性癌及轉移性癌相關的
核酸）
ZL200710045772.7
ZL200610118771.6
ZL03129140.6
Shanghai Sunway Biotech Co., 200480005146.X
Ltd.
Shanghai Ziyuan
Pharmaceutical Co., Ltd.
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
ZL98110844.X
ZL20052 0042122.3
ZL200510029715.0
ZL 02 3 15791.7
200610118327.4
Patent Number
Invention
Invention
Invention
Invention
Invention
Utility patent
Invention
Design
Invention
Type
10 years
20 years
Term of
the patent
20 years
20 years
20 years
10 years
January 28, 2004
20 years
September 11, 2007 20 years
November 24, 2006
June 9, 2003
May 15, 1998
June 2, 2005
September 16, 2005 20 years
July 5, 2002
November 14, 2006
Application date
Shanghai Institute of
Biochemistry of Chinese
Academy of Sciences (中
國科學院上海生物化學研
究所) is a joint patentee
Remarks
APPENDIX X
34
33
32
31
Biphenyl benzyl azoles aerosol and
Sine Pharmaceutical
preparing method thereof (聯苯唑氣
霧劑及其製備方法)
Packaging box (Peifeikang) (包裝盒（培 Shanghai Sine Pharmaceutical
菲康）)
Co., Ltd. (上海信誼藥業有限
公司)
Preparing method of tenatoprazole and Sine Pharmaceutical
its starting compound (泰妥拉唑及其
起始化合物的製備方法)
Dose controllable eyedrop bottle（一種 Shanghai Sine Kegongmao
新型控量滴眼液瓶）
Company（上海信誼科工貿公
司）
Express and purification of human
Shanghai No. 1 Biochemical
serum albumin in Pichia（人血清白蛋
白在畢赤酵母中的表達與純化）
30
Patent Owner
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-13 –
46
45
44
43
ZL 2004 3 0021525.0
ZL 2004 3 0021526.5
Design
Design
Invention
Invention
200410016000.7
200410049741.5
Invention
Invention
Invention
Invention
Type
3150897.9
2108531.5
1134314.1
1131218.1
Patent Number
20 years
20 years
20 years
Term of
the patent
March 25, 2004
March 25, 2004
June 25, 2004
January 17, 2004
10 years
10 years
20 years
20 years
September 10, 2003 20 years
March 26, 2002
October 29, 2001
September 3, 2001
Application date
Remarks
APPENDIX X
42
41
40
Recombinant adenovirus vector capable Shanghai Sunway Biotech Co.,
of being duplicated and spread
Ltd.
specifically inside tumor cell（可在腫
瘤細胞內特異性複製並擴散的重組腺病
毒載體）
Primary liver cancer cell-specific antiShanghai Sunway Biotech Co.,
adenovirus vector and using method
Ltd.
（特異性殺傷原發肝癌細胞的腺病毒載
體及使用方法）
New-type adenovirus with tumor cell
Shanghai Sunway Biotech Co.,
specific infection and transgenic
Ltd./Aiweiya Pharmaceutical/
expression capability（具有腫瘤細胞
Biotech Co., Ltd. (艾維亞醫藥
特異性感染和轉基因表達能力的新型腺
/生物技術有限公司) and
病毒）
Shanghai Sunve Bio-Tech
Co., Ltd. (上海三維生物技術
有限公司)
Adenovirus vector for idiopathy liver
Shanghai Sunway Biotech Co.,
genetherapy and using method（用
Ltd.
於原發性肝癌基因治療的腺病毒載體及
使用方法）
Shanghai Sunway Biotech Co.,
recombinant lyophilized adenovirus
Ltd.
preparation and Its preparing
method（重組腺病毒凍幹製劑及其製
備方法）
In vitro purification of selfShanghai Sunway Biotech Co.,
sanguifacient dry cell and kit（自體
Ltd.
造血幹細胞體外淨化的方法及試劑盒）
Tablet Packaging box（強力片包裝盒） Hangzhou Huqingyutang
Pharmaceutical Co.,Ltd
Tablet packaging box for gifts（強力片 Hangzhou Huqingyutang
禮品包裝盒）
Pharmaceutical Co.,Ltd
39
Patent Owner
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-14 –
56
Dental Materials Factory of
Shanghai Medical
instruments Co., Ltd. (a
subsidiary of Shanghai
Medical Instruments Co.,
Ltd.)
Method for preparing rehabilitation die Dental Materials Factory of
for oral cavity（口腔修復代型的製備
Shanghai Medical
方法）
Instruments Co., Ltd.
Dental Ni-Cr-Fe forged-alloy and its
making process （齒科用鎳—鉻—鐵
錘造合金及製造方法）
55
54
CN200410018239.8
CN00125732.3
ZL 2004 1 0025109.7
ZL 2010 3 0108023.7
ZL 2009 3 0147130.8
ZL 2006 3 0103927.4
ZL 03 1 36905.7
ZL 2004 3 0020744.7
ZL 2004 3 0020743.2
ZL 2004 3 0020742.8
Patent Number
Invention
Invention
Invention
Design
Design
Design
Invention
Design
Design
Design
Type
May 11, 2004
October 20,2000
June 11, 2004
February 11, 2010
July 23, 2009
January 24, 2006
May 25, 2003
March 9, 2004
March 9, 2004
March 9, 2004
Application date
20 years
20 years
20 years
10 years
10 years
10 years
20 years
10 years
10 years
10 years
Term of
the patent
Shanghai Industrial United
Holdings Co., Ltd. (上海
實業聯合集團藥物研究有
限公司) is the joint
patentee
Remarks
APPENDIX X
53
52
51
50
49
48
Iron dendrobium Packaging box (small) Hangzhou Huqingyutang
(鐵皮楓鬥晶包裝盒(小))
Pharmaceutical Co.,Ltd
Packaging box(middle) (包裝盒(中))
Hangzhou Huqingyutang
Pharmaceutical Co.,Ltd
Packaging box (Iron Dendrobium big)
Hangzhou Huqingyutang
(包裝盒(鐵皮楓鬥晶大))
Pharmaceutical Co.,Ltd
Antifatigue Chinese medicine
Hangzhou Huqingyutang
composition and its preparation
Pharmaceutical Co.,Ltd
process（一種抗疲勞的中藥組合物及
其製備方法）
Packaging box(1) (包裝盒 (1))
Hangzhou Huqingyutang
Pharmaceutical Co.,Ltd
Packaging box(middle) (包裝盒 (中) )
Hangzhou Huqingyutang
Pharmaceutical Co.,Ltd
Packaging bottle (包裝瓶)
Hangzhou Huqingyutang
Pharmaceutical Co.,Ltd
Content testing method of
Shanghai Industrial United
hydrochloride clonidine in Zhenju
Holdings Pharmaceutical
Antihypertensive agents (珍菊降壓製
Co., Ltd. (上海實業聯合集團
劑質量控制方法)
葯藥業有限公司)
47
Patent Owner
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Disposable anesthesia puncture box —
AS-E-type（一次性使用麻醉穿刺包裝
盒 AS-E型）
Self-locking hand-operated straight-line Medical Optical Instrument
displacement and rotating device
Factory of Shanghai Medical
(自鎖式手搖直線位移和旋轉裝置)
Instruments Co., Ltd. （上海
醫療器械股份有限公司醫用光
學儀器廠）(a subsidiary of
Shanghai Medical
Instruments Co., Ltd.)
Medical Optical Instrument
Single-hole illuminating medical
endoscope（單孔照明醫用內窺鏡）
Factory of Shanghai Medical
Instruments Co., Ltd.
Plastic shell sphygmomanometer with Medical Equipment Factory of
coaxial synchronous mercury-storage
Shanghai Medical
bottle switch（一種同軸同步儲汞瓶開
Instruments Co., Ltd. （a
關的塑殼血壓計）
subsidiary of Shanghai
Medical Instruments Co.,
Ltd.）
Transmission with balls crew pair drive Medical Equipment Factory of
（一種用滾珠絲杆付驅動的傳動裝置）
Shanghai Medical
Instruments Co., Ltd.
60
– X-15 –
64
63
Shanghai Shang Yi Kang Ge
Medical Instrument Co., ltd.
Shanghai Shang Yi Kang Ge
Medical Instrument Co., ltd.
CN03231138.9
CN02267040.8
CN200620041131.5
CN03231623.2
CN01344358.5
CN200530033624.5
CN200520039103.5
ZL03229444.1
Patent Number
Utility patent
Utility patent
Utility patent
Utility patent
Design
Design
Utility patent
Utility patent
Type
10 years
10 years
10 years
10 years
10 years
10 years
Term of
the patent
May 14, 2003
10 years
September 10, 2002 10 years
April 18, 2006
May 30, 2003
September 7, 2001
January 19, 2005
January 19, 2005
March 14, 2003
Application date
Remarks
APPENDIX X
62
61
59
Mycteric oxygen pipe with oxygen
inhaling tie-in（帶吸氧接頭的鼻氧
管）
oxygen inhaling tie-in（吸氧管接頭）
58
Dental Materials Factory of
Shanghai Medical
Instruments Co., Ltd.
Shanghai Shang Yi Kang Ge
Medical Instrument Co., ltd.
A fusible cone for measuring
temperature（一種測溫三角錐）
57
Patent Owner
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-16 –
71
70
69
68
CN02313134.9
CN02315486.1
CN03329495.X
CN02313135.7
CN200430019932.8
CN03329496.8
CN03210787.0
Patent Number
Design
Design
Design
Design
Design
Design
Utility patent
Type
Term of
the patent
March 29, 2002
June 21, 2002
April 9, 2003
March 29, 2002
February 11, 2004
April 9, 2003
10 years
10 years
10 years
10 years
10 years
10 years
September 19, 2003 10 years
Application date
Remarks
APPENDIX X
67
66
Safety device used in cylinder type
Medical Equipment Factory of
mechanical operation bed（一種用於
Shanghai Medical
汽缸式機械手術床中的安全裝置）
Instruments Co., Ltd.
Anesthesia machine MHJ-ⅢB (麻醉機
Co-held by Medical Equipment
MHJ-ⅢB 系列)
Factory of Shanghai Medical
Instruments Co., Ltd. and
Shanghai Dadi Network Co.,
Ltd. (上海大地網絡有限公司)
and Shanghai Medical
Instruments Co., Ltd.
Medical Equipment Brand
(上海醫療器械股份有限公司醫
療設備廠)
Gynecological examination bed
Medical Equipment Factory of
（FC-1）(婦科檢查床（FC-1）)
Shanghai Medical
Instruments Co., Ltd.
Anesthesia machin (MHJ-IC) (麻醉機
Medical Equipment Factory of
(MHJ-IC))
Shanghai Medical
Instruments Co., Ltd
Anesthesia machine (MHJ-IIC) (麻醉機 Co-held by Medical Equipment
(MHJ-IIC) 系列)
Factory of Shanghai Medical
Instruments Co., Ltd. and
Shanghai Dadi Network Co.,
Ltd.
Lean towards the column operation
Medical Equipment Factory of
bed (JT-3) (偏柱手術床（JT-3）)
Shanghai Medical
Instruments Co., Ltd.
Desk-top sphygmomanometer (台式血 Medical Equipment Factory of
壓計)
Shanghai Medical
Instruments Co., Ltd.
65
Patent Owner
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-17 –
80
79
78
77
ZL03331850.6
ZL02345605.1
ZL02313872.6
ZL01310794.1
CN200630040557.4
Design
Design
Design
Design
Design
Design
Utility patent
CN200720067808.7
CN02315487.X
Utility patent
Utility patent
Type
CN200620045881.X
CN200620045880.5
Patent Number
Term of
the patent
10 years
10 years
June 20, 2003
August 2, 2002
April 19, 2002
February 28, 2001
10 years
10 years
10 years
10 years
September 15, 2006 10 years
June 21, 2002
March 13, 2007
September 15, 2006 10 years
September 15, 2006 10 years
Application date
Remarks
APPENDIX X
76
75
74
73
Operation tabe angle amplifying
mechanism（手術台角度放大機構）
72
Patent Owner
Medical Equipment Factory of
Shanghai Medical
Instruments Co., Ltd.
Internal-hole-biased
Medical Equipment Factory of
sphygmomanometer transparent
Shanghai Medical
reading tube（內孔偏置血壓計透明示
Instruments Co., Ltd.
值管）
Automatically preventing longitudinal Medical Equipment Factory of
from gliding device after operating
Shanghai Medical
table face inclining（一種手術台檯面
Instruments Co., Ltd.
傾斜後自動阻止縱向下滑裝置）
Obstetric table （CC-1 type）(產床
Medical Equipment Factory of
（CC-1型）)
Shanghai Medical
Instruments Co., Ltd.
Shadowless operation lamp holder (FD) Medical Equipment Factory of
(手術無影燈燈頭 (FD))
Shanghai Medical
Instruments Co., Ltd.
Sphygmomanometer (XJ21 — vertical) ( Medical Equipment Factory of
血壓計（XJ21-立式）)
Shanghai Medical
Instruments Co., Ltd.
Love babies’ obstetric table
Medical Equipment Factory of
（CC-1type）(愛嬰產床（CC-1型）)
Shanghai Medical
Instruments Co., Ltd.
Conjuncted Sphygmomanometer（連體 Medical Equipment Factory of
血壓表）
Shanghai Medical
Instruments Co., Ltd.
Breathing machine (SC-300D) (呼吸機 Medical Equipment Factory of
(SC-300D))
Shanghai Medical
Instruments Co., Ltd.
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-18 –
86
85
84
ZL03116640.7
ZL02288303.7
ZL200520042810.X
ZL200430083378.X
ZL200430083377.5
ZL03329585.9
Patent Number
Invention
Utility patent
Utility patent
Design
Design
Design
Type
April 25, 2003
December 12, 2002
June 23, 2005
October 22, 2004
October 22, 2004
April 11, 2003
Application date
10 years
10 years
10 years
10 years
10 years
10 years
Term of
the patent
Remarks
APPENDIX X
83
82
Shadowless operation lamp (hole type
series) 手術無影燈（孔式系列）
81
Patent Owner
5th Medical Instruments
Factory of Shanghai Medical
Instruments Co., Ltd.（上海
醫療器械股份有限公司醫療器
械五廠）(a subsidiary of
Shanghai Medical
Instruments Co., Ltd.)
Slim leading light of slice (single)薄型導 5th Medical Instruments
光觀片燈（單聯）
Factory of Shanghai Medical
Instruments Co., Ltd.（上海
醫療器械股份有限公司醫療器
械五廠）
Optical film viewer (Triple) (導光觀片燈 No. 5 Medical Instruments
（三聯）)
Factory of Shanghai Medical
Instruments Co., Ltd. (上海醫
療器械股份有限公司醫療器械
五廠)
Fixture for wall shadowless lamp (一種 No. 5 Medical Instruments
壁式無影燈的固定裝置)
Factory of Shanghai Medical
Instruments Co., Ltd.
Controlling device for equipment of
Dental Instrument Factory of
dental treatment (一種用於牙科治療
Shanghai Medical
設備中的控制裝置)
Instruments Co., Ltd. (a
branch of Shanghai Medical
Instruments Co., Ltd.)
Pneumatic combination valve in use for Dental Instrument Factory of
interlocked controlling hand held
Shanghai Medical
appliances in device of dental
Instruments Co., Ltd.
treatment (一種用於牙科治療設備上聯
動控制手持器械的氣動組合閥)
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Automatic water draining pressure
reducing concentrator (自動排水減壓
濃縮器)
Automatic water draining pressure
reducing concentrator (自動排水減壓
濃縮器)
Packaging box (Hard cover
Qingchunbao) (包裝盒（精裝青春寶）)
Packaging box (Soft cover Qingchunbao)
(包裝盒（簡裝青春寶）)
Packaging box (Hard cover beauty
capsule) (包裝盒（精美容膠囊）)
Yongzheng tablet — Packaging box
(永真片-包裝盒)
Soft cover beauty capsule — Packaging
box (簡美容膠囊-包裝盒)
Hard cover American ginseng capsule
— Packaging box (精裝西洋參膠囊-包
裝盒)
Packaging box (Hard cover Yongzheng
tablet) (包裝盒（精裝永真片）)
Soft cover American ginseng capsule
— Packaging box (簡裝西洋參膠囊-包
裝盒)
Packaging box (Genseng royal jelly
capsule — soft cover) (包裝盒（人參
蜂王漿膠囊簡裝）)
Packaging box (Genseng royal jelly
capsule — gift cover) (包裝盒（人參
蜂王漿膠囊禮盒裝）)
87
– X-19 –
98
97
96
95
94
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Patent Owner
ZL200430023157.3
ZL200430023156.9
ZL03365996.6
ZL03365998.2
ZL03365997.4
ZL03308424.6
ZL03340153.5
ZL03308422.X
ZL03308439.4
ZL03308440.8
ZL03210281.X
ZL03150679.8
Patent Number
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Utility patent
Invention
Type
10 years
10 years
10 years
10 years
10 years
10 years
20 years
Term of
the patent
June 4, 2004
June 9, 2004
10 years
10 years
September 16, 2003 10 years
September 16, 2003 10 years
September 16, 2003 10 years
April 11, 2003
August 11, 2003
April 11, 2003
April 14, 2003
April 14, 2003
August 25, 2003
August 25, 2003
Application date
Remarks
APPENDIX X
93
92
91
90
89
88
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Packaging box (Antler ginseng kidney
nourishing capsule) (包裝盒（茸參補
腎膠囊）)
Packaging box (Yizhikang capsule) (包
裝盒（益之康膠囊）)
Packaging box (Lining for pearl
isoflavone capsule (4 bottles)) (包裝
盒（珍珠異黃酮膠囊4瓶裝內襯）)
Packaging box (Pearl isoflavone capsule
(2 bottles)) (包裝盒（珍珠異黃酮膠囊
2瓶裝）)
Packaging box (Pearl isoflavone capsule
(4 bottles)) (包裝盒（珍珠異黃酮膠囊
4瓶裝）)
Packaging box (Flunarizine
hydrochloride capsule) (包裝盒（鹽酸
氟桂利嗪膠囊）)
Packaging box (Nimoldipine tablets) (包
裝盒（尼莫地平片）)
Packaging box (Clary injection) (包裝盒
（香丹注射液）)
Packaging box (Astragalus injection)
(包裝盒（黃芪注射液）)
Packaging box (Shengmai injection
10ml) (包裝盒（參麥注射液10ml）)
Packaging box (Sugar-free Qingreling
granule) (包裝盒（無蔗糖清熱靈顆
粒）)
Packaging box (Sugar-free Niaoganning
granule) (包裝盒（無蔗糖尿感寧顆
粒）)
99
– X-20 –
110
109
108
107
106
105
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Patent Owner
200730326077.9
200730326068.X
200730326075.X
200730326074.5
200730326079.8
200730326080.0
200730326065.6
ZL200530107713.X
ZL200530107714.4
ZL200530107715.9
ZL200530103792.7
ZL200430071782.5
Patent Number
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Type
10 years
10 years
10 years
10 years
10 years
Term of
the patent
September 30, 2007 10 years
September 30, 2007 10 years
September 30, 2007 10 years
September 30, 2007 10 years
September 30, 2007 10 years
September 30, 2007 10 years
September 30, 2007 10 years
September 2, 2005
September 2, 2005
September 2, 2005
January 26, 2005
August 14, 2004
Application date
Remarks
APPENDIX X
104
103
102
101
100
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Packaging box (Red sage root injection)
(包裝盒（丹參注射液）)
Packaging box (Sugar-free Yangwei
Granular) (包裝盒（無糖型養胃顆粒）)
Packaging box (Shengmai injection
50ml) (包裝盒（參麥注射液50ml）)
Packaging box (Shengmai capsule) (包
裝盒（生脈膠囊）)
Packaging box (Jinpingfeng capsule)
(包裝盒（金屏風膠囊）)
Packaging box (Shenkangning tablet)
(包裝盒（腎康寧片）)
Packaging box (Lomefloxacin
Hydrochloride capsule) (包裝盒（鹽酸
洛美沙星膠囊）)
Packaging box (Ganoderma capsule)
(包裝盒（靈芝膠囊）)
Packaging box (Motherwort particle)
(包裝盒（益母草顆粒）)
Codonopsis Low sugar Shengmaiyin —
Packaging box (黨參方低糖生脈飲-包
裝盒)
Sugar-free Yangwei Granular —
packaging box (無糖型養胃顆粒-包裝
盒)
Packaging box (Ning Xin Bao Capsule)
(包裝盒（寧心寶膠囊）)
Preparing method of red sage root
total phenolic acid (一種丹酚總酚酸的
製備方法)
111
– X-21 –
123
122
121
120
119
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Patent Owner
200510061128.X
200730326069.4
200730236063.7
200730326064.1
200730326072.6
200730326070.7
200730326066.0
200730326078.3
200830097963.3
200730326067.5
200730326073.0
200730326071.1
200730326076.4
Patent Number
Invention
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Type
Term of
the patent
10 years
October 12, 2005
20 years
September 30, 2007 10 years
September 30, 2007 10 years
September 30, 2007 10 years
September 30, 2007 10 years
September 30, 2007 10 years
September 30, 2007 10 years
September 30, 2007 10 years
May 4, 2008
September 30, 2007 10 years
September 30, 2007 10 years
September 30, 2007 10 years
September 30, 2007 10 years
Application date
Remarks
APPENDIX X
118
117
116
115
114
113
112
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Preparation for chemical composition
of Shenmai injection and application
in treating cardiovascular and
cerebrovascular diseases thereof (參
麥注射液的化學成分的製備及其在治療
心腦血管疾病中的應用)
Tumbling-box type medicine-washing
machine (滾筒式洗藥機)
Sugar-free Yangwei Granular —
packaging bag (無糖型養胃顆粒-包裝
袋)
Label for can (Herb tea) (易拉罐瓶貼
（涼茶）)
Red sage root salvianolic acid A
injection formulation for treating
cardiovascular diseases and
preparation process thereof (一種治
療心血管疾病的丹參丹酚酸A注射製劑
及其製備方法)
Use of pulse beat restoring capsule
fingerprint pattern detect technology
(一種生脈膠囊指紋圖譜檢測技術及其
應用)
Preparing method of salvia miltiorrhiza
tanshinoate A (丹參丹酚酸A的製備方
法)
Extraction of effective parts for
Danshen root and rhizoma
chuanxiong (丹參和川芎中藥有效部位
的提取方法)
124
– X-22 –
131
130
129
2006 1 0165779.8
2005 1 0049292.9
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
2007 1 0069903.5
2006 1 0170267.0
2009 3 0135563.1
200730326063.7
200820163049.9
200710187422.4
Patent Number
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Patent Owner
Invention
Invention
Invention
Invention
Design
Design
Utility patent
Invention
Type
10 years
20 years
Term of
the patent
January 31, 2005
December 18, 2006
July 10, 2007
December 26, 2006
April 3, 2009
20 years
20 years
20 years
20 years
10 years
September 30, 2007 10 years
August 21, 2008
November 23, 2007
Application date
Remarks
APPENDIX X
128
127
126
125
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-23 –
142
141
140
139
200410035646.X
200410035647.4
200410035650.6
200510071045.9
ZL03308424.6
ZL03365997.4
ZL 033401535.5
ZL 033659966.6
2008 2 0170019.0
2008 2 0170018.6
2007 3 0326064.1
Patent Number
Invention
Invention
Invention
Invention
Design
Design
Design
Design
Utility patent
Utility patent
Design
Type
Term of
the patent
10 years
10 years
10 years
September 6, 2004
September 6, 2004
September 6, 2004
May 23, 2005
April 11, 2003
20 years
20 years
20 years
20 years
10 years
September 16, 2003 10 years
August 11, 2003
September 16, 2003 10 years
December 12, 2008
December 12, 2008
September 30, 2007 10 years
Application date
Remarks
APPENDIX X
138
137
136
135
134
133
Packaging box (Codonopsis Low sugar Chiatai Qingchunbao
Shengmaiyin) (包裝盒（黨參方低糖生
Pharmaceutical Co., Ltd.
脈飲）)
One-step palletizing device (一種一步制 Chiatai Qingchunbao
粒裝置)
Pharmaceutical Co., Ltd.
Liquid distributing device (一種配液裝置) Chiatai Qingchunbao
Pharmaceutical Co., Ltd.
Packaging box (Soft cover American
Chiatai Qingchunbao
ginseng capsule) (包裝盒（簡裝西洋
Pharmaceutical Co., Ltd.
參膠囊）)
Packaging box (Yongzheng tablet) (包 Chiatai Qingchunbao
裝盒（永真片）)
Pharmaceutical Co., Ltd.
Packaging box (Hard cover American
Chiatai Qingchunbao
ginseng capsule)包裝盒（精裝西洋參
Pharmaceutical Co., Ltd.
膠囊）
Packaging box (Soft cover beauty
Chiatai Qingchunbao
capsule)包裝盒（簡美容膠囊）
Pharmaceutical Co., Ltd.
Raffinoses oligosaccharide with
Qingdao Growful
stachyose as main materials and
Pharmaceutical Co., Ltd
method for preparing same (以水蘇糖
為主的棉籽糖族低聚糖極其生產方法)
Oral Chinese medicinal composition for Qingdao Growful
treating hypertension (一種治療高血
Pharmaceutical Co., Ltd
壓的口服中藥組合物)
Oral Chinese medicinal composition for Qingdao Growful
treating virus myocarditis (一種治療病 Pharmaceutical Co., Ltd
毒性心肌炎的口服中藥組合物)
Oral Chinese medicinal composition for Qingdao Growful
treating apoplexia (一種治療中風病的
Pharmaceutical Co., Ltd
口服中藥組合物)
132
Patent Owner
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Pharmaceutical composition for
treating gastritis, gastric ulcer and
doudenal ulcer (一種治療胃炎胃潰瘍
及十二指腸潰瘍的藥物組合物)
Medicinal composition, preparation
and quality control thereof (一種藥物
組合物極其製備方法和質量控制方法)
Kidney replenishing medicinal
composition and its preparation
process and novel use (一種補腎的藥
物組合物及其製備方法和新用途)
Oral Chinese medicinal preparation for
treating vascular dementia (一種治療
血管性癡呆的中藥口服製劑)
Oral Chinese medicinal preparation for
treating acute pharyngolaryngitis (一
種治療急性咽炎的中藥口服製劑)
Synthetic method of 4-acetoxy-2ethoxy ethyl benzoate (4-羧甲基 -2乙氧基苯甲酸乙酯的合成方法)
Purification method of 6,10,14trimethyl-5E, 9E, 13pentadecatricene-2-ketone (6.10.14三甲基 -5E.9E.13-十五碳三烯 -2-酮的
純化方法)
143
– X-24 –
149
148
ZL200410016160.1
ZL02145191.5
Shanghai Sunve
Pharmaceutical Co., Ltd.
Shanghai Sunve
Pharmaceutical Co., Ltd.
200410035648.9
200410035649.3
200510075261.0
200510079757.5
200510089001.9
Patent Number
Qingdao Growful
Pharmaceutical Co., Ltd
Qingdao Growful
Pharmaceutical Co., Ltd
Qingdao Growful
Pharmaceutical Co., Ltd
Qingdao Growful
Pharmaceutical Co., Ltd
Qingdao Growful
Pharmaceutical Co., Ltd
Patent Owner
Invention
Invention
Invention
Invention
Invention
Invention
Invention
Type
February 6, 2004
November 12, 2002
September 6, 2004
September 6, 2004
June 9, 2005
June 28, 2005
August 2, 2005
Application date
20 years
20 years
20 years
20 years
20 years
20 years
20 years
Term of
the patent
Will apply for registration
for the change of patent
owner
Will apply for registration
for the change of patent
owner
Remarks
APPENDIX X
147
146
145
144
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-25 –
Preparing method of Ethyl methyl
3-[(1s)-1-(dimethylamino) ethyl]
phenyl carbamate (乙基甲基氨甲酸
3-[(1S)-1-(二甲氨基)乙基]苯酯鹽的製
備方法)
Method for preparing high-purity
cefpoxime proxetil (製備高純度頭孢泊
肟酯的方法)
A Chinese medicine preparation of anti
herpes virus and the preparing
method (一種抗皰疹病毒的中藥製劑及
製備方法)
Longhu Rendan 100 Granules Package
(龍虎人丹100粒包裝)
154
157
156
155
Packaging box (Cefpodoxime Proxetil)
(包裝盒(維潔信))
ZL200920208426.0
ZL02157664.5
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
ZL200410015693.8
ZL03141995.X
Shanghai Sunve
Pharmaceutical Co., Ltd.
Shanghai Sunve
Pharmaceutical Co., Ltd.
ZL03343990.7
Shanghai Sunve
Pharmaceutical Co., Ltd.
ZL200530033302.0
ZL03129670.X
ZL95111510.3
Patent Number
Utility patent
Invention
Invention
Invention
Design
Design
Invention
Invention
Type
August 25, 2009
December 23, 2002
January 8, 2004
July 31, 2003
July 31, 2003
January 5, 2005
July 1, 2003
January 11, 1995
Application date
10 years
20 years
20 years
20 years
10 years
10 years
20 years
20 years
Term of
the patent
Will apply for registration
for the change of patent
owner
Shanghai TCM
Pharmaceutical
Technology Co., Ltd. is a
joint patentee
Will apply for registration
for the change of patent
owner
Will apply for registration
for the change of patent
owner
Will apply for registration
for the change of patent
owner
Will apply for registration
for the change of patent
owner
Will apply for registration
for the change of patent
owner
Remarks
APPENDIX X
153
Shanghai Sunve
Pharmaceutical Co., Ltd.
Packaging box (Rosiglitazone
Hydrochloride) (包裝盒（維戈洛）)
152
151
Shanghai Sunve
Preparing method of 1-【2-(2,4difluorophenyl)2,3-epoxypropyl】-1H- Pharmaceutical Co., Ltd.
1,2,4-triazole as intermediate of
fluconazole and its methyl
sulphonate (氟康唑中間體1-【2（2,4-二氟苯基） 2,3-環氧丙基】
-1H-1,2,4-三氟唑及其甲磺酸鹽的製備
方法)
Purification process of Sulfasalazine (柳 Shanghai Sunve
氮磺吡啶純化工藝)
Pharmaceutical Co., Ltd.
150
Patent Owner
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-26 –
166
165
164
Invention
Invention
Invention
00125406.5
00125405.7
Invention
Invention
Invention
Invention
Utility patent
Utility patent
Type
003128415.9
00115425.7
00115423.0
99124228.9
97102049.3
ZL200920208414.8
ZL200920208422.2
Patent Number
20 years
20 years
20 years
20 years
20 years
10 years
10 years
Term of
the patent
September 26, 2000 20 years
September 26, 2000 20 years
April 21, 2000
April 21, 2000
April 21, 2000
December 9, 1999
January 13, 1997
August 25, 2009
August 25, 2009
Application date
Remarks
APPENDIX X
163
162
161
160
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Patent Owner
Shanghai TCM Pharmaceutical
No. 3 Laboratories (上海中藥
製藥三廠)
Shanghai Traditional Chinese
Medicine Research Institute
(a branch of Shanghai
Medical Material Co.)
Medicine containing active components Shanghai Traditional Chinese
of Rhodiola crennulata root and
Medicine Research Institute
preparing method thereof (大花紅景
(a branch of Shanghai
天有效成分製劑及製備方法)
Medical Material Co.)
Medicine containing active components Shanghai Traditional Chinese
of Panax japonicum root and
Medicine Research Institute
preparing method thereof (珠子參有
效成分製劑及製備方法)
Medicine containing active components Shanghai Traditional Chinese
of Rhodiola crennulata root and
Medicine Research Institute
preparing process thereof (branch)
(大花紅景天有效成分製劑及製備方法
(分案）)
Shanghai Traditional Chinese
Method of extracting and separating
Medicine Research Institute
anthraquinone chemical compound
from Botanicals (一種從植物藥中提、
分離蒽醌類化合物的方法)
Shanghai Traditional Chinese
Concrete of extracting Free
Medicine Research Institute
Anthraquinone from rhubarb and
the preparing method (一種從大黃中
提取游離蒽醌的浸膏及製備方法)
Longhu Rendan 60 Granules Package
(龍虎人丹60粒包裝)
Dip-plug Vaseline Dissolution Device
(浸插式凡士林溶解裝置)
Process for preparing cold defervescent
powder by using flocculating method
(感冒退熱沖劑的絮凝法製備工藝)
Method for preparing ginkgo injection
(一種銀杏注射液的製備方法)
158
159
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Jisongrong-contained Chinese medicine
compound preparation and the
preparing method (一種含姬松茸的中
藥複方製劑及製備方法)
Preparing method of Maodongqing
extract (治療勃起功能障碍的毛冬青提
取物制劑及其制備方法)
Chinese medicine health tonic for
raising antisenility capacity and
improving memory (一種具有提高抗
衰老能力改善記憶的中藥保健品)
Medicine composition with spot
dispelling function and preparing
method thereof (一種具有祛斑作用的
藥物組合物及製備方法)
Chinese medicine composition for
lowering blood fat and reducing
weight and preparing method
thereof (一種具有降脂減肥作用的中藥
組合物及製備方法)
Quality control method for rare
chrysanthemum antihypertension
tablet (一種珍菊降壓片質量控制方法)
Hypericum perforatum extract and the
preparing method (貫葉連翹提取物及
製備方法)
Triptolide purification method (一種雷
公藤內脂醇純化方法)
167
– X-27 –
174
173
172
Shanghai Traditional Chinese
Medicine Research Institute
Shanghai Traditional Chinese
Medicine Research Institute
Shanghai Traditional Chinese
Medicine Research Institute
Shanghai Traditional Chinese
Medicine Research Institute
Shanghai Traditional Chinese
Medicine Research Institute
Shanghai Traditional Chinese
Medicine Research Institute
Shanghai Traditional Chinese
Medicine Research Institute
Shanghai Traditional Chinese
Medicine Research Institute
Patent Owner
200510026668.4
200410017828.4
200410016223.3
200310108461.2
200310108460.8
200310108036.3
00127593.3
00125765.X
Patent Number
Invention
Invention
Invention
Invention
Invention
Invention
Invention
Invention
Type
June 10, 2005
April 21, 2004
February 11, 2004
November 6, 2003
November 6, 2003
October 17, 2003
November 28, 2000
October 25, 2000
Application date
20 years
20 years
20 years
20 years
20 years
20 years
20 years
20 years
Term of
the patent
Shanghai Leiyunshang
Technology Development
Co., Ltd. (上海雷允上科技
發展有限公司) is a joint
patentee
Remarks
APPENDIX X
171
170
169
168
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Extract of ginkgo biloba leaves and
dipyridamole composite and
preparing method and application
thereof (銀杏酮酯與雙嘧達莫的組合物
及製備方法和應用)
Chinese medicine preparation for
treating respiratory tract infection
and virus flu, preparing method
thereof (一種治療呼吸道感染和病毒性
感冒的中藥製劑及製備方法)
Method for measuring ginkgo acid
content in compositions extracted
from Ginkgo biloba leaves (檢測銀杏
葉組合物中銀杏酸的方法)
Method for measuring tepene lactone
content in compositions extracted
from Ginkgo biloba leaves (檢測銀杏
葉組合物中萜內酯含量的方法)
Method for measuring total flavone
content in compositions extracted
from gingko biloba leaves (檢測銀杏
葉組合物中總黃酮含量的方法)
Healthcare products with blood-sugar
decreasing function, and preparing
method thereof (一種具有降血糖功能
的保健品及製備方法)
Healthcare products with anti-fatigue
and anti-oxidation function and
preparing method thereof (一種具有
抗疲勞和抗氧化功能的保健品及製備方
法)
175
– X-28 –
181
180
179
200410053001.9
200410053000.4
Shanghai Xingling
Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling
Pharmaceutical Technology
Co., Ltd.
200510105218.4
200510105217.x
200310118517.2
200310122718.X
200910056648.X
Patent Number
Shanghai Xingling
Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling
Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling
Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling
Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling
Pharmaceutical Technology
Co., Ltd.
Patent Owner
Invention
Invention
Invention
Invention
Invention
Invention
Invention
Type
July 20, 2004
July 20, 2004
March 19, 1999
March 19, 1999
March 19, 1999
December 19, 2003
August 19, 2009
Application date
20 years
20 years
20 years
20 years
20 years
20 years
20 years
Term of
the patent
Remarks
APPENDIX X
178
177
176
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Healthcare products with functions of
relaxing the bowels and beautifying,
and preparing method thereof (一種具
有通便美容功能的保健品及製備方法)
Use of ginkgo biloba extract in
cholesterol reduction (銀杏葉提取物
在降低膽固醇方面的用途)
Use of ginkgoic acid in preparation of
biological pesticide for killing
Oncomelania snail and preventing
schistosomiasis (銀杏酸在製備殺滅釘
螺、防治血吸蟲病的生物農藥中的
用途)
Ginkgo biloba composition and its
preparation method and application
(銀杏葉組合物及製備方法與應用)
Packaging Box (Babaodan Capsules) (包
裝盒（八寶丹膠囊）)
Packaging Box (Fushou Capsules) (包裝
盒（福壽膠囊）)
Packaging Box (Tongmai lipid-lowering
Capsules) (包裝盒（通脈降脂膠囊）)
Packaging Box (Qigu Capsules) (包裝盒
（芪骨膠囊）)
Method for detecting animalcule in
chinese medicinal materials with
AOTF near-infrared spectrometer (一
種利用AOTF近紅外光譜儀檢測中藥中
微生物的方法)
Heating encapsulation mechanism of
packaging machine (封裝機的加熱封
裝機構)
182
– X-29 –
191
190
189
188
187
186
Xiamen Traditional Chinese
Medicine Co., Ltd.
Shanghai Xingling
Pharmaceutical Technology
Co., Ltd.
Xiamen Traditional Chinese
Medicine Co., Ltd.
Xiamen Traditional Chinese
Medicine Co., Ltd.
Xiamen Traditional Chinese
Medicine Co., Ltd.
Xiamen Traditional Chinese
Medicine Co., Ltd.
Xiamen Traditional Chinese
Medicine Co., Ltd.
Shanghai Xingling
Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling
Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling
Pharmaceutical Technology
Co., Ltd.
Patent Owner
Utility patent
Invention
ZL 2007 1 0017123.6
ZL 2008 2 0103169.X
Design
Design
Design
Design
Invention
Invention
Invention
Invention
Type
ZL 2009 3 0322329.X
ZL200530135902.8
ZL200630090695.3
ZL200530091140.6
99803683.8
200610024040.5
200510030719.0
200410053002.3
Patent Number
July 23, 2008
September 4, 2007
October 29, 2009
December 1, 2005
February 16, 2006
February 5, 2005
March 19, 1999
February 21, 2006
October 26, 2005
July 20, 2004
Application date
10 years
20 years
10 years
10 years
10 years
10 years
20 years
patentee
20 years
20 years
20 years
Term of
the patent
Jinan Jinhongli Industrial
Co., Ltd. (濟南金宏利實業
有限公司) is a joint
patentee
Shanghai Biochip Co., Ltd.
(上海生物芯片有限公司)
as a joint patentee
Fudan University is a joint
patentee
Remarks
APPENDIX X
185
184
183
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-30 –
198
197
Invention
Invention
ZL 02 1 33148.0
ZL200310105219.x
Invention
Invention
Invention
Invention
Invention
Type
200510126433.2
ZL 2006 1 0046816.3
ZL 2006 1 0045983.6
ZL2005 1 0136745.1
ZL 2005 1 0136744.7
Patent Number
November 28, 2003
October 10, 2002
December 9, 2005
June 5, 2006
March 7, 2006
December 29, 2005
December 29, 2005
Application date
20 years
20 years
20 years
20 years
20 years
20 years
20 years
Term of
the patent
Remarks
APPENDIX X
196
195
194
193
Mammary aggregation elimination
Liaoning Herbapex
capsule and its preparing method (乳
Pharmaceutical (Group) Co.,
癖消軟膠囊及其製備方法)
Ltd.
Bee snake capsule and its preparing
Liaoning Herbapex
method (蜂蛇膠囊及其製備方法)
Pharmaceutical (Group) Co.,
Ltd.
Chinese patent medicine for treating
Liaoning Herbapex
astenia wind-heat syndrome and
Pharmaceutical (Group) Co.,
preparing method (一種治療腎炎風熱
Ltd.
證的中成藥及製備方法)
Chinese medicine for treating
Liaoning Herbapex
osteoporosis and its preparing
Pharmaceutical (Group) Co.,
method (一種治療骨質疏鬆症的中藥及 Ltd.
製備方法)
Traditional Chinese medicine
Liaoning Herbapex
composition for treating arthritis and
Pharmaceutical (Group) Co.,
preparing method thereof (一種治療
Ltd.
關節炎的中藥組合物和其製備方法)
Liaoning Herbapex
Chinese patent medicine for treating
hypotension and preparing method
Pharmaceutical (Group) Co.,
thereof (一種治療低血壓的中成藥及其
Ltd.
製備方法)
Medicine for treating hysteromyoma
Liaoning Huanren
(一種治療子宮肌瘤的藥物)
Pharmaceutical Co., Ltd. (遼
寧桓仁藥業有限公司) (the
predecessor of Liaoning
Herbapex Pharmaceutical
(Group) Co., Ltd.)
192
Patent Owner
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-31 –
205
204
203
02136088.X
00127910.6
00125898.2
00125897.4
00115424.9
99113718.3
ZL200710012332.1
Patent Number
Invention
Invention
Invention
Invention
Invention
Invention
Invention
Type
July 18, 2002
December 14, 2000
October 31, 2000
October 31, 2000
April 21, 2000
May 18, 1999
July 31, 2007
Application date
20 years
20 years
20 years
20 years
20 years
20 years
20 years
Term of
the patent
Remarks
APPENDIX X
202
201
200
Chinese traditional medicine having
Liaoning Herbapex
functions of promoting blood
Pharmaceutical (Group) Co.,
circulation, relaxing vein and
Ltd.
strengthening muscles and bones
and method for preparing the same
(一種具有活血通絡強筋壯骨的中藥及
其製備方法)
Method for preparing Chinese
Shanghai Medicine Co., Ltd.
medicinal pills containing borneol (一 No.1 Chinese Medicine Plant
種含有冰片的中藥丸劑的製備方法)
(上海市葯材有限公司中葯制葯
一廠)
Method for preparing Chinese
Shanghai Medicine Co., Ltd.
medicinal pills containing borneol (一 No.1 Chinese Medicine Plant
種含有冰片的中藥丸劑的製備方法)
(上海市葯材有限公司中葯制葯
一廠)
Compound ultra-fine pearl powder
Shanghai Medicine Co., Ltd.
cosmetics and the preparing method
No.1 Chinese Medicine Plant
(一種複方超細珍珠粉化妝品及製備方
(上海市葯材有限公司中葯制葯
法)
一廠)
Compound ultra-fine pearl powder soft Shanghai Medicine Co., Ltd.
capsule and the preparing method
No.1 Chinese Medicine Plant
(一種複方超細珍珠粉軟膠囊及製備方
(上海市葯材有限公司中葯制葯
法)
一廠)
Preparing method of Xianjia Granules Shanghai Medicine Co., Ltd.
No.1 Chinese Medicine Plant
for treating Hyperprolactinemia (一種
治療高泌乳素血症的仙甲顆粒的製備方
(上海市葯材有限公司中葯制葯
法)
一廠)
Compound Chinese medicine
Leiyunshang Pharmaceutical
preparation for treating prostate
hyperplasia and its preparing process
(一種治療良性前列腺增生症的複方中
藥製劑及製備工藝)
199
Patent Owner
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-32 –
212
211
210
Invention
Invention
200510027453.4
200510027556.0
Invention
Invention
Invention
Invention
Invention
Type
200410089326.2
200410089330.9
200410053860.8
200410053322.9
200410016240.7
Patent Number
July 6, 2005
July 1, 2005
December 9, 2004
December 9, 2004
August 19, 2004
July 30, 2004
February 11 ,2004
Application date
20 years
20 years
20 years
20 years
20 years
20 years
20 years
Term of
the patent
Fudan University is a joint
patentee
Remarks
APPENDIX X
209
208
207
Molecular mark of wild mountain
Shanghai Leiyunshang
ginseng and discrimination method
Pharmaceutical Co., Ltd
therefore (野山人參的分子標記及鑒別
Shen Xiang Ginseng and
方法)
Pilose-Antler Branch (上海雷
允上藥業有限公司神象參茸分
公司)
Method for pressing condensed pills of Leiyunshang Pharmaceutical
Chinese traditional medicine (中藥濃
縮丸的壓制方法)
Compound Chinese medicinal
Leiyunshang Pharmaceutical
formulation for treating chronic
atrophic gastritis and its preparing
method (一種用於治療慢性萎縮性胃炎
的中藥複方製劑及製備方法)
Method for detecting kidney tonifying Leiyunshang Pharmaceutical
mind easing extractive quality
standard (益腎安神膏質量標準檢測方
法)
Method for detecting blood enriching Leiyunshang Pharmaceutical
extractive quality standard (參龍養血
膏質量標準檢測方法)
Mint oil adding method in production Leiyunshang Pharmaceutical
of Chinese medicine ‘pinellia dew
Tablets’ (中藥半夏露片生產中的薄荷油
添加方法)
Coating method for Chinese medicine Leiyunshang Pharmaceutical
Zuogui Granules (中藥左歸顆粒包衣方
法)
206
Patent Owner
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-33 –
219
218
217
216
03329002.4
03326344.2
200510030092.9
200710042421.0
200710046601.6
200710036926.6
200610028741.6
Patent Number
Design
Design
Invention
Invention
Invention
Invention
Invention
Type
20 years
20 years
Term of
the patent
20 years
March 21, 2003
January 17, 2003
10 years
10 years
September 28, 2005 20 years
June 22, 2007
September 28, 2007 20 years
January 29, 2007
July 7, 2006
Application date
Remarks
APPENDIX X
215
214
Blood pressure lowering sustainedShanghai Leiyunshang
release preparation with
Technology Development
chrysanthemum flower and pearl (珍
Co., Ltd. (上海雷允上科技發
菊降壓緩釋製劑)
展有限公司), Shanghai
Traditional Chinese Medicine
Research Institute
Characteristic DNA sequence for
Shanghai Leiyunshang
dendrobium officinale test-tube
Technology Development
plantlet and application thereof
Co., Ltd.(上海雷允上科技發展
(鐵皮石斛試管苗的特徵 DNA序列及其
有限公司), Shanghai
應用)
Traditional Chinese Medicine
Research Institute
Traditional Chinese medicine valid
Shanghai Leiyunshang
target composition of preventing
Technology Development
and treating diabetes as well as
Co., Ltd.(上海雷允上科技發展
preparation and application (預防及
有限公司), Shanghai
治療糖尿病的中藥有效部位組合物及其
Traditional Chinese Medicine
製備和應用)
Research Institute
Use of ball containing moschus, bear
Leiyunshang Pharmaceutical
gall and antelope horn in preparing
medicament for treating
coronaryheart disease (麝香熊羚丸在
製備治療冠心病藥物中的應用)
American ginseng effervescence Tablets Leiyunshang Pharmaceutical
and its preparing method (西洋參泡
騰片及其製備方法)
Packaging box (Longkai Granules (包裝 Leiyunshang Pharmaceutical
盒(癃開顆粒))
Packaging box (Shanghai Gen-seng Oral Leiyunshang Pharmaceutical
Liquid (包裝盒(上海西洋參口服液))
213
Patent Owner
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Packaging box (Medical Capsules for
reinforcing vital energy of kidney
and making body stronger) (包裝盒
(補腎強身膠囊))
Packaging box (Toad Venom
Cataplasma) (包裝盒(蟾烏巴布膏))
Packaging box (Qiju Dihuang Capsules)
(包裝盒(杞菊地黃膠囊))
Packaging box (Shanghai Ginseng
Royal Jelly) (包裝盒(上海人參蜂皇漿))
Packaging box (Cornu Saigae Tataricae)
(包裝盒(羚羊角散))
Packaging box (Inflammation-Resolving
Gall-Bladder-Excreting Tablets) (包裝
盒(消炎利膽片))
Packaging box (Compound Danshen
Tablets (包裝盒(複方丹參片))
Packaging box (Yinqiao Tablets) (包裝盒
(銀翹片))
Packaging box (Mighty Soft Capsules of
Gastrodia Tuber and Eucommia) (包裝
盒(強力天麻杜仲膠囊）
Packaging box (Ganmao Tuire
Granules) (包裝盒(感冒退熱顆粒))
Packaging box (Hericium Erinaceus
Tablets) (包裝盒(猴頭菌片))
Packaging box (Bezoar Antidotal
Tablets) (包裝盒(牛黃解毒片))
Packaging box (Danshen Tablets) (包裝
盒(丹參片))
Packaging box (Jindan Tablets) (包裝盒
(金膽片))
220
– X-34 –
233
232
231
230
229
228
227
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Patent Owner
03329016.4
03329015.6
03329014.8
003329013.X
03329012.1
03329011.3
03329010.5
03329009.1
03329008.3
03329007.5
03329006.7
03329005.9
03329004.0
03329003.2
Patent Number
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Type
March 21, 2003
March 21, 2003
March 21, 2003
March 21, 2003
March 21, 2003
March 21, 2003
March 21, 2003
March 21, 2003
March 21, 2003
March 21, 2003
March 21, 2003
March 21, 2003
March 21, 2003
March 21, 2003
Application date
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
Term of
the patent
Remarks
APPENDIX X
226
225
224
223
222
221
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Packaging box (Gynecology Tablets of
Regulating Menstruation) (包裝盒(婦
科調經片))
Packaging box (Zuogui Pills) (包裝盒(左
歸丸))
Packaging box (Pills of Six Ingredients
with Rehmannia) (包裝盒(六味地黃丸))
Packaging box (Leishi High Protein
Nutrition Powder) (包裝盒(雷氏高蛋白
質營養粉))
Packaging box (Leishi Propolis High
Protein Nutrition Powder) (包裝盒(雷
氏蜂膠高蛋白質粉營養粉))
Packaging box (Leishi High Protein Gift
Box) (包裝盒(雷氏蛋白粉禮盒))
Packaging box (Wild Drying Ginseng) (包
裝盒(野山人參))
Packaging box (Qingzi Tea) (包裝盒(清
滋茶))
Packaging box (Rare Chrysanthemum
Antihypertension Tablets A) (包裝盒(珍
菊降壓片A))
Packaging box (Rare Chrysanthemum
Antihypertension Tablets B) (包裝盒(珍
菊降壓片B))
Packaging box (Sachet) (包裝盒(香袋))
Packaging box (Sachet) (包裝盒(香袋))
Packaging box (Leishi Gen-seng Oral
Liquid) (包裝盒(雷氏牌西洋參口服液))
Packaging box (Taikang Capsules) (包裝
盒(泰康膠囊))
234
– X-35 –
247
244
245
246
243
242
241
240
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Patent Owner
200630034135.6
200530046161.6
200530046162.0
200630034133.7
200530041810.3
200530041811.8
200430106411.6
200430035930.8
200430023938.2
200430023937.8
200430023939.7
03329790.8
03329789.4
03329788.6
Patent Number
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Design
Type
March 3, 2006
December 13, 2005
December 13, 2005
March 3, 2006
July 29, 2005
July 29, 2005
December 3, 2004
July 21, 2004
April 23, 2004
April 23, 2004
April 23, 2004
April 17, 2003
April 17, 2003
April 17, 2003
Application date
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
Term of
the patent
Remarks
APPENDIX X
239
238
237
236
235
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-36 –
257
256
255
254
253
252
251
250
Leiyunshang Pharmaceutical,
Shanghai Huayu
Pharmaceutical Co., Ltd.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Patent Owner
200830064038.0
200730075073.8
200630047438.1
200630040977.2
200630038607.5
200630038606.0
200630034134.1
Patent Number
10 years
10 years
10 years
Term of
the patent
February 3, 2004
Invention
20 years
20 years
August 14, 2003
Invention
10 years
10 years
10 years
September 29, 2009 10 years
June 11, 2008
April 26, 2007
December 13, 2006
September 26, 2006 10 years
July 7, 2006
July 7, 2006
March 3, 2006
Application date
Design
Design
Design
Design
Design
Design
Design
Design
Type
Leiyunshang Pharmaceutical
and Shanghai Huayu
Pharmaceutical Co., Ltd.
are joint patentees
Remarks
APPENDIX X
Leiyunshang Pharmaceutical
200930228451.0
Packaging box (Liushenwan
Rengongfang) (包裝盒(六神丸人工方))
Shanghai Hutchison and Fudan ZL03142266.7
Use of pulse-activating injection in
University affiliated Cancer
preparing synergetic medicine for
Hospital (復旦大學附屬腫瘤醫
treating tumor (生脈注射液在製備治
院)
療腫瘤增效藥物中的用途)
ZL200410016071.7
Medicine preparation for treating liver Shanghai Hutchison
and gallbladder disease and its
preparing process (一種治療肝膽疾病
的藥物製劑及其製備方法)
Packaging box (Paotianhong Taikang
Capsules) (包裝盒(炮天紅牌泰康膠囊))
Packaging box (CaterPillsar Fungus A)
(包裝盒(冬蟲夏草A))
Packaging box (CaterPillsar Fungus B)
(包裝盒(冬蟲夏草B))
Packaging box (Shen Xiang Wild
Mountain Genseng) (包裝盒(神象野山
參))
Packaging box (Paotianhong
Nourishing Spirits) (包裝盒(炮天紅養
身酒))
Beverage bottle (Leishi Chrysanthemum
Dew) (飲料瓶(雷氏菊花露))
Packaging box (Health Tea) (包裝盒(養
身茶))
248
249
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Fingerprint analysis method for
traditional Chinese medicine
composition to treat cardiovascular
disease (一種治療心血管疾病的中藥組
合物的指紋圖譜分析方法)
Hyperlipemia treating Chinese
medicine prepn (一種治療高血壓疾病
的中葯制劑)
Packaging box (Shexiang Baoxin Pills)
(包裝盒(麝香保心丸))
Packaging box (Danning Tablets) (包裝
盒(膽寧片))
Packaging box (Weikesheng Tablets)
(包裝盒(胃可寧片))
Packaging box (Ganshao Xiaoke
Tablets) (包裝盒(幹芍消渴片))
Exendin 4 polypeptide segment
(Exendin 4多肽片段)
Medicine box (Katuo Puli Tablets)
(藥品盒包裝(卡托普利片))
Medicine box (Kaifute)
(藥品盒(開富特))
Aspirin sustained release tablet and its
preparing method (一種阿司匹林緩釋
片及其製備方法)
Preparing method of 3, 5-dihydroxy
heptyl-6-gadoleic acid derivative (一
種 3,5-二羥基庚 -6-烯酸衍生物的製備
方法)
Packaging box (Ganmao Tuire
Granules) (包裝盒 (感冒退熱顆粒))
258
– X-37 –
269
268
267
266
265
264
263
Leiyunshang Pharmaceutical
Changzhou Pharmaceutical
Factory Co., Ltd
Changzhou Pharmaceutical
Factory Co., Ltd
Changzhou Pharmaceutical
Factory Co., Ltd
Changzhou Pharmaceutical
Factory Co., Ltd
Changzhou Pharmaceutical
Factory Co., Ltd
Shanghai Hutchison
Shanghai Hutchison
Shanghai Hutchison
Shanghai Hutchison
Shanghai Hutchison
Shanghai Hutchison
Patent Owner
03329012.1
200810110709.1
200810020313.8
CN 200530045313.0
CN 200530045312.6
CN 200510040823.8
ZL201030026958.0
ZL201030026957.6
ZL201030026956.1
ZL200930226393.8
ZL200610116220.6
ZL200610029707.0
Patent Number
Design
Invention
Invention
patent
Design
Invention
patent
Design
Design
Design
Design
Design
Invention
Invention
Type
20 years
Term of
the patent
March 21, 2003
May 27, 2008
February 29, 2008
November 21, 2005
November 21, 2005
June 29, 2005
January 7, 2010
January 7, 2010
January 7, 2010
10 years
20 years
20 years
10 years
10 years
20 years
10 years
10 years
10 years
September 11, 2009 10 years
September 19, 2006 20 years
August 3, 2006
Application date
Remarks
APPENDIX X
262
261
260
259
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Packaging box (Mighty Soft Capsules
of Gastrodia Tuber and Eucommia)
(包裝盒 (強力天麻杜仲膠囊)
Packaging box (Shanghai Gen-seng
Oral Liquid (包裝盒 (上海西洋參
口服液))
Coating method for Chinese medicine
Zuogui Granules (中藥左歸顆粒包衣
方法)
Packaging box (Shen Xiang Wild
Mountain Genseng) (包裝盒 (神象野
山參))
Packaging box (Paotianhong
Nourishing Spirits) (包裝盒 (炮天紅養
身酒))
Packaging box (Liushenwan
Tianranfang) (包裝盒 (六神丸天然方))
Chinese medicine composition for
treating arthritis and its preparing
method (一種治療關節炎的中藥組合物
和其製備方法)
Packaging Box for Medicament
(Shenshu Powder-1) (藥品包裝盒 (腎
舒沖劑-1))
Packaging Box for Medicament (Zhupo
Jingfeng San-1) (藥品包裝盒 (珠珀驚
風散-1))
Packaging Box for Medicament
(Xinhuang Tablet-1) (藥品包裝盒 (新
癀片-1))
Packaging Box for Medicament (Daqili
San) (藥品包裝盒 (大七厘散-1))
270
– X-38 –
280
279
278
277
276
275
Xiamen Traditional Chinese
Medicine Co., Ltd.
Xiamen Traditional Chinese
Medicine Co., Ltd.
Xiamen Traditional Chinese
Medicine Co., Ltd.
Xiamen Traditional Chinese
Medicine Co., Ltd.
Liaoning Herbapex
Pharmaceutical (Group) Co.,
Ltd.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Patent Owner
01316368.X
01316369.8
01316370.1
01316371.X
200510126433.2
200930228300.5
200630047438.1
200630040977.2
200510027556.0
03329002.4
03329011.3
Patent Number
Design
Design
Design
Design
Invention
Design
Design
Design
Invention
Design
Design
Type
20 years
10 years
10 years
Term of
the patent
10 years
January 15, 2001
January 15, 2001
January 15, 2001
January 15, 2001
December 9, 2005
10 years
10 years
10 years
10 years
20 years
September 29, 2009 10 years
December 13, 2006
September 26, 2006 10 years
July 6, 2005
March 21, 2003
March 21, 2003
Application date
Remarks
APPENDIX X
274
273
272
271
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-39 –
288
287
286
285
200510110977.X
95111763.7
Patent Number
Term of
the patent
June 30, 2005
September 2, 2005
March 16, 2006
Invention
Invention
August 17, 2010
January 15, 2010
August 18, 2006
November 30, 2005
20 years
20 years
20 years
20 years
10 years
20 years
20 years
September 15, 1995 20 years
Application date
Invention
Invention
Utility patent
Invention
Invention
Invention
Type
Remarks
APPENDIX X
284
283
Shanghai Traditional Chinese
Medicine Research Institute
Shanghai Xingling
Pharmaceutical Technology
Co., Ltd.
Patent Owner
Shanghai Leiyunshang
200610030214.9
Technology Development
Co., Ltd. (上海雷允上科技發
展有限公司), Shanghai
Traditional Chinese Medicine
Research Institute
Apparatus for applying cosmetics (化妝 Zhonghua Pharmaceutical
201020033100.1
品塗抹裝置)
2, 3-dihydro-4(1H)-Quinazolone
Shanghai Pharmaceuticals
201010254655.3
derivatives and its application (2, 3二氫 -4(1H)- 唑酮衍生物及其應用)
Lincomycin hydrochloride composition Sine Pharmaceutical
200510027392.1
and its preparing method (鹽酸林可
霉素組合物及其製備方法)
Sine Pharmaceutical
200510029346.5
Phthiobuzonum eye drops containing
sodium hyaluronate and its preparing
method (含玻璃酸鈉的酞丁安滴眼液及
其製備方法)
Shanghai Sine Wanxiang
200610024776.2
Hydrochlorothiazide grain and sugarPharmaceutical Co., Ltd.
coat producing technique of
Compound Luobuma Tablets I
(複方羅布麻片I中氫氯噻嗪的制粒、
包衣工藝)
High content ginko leaves flavone
lactone extract and its preparing
Method (高含量銀杏葉黃酮內酯浸膏
及其製備方法)
Method for regulating baicalin and
baicalein ratio in scutellariae root
extract (一種調節黃芩提取物中黃芩苷
和黃芩素成分比例的方法)
Method for cultivating tissue cultured
gloden line lotus seedling (金線蓮組
培苗培養方法)
281
282
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-40 –
297
296
295
294
292
293
Design
Design
Design
Design
Invention
Design
Invention
Design
Invention
Type
Term of
the patent
December 18, 2009
December 18, 2009
December 18, 2009
December 18, 2009
December 12, 2008
December 18, 2009
June 15, 2006
10 years
10 years
10 years
10 years
20 years
20 years
September 15, 2006 10 years
September 11, 2006 20 years
Application date
Remarks
APPENDIX X
291
290
Traditional Chinese medicine
Hangzhou Huqingyutang
200610153526.9
preparation for treating stomach and
Pharmaceutical Co., Ltd.
intestinal disease and its preparing
method (一種治療胃部及腸道疾病的中
藥製劑及其製備方法)
Operation shadowless lamp lamp
Shanghai Medical Instruments 200630040557.4
holder (FD) (手術無影燈燈頭 (FD))
Co., Ltd. No.5 Medical
Instruments Plant (上海醫療
器械股份有限公司醫療器械五
廠) (a branch of Shanghai
Medical Instruments Co.,
Ltd.)
High purity wild Radix scutellariae
Chiatai Qingchunbao
200610087555.X
glucoside medicine composition, and
application of making medicine to
treat diseases of cardiovascular and
cerebrovascular (一種高純度野黃芩苷
藥物組合物及其在製備心、腦血管藥物
方面的醫藥用途)
Liquid dispensing device (一種配液裝置) Chiatai Qingchunbao
200810163265.8
Packeging box (Yangyin Jiangtang
Chiatai Qingchunbao
200930329848.9
Tablets) (包裝盒 (養陰降糖片))
Packeging box (Metoprolol Tartrate
Chiatai Qingchunbao
200930329847.4
Injection) (包裝盒 (酒石酸美托洛爾注
射液))
Packeging box (Fudosteine Tablets)
Chiatai Qingchunbao
200930329846.X
(包裝盒 (福多司坦片))
Packeging box (Fudosteine Capsules)
Chiatai Qingchunbao
200930329845.5
(包裝盒 (福多司坦膠囊))
Packeging box (Fluconazole Capsules
Chiatai Qingchunbao
200930329843.6
150mg) (包裝盒 (氟康唑膠囊150mg))
Patent Number
289
Patent Owner
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Packeging box (isosorbide mononitrate
injection) (包裝盒 (單硝酸異山梨酯注
射液))
Packeging box (Houttuynia Injection)
(包裝盒 (魚腥草注射液))
Packeging box (Children Coughrelieving Syrup) (包裝盒 (小兒止咳
糖漿))
Packeging box (Fudosteine Granules)
(包裝盒 (福多司坦顆粒))
Packeging box (Pinellia Syrup) (包裝盒
(半夏糖漿))
Packeging box (fluconazole Capsules)
(包裝盒 (氟康唑膠囊))
Packeging box (Azithromycin
Dispersible Tablets 0.25g) (包裝盒
(阿奇霉素分散片0.25g))
Packeging box (Azithromycin
Dispersible Tablets 0.1g) (包裝盒
(阿奇霉素分散片0.1g))
Pharmaceutical composition for
treating chronic atrophic gastritis (一
種用於治療慢性萎縮性胃炎的藥物組合
物)
Method for preparing total salvianolic
acid and the application in the
preventing and treating of diabetes
and the complication thereof (一種丹
參總酚酸的製備方法及其在防治糖尿病
及併發症中的應用)
298
– X-41 –
307
306
305
200930329838.5
200810182406.0
200710070020.6
Chiatai Qingchunbao
Chiatai Qingchunbao
200930329840.2
200930329740.X
200930329739.7
200930329742.9
200930329744.8
200930329745.2
200930329842.1
Patent Number
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Patent Owner
Invention
Invention
Design
Design
Design
Design
Design
Design
Design
Design
Type
July 16, 2007
December 5, 2008
December 18, 2009
December 18, 2009
December 18, 2009
December 18, 2009
December 18, 2009
December 18, 2009
December 18, 2009
December 18, 2009
Application date
20 years
20 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
10 years
Term of
the patent
Remarks
APPENDIX X
304
303
302
301
300
299
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Medicine composition with anti-virus
function and its preparing method (
一種具有抗病毒作用的藥物組合物及其
製備方法)
Packaging Box for Medicament
(Aripiprazole tablet) (藥品包裝盒 (阿
立呱唑片))
Packaging Box for Medicament
(Hydroxychloroquine Sulfate tablet)
(藥品包裝盒 (硫酸氫氯 片))
Packaging Box for Medicament
(Duloxetine Hydrochloride Enteric
tablet) (藥品包裝盒 (鹽酸度洛西汀腸
溶片))
Packaging Box for Medicament
(Danxiang Guanxin injection) (藥品包
裝盒 (丹香冠心注射液))
Packaging Box for Medicament
(Duloxetine Hydrochloride Enteric
capsule) (藥品包裝盒 (鹽酸度洛西汀腸
溶膠囊))
A solid oral pharmaceutical
composition containing aripiprazole
microcrystalline (一種含有阿立呱唑微
晶的固體口服藥物組合物)
Compound aminophylline tablet and its
preparation method (複方氨茶鹼片劑
及其製備方法)
Chinese herbal compound containing
ginseng and American ginseng and
its preparation method (含有人參和
西洋參的中藥複方製劑及製備方法)
308
– X-42 –
316
315
314
313
Design
Invention
Invention
Invention
200830063016.2
200710041323.5
200410067287.6
96116402.6
Shanghai Zhongxi
Pharmaceutical Co., Ltd. (上
海中西製藥有限公司)
Shanghai Zhongxi
Pharmaceutical Co., Ltd. (上
海中西製藥有限公司)
Zhongxi Pharmaceutical
Design
Design
Design
Invention
Type
Design
200830063015.8
200730074869.1
200730079447.3
200710086424.4
Patent Number
200730074870.4
Shanghai Zhongxi
Pharmaceutical Co., Ltd. (上
海中西製藥有限公司)
Shanghai Zhongxi
Pharmaceutical Co., Ltd. (上
海中西製藥有限公司)
Shanghai Zhongxi
Pharmaceutical Co., Ltd. (上
海中西製藥有限公司)
Shanghai Zhongxi
Pharmaceutical Co., Ltd. (上
海中西製藥有限公司)
Shanghai Zhongxi
Pharmaceutical Co., Ltd. (上
海中西製藥有限公司)
Chiatai Qingchunbao
Patent Owner
June 24, 1996
October 19, 2004
May 28, 2007
May 23, 2008
April 20, 2007
May 23, 2008
April 20, 2007
July 26, 2007
March 8, 2007
Application date
20 years
20 years
20 years
10 years
10 years
10 years
10 years
10 years
20 years
Term of
the patent
Patentee will be changed
to Zhongxi Sunve
Chongqing Pharmaceutical
Research Institute Co.
Ltd. as a joint patentee
Remarks
APPENDIX X
312
311
310
309
Patent
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Steroids, its preparation method and
pharmaceutical composition and
application (甾體化合物 ,其製備方法
和其藥物組合物及其應用)
Packaging Box (Cefpodoxime proxetil
tablets) (包裝盒 (維潔信))
Purpose of cymipristone for the
treatment of depression (賽米司酮類
用於治療抑鬱症的用途)
317
318
319
Patent
No.
03343900
99116829
Patent Number
Shanghai Sanhe Biotechnology 200410093036.5
Co., Ltd.
Sunve Pharmaceutical
Zhongxi Pharmaceutical
Patent Owner
Invention
Design
Invention
Type
December 15, 2004
July 31, 2003
September 2, 1999
Application date
20 years
10 years
20 years
Term of
the patent
Patentee will be changed
to Zhongxi Sunve;
Zhejiang Xianju
Pharmaceutical and
Shanghai Siniwest
Medical Chemical
Technology are joint
patentees
Patentee will be changed
to Zhongxi Sunve
Remarks
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
APPENDIX X
STATUTORY AND GENERAL INFORMATION
– X-43 –
Patents under application:
– X-44 –
Leiyunshang Pharmaceutical.
Shanghai Leiyunshang Technology Development Co., Ltd.
(上海雷允上科技發展有限公司), Shanghai Traditional
Chinese Medicine Research Institute
Shanghai Leiyunshang Technology Development Co., Ltd.
(上海雷允上科技發展有限公司), Shanghai Traditional
Chinese Medicine Research Institute
Shanghai Leiyunshang Technology Development Co., Ltd.
(上海雷允上科技發展有限公司), Shanghai Traditional
Chinese Medicine Research Institute
6
7
9
8
Leiyunshang Pharmaceutical.
Shanghai Leiyunshang Technology Development Co., Ltd.
(上海雷允上科技發展有限公司), Shanghai Traditional
Chinese Medicine Research Institute
Shanghai Leiyunshang Technology Development Co., Ltd.
(上海雷允上科技發展有限公司), Shanghai Traditional
Chinese Medicine Research Institute
Shanghai Leiyunshang Technology Development Co., Ltd.
(上海雷允上科技發展有限公司), Shanghai Traditional
Chinese Medicine Research Institute
Leiyunshang Pharmaceutical
Applicant
Health care beverage containing honeysuckle flower,
momordica grosvenori and preparing method thereof
(一種含金銀花、羅漢果的保健飲料及製備方法)
Method for detecting contents of puerarin and rhodiola
rosea glycosides in Paotianhongyangshejiu (炮天紅養身酒
中葛根素和紅景天苷的含量測定方法)
Qualitative identification of Chinese medicine Bairui tablet
and method for measuring kaempferol content therein
(中藥百蕊片的定性鑒別及其中的山萘素含量測定方法)
Salvia root composition and preparation thereof, and
detecting method and use (一種丹參組合物及其製備方法
和檢測方法以及應用)
Medicaments composite for breast hyperplasia and
preparing method thereof (一種治療乳腺增生性疾病的中
藥組合物及其製備方法)
Composition from effective part of a wild chrysanthemam
flower, its preparing method and application and
medicament that contains it
(一種野菊花有效部位組合物及其製備方法和應用以及含其
的藥物製劑)
Cudrania tricuspidata extract, preparation and application
thereof (一種柘木提取物、其製備及應用)
Application of meletin-7-0-glycoside in mass control of
cudrania tricuspidata or preparations thereof (槲皮
素-7-O-葡萄糖甙在柘木或其製劑品質控制中的應用)
Cudrania tricuspidata extract, preparation and application
thereof (一種柘木提取物、其製備及應用)
Patent
200710173681.1
200710172332.8
200710170506.7
200710170833.2
200710170834.7
200710047895.4
200710045424.x
200710045425.4
200610118154.6
Application No.
Remarks
APPENDIX X
5
4
3
2
1
Serial
No.
As of the Latest Practicable Date, the relevant member of our Company had applied for the registration of the following patents:
(b)
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Shanghai Leiyunshang Technology Development Co., Ltd.
(上海雷允上科技發展有限公司), Shanghai Traditional
Chinese Medicine Research Institute
Shanghai Leiyunshang Technology Development Co., Ltd.
(上海雷允上科技發展有限公司), Shanghai Traditional
Chinese Medicine Research Institute
Shanghai Leiyunshang Technology Development Co., Ltd.
(上海雷允上科技發展有限公司), Shanghai Traditional
Chinese Medicine Research Institute
Shanghai Leiyunshang Technology Development Co., Ltd.
(上海雷允上科技發展有限公司), Shanghai Traditional
Chinese Medicine Research Institute
Shanghai Leiyunshang Technology Development Co., Ltd.
(上海雷允上科技發展有限公司), Shanghai Traditional
Chinese Medicine Research Institute
Shanghai Xingling Pharmaceutical Technology Co., Ltd. and
Shanghai Biochip Co., Ltd. (上海生物芯片有限公司)
Shanghai Xingling Pharmaceutical Technology Co., Ltd.
10
11
– X-45 –
Shanghai Huayu Pharmaceutical Co., Ltd.
Shanghai Huayu Pharmaceutical Co., Ltd.
Shanghai Hutchison
18
19
20
17
16
15
Use of ginkgo biloba extract in cholesterol reducing (銀杏
葉提取物在降低膽固醇方面的用途)
Extract of ginkgo biloba leaves and dipyridamole
composite and preparing method and application
thereof (銀杏酮酯與雙密達莫組合物及其製備方法與應用)
Crocus virus detection method (番紅花病毒檢測方法)
Tissue culture rapid propagation method for crocus
(番紅花的組織培養快速繁殖方法)
Chinese traditional medicine composition for treating
cholecyst disease and fingerprint pattern analyzing
method thereof (一種治療膽囊疾病的中藥組合物及其指紋
圖譜分析方法)
A kind of Subing drop pills and preparing method and its
preparing method (一種蘇冰滴丸製劑及其製備)
Extracts of purple daisy and its preparing method and
detection method for its phenol composition (一種紫錐
菊提取物和其製備方法及其酚類成分的檢測方法)
Quality control methods of hairy holly root medicinal
materials, extract or hairy holly root preparation (毛冬青
藥材、提取物或毛冬青製劑的質量控制方法)
Hairy holly root extract, its preparation and application
(毛冬青提取物、其製備及應用)
Chinese traditional medicine health-care wine for
enhancing immunity and relieving physical fatigue and
preparing method thereof (增強免疫力和緩解體力疲勞的
中藥保健品及其製備方法)
Dispersion tablet of red sage root and its application
(一種丹參分散片及其應用)
Patent
200710040014.6
200810201020.X
200810201021.4
200910056648.X
200510030719.0
201010206313.4
200810038468.4
200810038467.X
200810205105.5
200810205102.1
200810201536.4
Application No.
Remarks
APPENDIX X
14
13
12
Applicant
Serial
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai New Asiatic and Shanghai Asia Pioneer
Shanghai Asia Pioneer
Shanghai Asia Pioneer
Shanghai Asia Pioneer
30
31
32
33
Shanghai New Asiatic and Shanghai Asia Pioneer
26
Shanghai New Asiatic and Shanghai Asia Pioneer
Shanghai New Asiatic
25
29
Shanghai Hutchison
24
Shanghai New Asiatic and Shanghai Asia Pioneer
Shanghai Hutchison
23
28
Shanghai Hutchison
22
Shanghai New Asiatic and Shanghai Asia Pioneer
Shanghai Hutchison
21
Method for detecting anthraquinone content in
medicaments (一種測定藥物中蒽醌含量的方法)
Method for determining active medical ingredients in
serum (一種血清中測定藥物活性成分的方法)
Application of pharmaceutical composition that contains
licorice and white peony in preparing synergetic
medicine for treating diabetes (含有甘草和白芍的藥物組
合物在製備治療糖尿病增效藥物中的應用)
Drug for treating sugar governing damage model and its
preparation (一種用於治療糖調節受損的藥物及其製備
方法)
Phenytoin sodium powder injection and preparing method
thereof (苯妥英鈉粉針劑及其製備方法)
Cefpirome sulfate preparing technology (硫酸頭孢匹羅製備
工藝)
Method for synthesizing carbenicillin sodium (羧苄西林鈉的
合成方法)
Method for preparing ceftazidime pentahydrate (頭孢他啶
五水合物的製備方法)
Synthetic method for cephalosporin intermediate (頭孢中間體
的合成方法)
Refining process of 7-ACP.HCL (7-ACP•HCl的精製工藝)
Medicine bottle label information online detection system
in powder injection production based on mechanical
vision (基於機器視覺的粉針劑生產中藥品標貼信息在線檢
測系統)
Aluminum cap packaging online detection system in
medical powder injection production based on
mechanical vision (基於機器視覺的藥品粉針劑生產中鋁蓋
包裝在線檢測系統)
Automatic removing device for sorting powder injection
medicine bottle (一種用於粉針劑藥品分揀的自動撇除裝置)
Patent
– X-46 –
200820057636.X
200810036518.5
200810207954.4
200810036517.0
200810204984.X
200810039234.1
200710173650.6
200710044779.7
200710038520.1
201010129887.6
201010129878.7
200910049665.0
200810207225.9
Application No.
Remarks
APPENDIX X
27
Applicant
Serial
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai New Asiatic and Shanghai Asia Pioneer
Shanghai New Asiatic and Shanghai Asia Pioneer
Shanghai Medical Science and Technology Development
Co., Ltd. (上海醫藥科技發展有限公司)
Shanghai Medical Science and Technology Development
Co., Ltd. (上海醫藥科技發展有限公司)
Shanghai Medical Science and Technology Development
Co., Ltd. (上海醫藥科技發展有限公司)
Shanghai Medical Science and Technology Development
Co., Ltd. (上海醫藥科技發展有限公司)
Shanghai Medical Science and Technology Development
Co., Ltd. (上海醫藥科技發展有限公司)
Shanghai Medical Science and Technology Development
Co., Ltd. (上海醫藥科技發展有限公司)
Sunve Pharmaceutical
Sunve Pharmaceutical
36
37
38
39
40
42
– X-47 –
45
44
43
Preparing method for cefuroxime sodium (頭孢呋辛鈉的製
備方法)
Method for detecting acetone and ethyl acetate residue in
drugs using gas chromatographic用氣相色譜同時檢測藥
物中丙酮和乙酸乙酯殘留的方法)
Refining method for Faropenem sodium (法羅培南鈉的精製
方法)
Venlafaxine hydrochloride sustained-release tablet
preparation and preparing method thereof (一種鹽酸文
拉法辛緩釋片製劑及其製備方法)
Ixers sonchifolia freeze-dried powder for injection and
preparing method thereof (一種注射用苦碟子凍乾粉針及
其製備方法)
Antifungal pharmaceutical composition (一種抗真菌藥物組
合物)
Method for preparing cilnidipine used as dihydropyridine
calcium antagonist (啶類鈣拮抗劑西尼地平及其製劑的製
備方法)
Omeprazole capsule and preparing method thereof
(一種奧美拉唑膠囊及其製備方法)
Flunarizine voglibose tablets and preparing method
thereof (一種氟桂利嗪口崩片及其製備方法)
Preparing method for Rivastigmine midbody 3-hydroxylalpha-N, N-dimethyl phenylethylamine (利伐斯的明中間體
3-羥基 -a-N,N-二甲基苯乙胺的製備方法)
Split method for (S)3-hydroxyl-alpha-N, N-dimethyl
phenylethylamine ((S)3-羥基 -a-N,N-二甲基苯乙胺的拆分
方法)
Preparing method for sodium fructose diphosphate
granule agent (果糖二磷酸鈉粉針劑的製備方法)
Patent
200710043636.4
200710043635.X
200910051812.8
200810207913.5
200810038932.X
200810037756.8
200810037755.3
200810037757.2
200910200644.4
200910200583.1
200910054834.X
200910054818.0
Application No.
Remarks
APPENDIX X
41
35
Shanghai New Asiatic, Shanghai Asia Pioneer and Shanghai
Medical Science and Technology Development Co., Ltd. (
上海醫藥科技發展有限公司)
Shanghai New Asiatic and Shanghai Asia Pioneer
Applicant
34
Serial
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
55
56
57
Sine Pharmaceutical
50
54
Sine Pharmaceutical
49
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
48
52
53
Sunve Pharmaceutical
47
Sine Pharmaceutical
Sunve Pharmaceutical
46
Preparing method for (2R,3S)-2-hydroxyl-3-amido-3benzene propanoic methyl ester ((2R,3S)-2-羥基 -3-胺基
-3-苯丙酸甲酯的製備方法)
Purification process for Oseltamivir Phosphate (磷酸奧司他韋
的純化方法)
Milrinone lyophilized powder for injection and preparing
method thereof (注射用米力農凍乾粉及其製備方法)
Boletic acid ketotifen eye drops containing sodium
hyaluronate and its preparing process (含玻璃酸鈉的富馬
酸酮替芬滴眼液及其製備方法)
Eye preparation containing sodium hyaluronate for
treating fundus macular degeneration and its preparing
method (含玻璃酸鈉的治療眼底黃斑變性的眼用製劑及其製
備方法)
High purity cortex fraxini and its preparing method (高純度
秦皮甲素及其製備方法)
Racanisodamine eye drops (消旋山莨菪鹼滴眼液)
Injection tyxolazo and its making method (一種注射用泰妥
拉唑及其製備方法)
Preparations containing rosuvastatin calcium and
amlodipine and method for preparing the same (含有瑞
舒伐他汀鈣和氨氯地平的製劑及其製備方法)
Preparations containing rebeprazole and sodium
bicarbonate and method for preparing the same (含有雷
貝拉唑和碳酸氫鈉的製劑及其製備方法)
Novel lactic acid bacillus mycopremna, pharmaceutical
composition and uses thereof, and production method
(新的乳酸桿菌菌株、藥物組合物及其用途、以及製造方法)
Medicinal composition for regrouping human P43 protein
and its application in medication (一種重組人P43蛋白的
藥物組合物及其在醫藥上的應用)
Patent
– X-48 –
200610118859.8
200610117825.7
200610030513.2
200610028434.8
200510028069.6
200510111465.5
200510030722.2
200510030723.7
200510029347.X
200510026706.6
200710043638.3
200710043637.9
Application No.
Remarks
APPENDIX X
51
Applicant
Serial
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
58
59
60
61
62
Shanghai Sine Jiahua Pharmaceutical Co., Ltd. (上海信誼嘉
華藥業有限公司)
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
64
65
66
67
68
Medicament compound containing levorotatory ammonia
chlorine horizon and atorvastatin (含有左旋氨氯地平和阿
托伐他汀的治療組合物)
Preparing technology of recombinant human p43 protein
(重組人p43蛋白的製備工藝)
Lactobacillus acidophilus/enterococcus faecalis culture
medium, preparations and technique (嗜酸乳桿菌/糞腸球
菌培養基、製劑及其工藝)
Long bifidobacterium culture medium, preparation and
technique (長型雙歧桿菌培養基製劑及其工藝)
Low molecular weight biodegradable triblock copolymer
(lactide — copolymerization — glycolide) polyethylene
glycol ester copolymer with invertible thermal gelling
property (具有可逆熱膠凝性質的可生物降解低分子量三嵌
段聚 (丙交酯-共聚 -乙交酯)聚乙二酯共聚物)
Composition containing telmisartan and preparing method
thereof (一種包含替米沙坦片的組方及其製備方法)
Pharmaceutical preparation containing alendronate sodium
and cholecalciferol-cholesterol (包含阿侖膦酸鈉和膽維丁
的藥物製劑)
New lactobacillus rhamnosus strain, its pharmaceutical
composition and the uses thereof and the method for
preparation
(新的乳酸桿菌菌株、藥物組合物及其用途、以及製造方法)
Pharmaceutical composition comprising P43 Protein for
the treatment of gastric adenocarcinoma (含有P43蛋白用
予治療胃癌的藥物組合物)
Anticoagulant compound, composition and application
thereof (抗凝化合物、組合物及其用途)
Packaging box (Ofloxacin Eye Drops)
(包裝盒 (氧氟沙星滴眼液))
Patent
– X-49 –
200830064037.6
200810041855.3
PCT/CN2007/070965
PCT/CN2007/070962
200710170980.X
200710041363.X
200710042905.5
200710037650.3
200710037649.0
200710036577.8
200610147240.X
Application No.
Remarks
APPENDIX X
63
Applicant
Serial
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
78
79
80
81
82
Sine Pharmaceutical
74
Sine Pharmaceutical
Sine Pharmaceutical
73
77
Sine Pharmaceutical
72
Sine Pharmaceutical
Sine Pharmaceutical
71
76
Sine Pharmaceutical
70
Sine Pharmaceutical
Sine Pharmaceutical
69
Anticoagulant compound, composition and application
thereof (抗凝化合物、組合物及其用途)
Anticoagulant compound, composition and application
thereof (抗凝化合物、組合物及其用途)
Anticoagulant compound, composition and application
thereof (抗凝化合物、組合物及其用途)
Hydrofluoroalkane aerosol containing lidocaine (含利多卡
因的氫氟烷烴氣霧劑)
Preparation process of recombinant human P43
(重組人p43蛋白的製備工藝)
Culture medium for lactobacillus acidophilus and
streptococcus faecalis composition the same and
preparation method thereof (嗜酸乳桿菌糞腸球菌培養
基、製劑及其工藝)
Culture Medium for bifidobacterium longum, composition
comprising the same and preparation method thereof
(長型雙歧桿菌培養基製劑及其工藝)
Rabeprazole composite and preparation thereof (雷貝拉唑
組合物及其製備方法)
N end missing p43 protain and its application in anticancer drugs (N端缺失型 p43蛋白及其在腫瘤治療藥物中
的應用)
C end missing p43 protain and its application in anticancer drugs (C端缺失型 p43蛋白及其在腫瘤治療藥物中
的應用)
Eye gel and its preparing method (眼用凝膠及其製備方法)
Racanisodamine eye drops (消旋山莨菪堿滴眼液)
Recombination human epidermal growth factor spray and
its preparing method (一種重組人表皮生長因子噴霧劑及
其製備方法)
Digitalis extract and its preparing method (一種洋地黃提取
物及其製備方法)
Patent
– X-50 –
200610147972.9
200510025018.8
200510028069.6
200610147971.4
200910047144.1
200910047143.7
200910047142.2
PCT/CN2008/070254
PCT/CN2008/070255
PCT/CN2008/070132
200810207656.5
200810041854.9
200810041856.8
200810041853.4
Application No.
on examination
on examination
on examination
on examination
Remarks
APPENDIX X
75
Applicant
Serial
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai No.1 Biochemical
Shanghai Sunhe Biotechnology Co., Ltd. (上海三合生物技術
有限公司)
Shanghai Zhongxi Pharmaceutical Co., Ltd.
Shanghai Zhongxi Pharmaceutical Co., Ltd.
92
93
94
95
Sine Pharmaceutical
88
Shanghai No.1 Biochemical
Sine Pharmaceutical
87
91
Sine Pharmaceutical
86
Shanghai Sine Wanxiang Pharmaceutical Co., Ltd.
Sine Pharmaceutical
85
90
Sine Pharmaceutical
84
Sine Pharmaceutical
Sine Pharmaceutical
83
Medicament compound containing levorotatory ammonia
chlorine horizon and atorvastatin and preparing method
thereof (含有左旋氨氯地平和阿托伐他汀的藥物組合物及製
備方法)
Long bifidobacterium culture medium, preparation and
technique (長型雙岐桿菌培養基、製劑及其工藝)
Biodegradable triblock copolymer with invertible thermal
gelling property (具有可逆熱膠凝性質的可生物降解三嵌段
共聚物)
Anticoagulant compound, composition and application
thereof (抗凝化合物、組合物及其用途)
Anticoagulant compound, composition and application
thereof (抗凝化合物、組合物及其用途)
Anticoagulant compound, composition and application
thereof (抗凝化合物、組合物及其用途)
Anticoagulant compound, composition and application
thereof (抗凝化合物、組合物及其用途)
Testing method for Accutane capsule (異維A酸軟膠丸的測
試方法)
3-hydroxy tanshinone IIA sodium sulfonate and its
application (3-羥基丹參酮 IIA磺酸鈉及其製備方法和用途)
A preparing method of Sodium Tanshinon II Asilate for
injection (一種供注射用丹參酮IIA磺酸鈉的製備方法)
Use of symipristone compound for treating AIDS (賽米司酮
類化合物用於治療愛滋病的用途)
‘Yinhuanghanhua’ dropping pill for treating upper
respiratory tract infection (一種用於治療上呼吸道感染的
銀黃含化滴丸)
Aripiprazole dropping pill and preparing method thereof
(阿立呱唑滴丸劑及其製備方法)
Patent
– X-51 –
200610148257.7
200610148060.3
200510028057.3
201010143887.1
201010500755.X
200910205111.5
200810041853.4
200810041854.9
200810041855.3
200810041856.8
200710042905.5
on examination
on examination
open stage
open stage
open stage
open stage
on examination
on examination
on examination
200610147240.X
200710037650.3
Remarks
Application No.
APPENDIX X
89
Applicant
Serial
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Applicant
Shanghai Zhongxi Pharmaceutical Co., Ltd.
Shanghai Far-East Pharmaceutical Machinery Co., Ltd. (上海
遠東製藥機械總廠有限公司)
Zhongxi Sunve
Shanghai Zhongxi Pharmaceutical Co., Ltd.
Shanghai Zhongxi Pharmaceutical Co., Ltd. and Chongqing
Pharmaceutical Research Institute Co., Ltd. (重慶醫藥工業
有限責任公司)
Shanghai Zhongxi Pharmaceutical Co., Ltd.
Shanghai Zhongxi Pharmaceutical Co., Ltd.
Shanghai Zhongxi Pharmaceutical Co., Ltd.
Shanghai Zhongxi Pharmaceutical Co., Ltd.
Shanghai Zhongxi Pharmaceutical Co., Ltd.
Shanghai Zhongxi Pharmaceutical Co., Ltd.
Shanghai Zhongxi Pharmaceutical Co., Ltd.
Zhonghua Pharmaceutical
Serial
No.
96
97
98
99
100
101
102
103
104
105
106
107
108
Duloxetine enteric-coated preparation and core material
and preparing method thereof (一種度洛西汀腸溶製劑及
其芯材和製備方法)
Build-in preheating tube type multiple-effect water distiller
(內置預熱管式多效蒸餾水機)
Duloxetine enteric-coated preparation and core material
and preparing method thereof (一種度洛西汀腸溶製劑及
其芯材和製備方法)
Duloxetine slow-release enteric-coated preparation and
core material and preparing method thereof (一種度洛西
汀的緩釋腸溶製劑及其芯材和製備方法)
Solid oral medicine composition containing aripiprazole
microcrystal (一種含有阿立呱唑微晶的固體口服藥物
組合物)
Packaging Box for Medicament (Hydroxychloroquine
Sulfate tablet) (藥品包裝盒 (硫酸羥氯 片))
Packaging Box for Medicament (Danxiang Guanxin
injection) (藥品包裝盒(丹香冠心注射液))
Packaging Box for Medicament (Aripiprazole tablet)
(藥品包裝盒(阿立呱唑片))
Packaging Box for Medicament (Aripiprazole capsule)
(藥品包裝盒(阿立呱唑膠囊))
Packaging Box for Medicament (Duloxetine Hydrochloride
Enteric tablet) (藥品包裝盒 (鹽酸度洛西汀腸溶片))
Packaging Box for Medicament (Duloxetine Hydrochloride
Enteric capsule) (藥品包裝盒(鹽酸度洛西汀腸溶膠囊))
Packaging Box for Medicament (Fluoxetine Hydrochloride
capsul (藥品包裝盒(鹽酸氟西汀膠囊))
Dragon and tiger rentan plant medicine composition,
preparing method and application thereof (一種龍虎人丹
植物藥組合物及其製備和應用)
Patent
– X-52 –
200910194559.1
201030167753.4
201030167744.5
201030167739.4
201030167736.0
201030167726.7
201030167775.0
Remarks
APPENDIX X
201030167763.8
201010119171.8
200910215411.1
PCT/CN2009/074786
200820061007.4
200810207877.2
Application No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Central Research Institute of Shanghai Pharmaceutical
(Group) Co., Ltd and Shanghai Pharmaceutical Research
Institute
Shanghai Pharmaceutical (Group) Co., Ltd (上海醫藥(集團)
有限公司)
Shanghai Pharmaceutical (Group) Co., Ltd (上海醫藥(集團)
有限公司)
Shanghai Pharmaceutical (Group) Co., Ltd (上海醫藥(集團)
有限公司)
Shanghai Pharmaceutical (Group) Co., Ltd (上海醫藥(集團)
有限公司)
Shanghai Pharmaceutical (Group) Co., Ltd (上海醫藥(集團)
有限公司)
Shanghai Pharmaceutical (Group) Co., Ltd (上海醫藥(集團)
有限公司)
Shanghai Pharmaceutical (Group) Co., Ltd (上海醫藥(集團)
有限公司)
Changzhou Pharmaceutical Factory Co., Ltd
Changzhou Pharmaceutical Factory Co., Ltd
Changzhou Pharmaceutical Factory Co., Ltd
Changzhou Pharmaceutical Factory Co., Ltd
109
110
111
112
– X-53 –
118
122
123
120
121
119
117
116
Morpholine derivative (Jointly with Tanabe Seiyaku for
application) (嗎啉衍生物 (與日本田邊共同申請))
Letrozole ground mixture and preparing method thereof
and medicine composition containing it (一種來曲唑共研
磨物及其製備方法和含其藥物組合物)
Method for preparing Clofarabine and its intermediary
compound (一種氯法拉濱及其中間體化合物的製備方法)
2,3-dihydro-4(1H）-Quinazolinedione derivative and its
application (2,3-二氫 -4(1H）- 唑酮衍生物及其應用)
Exendin4 polypeptide fragments (Exendin4多肽片段)
Method for preparing D-3-thioacetyl-2-methylpropionyl-Lproline (製備D-3-乙醯硫基-2-甲基丙醯 -L-脯氨酸的方法)
Preparing method of heptenoic acid ester derivative (一種
庚烯酸酯衍生物的製備方法)
Method for preparing Felodipine Sustained Release Tablets
(非洛地平緩釋片的製備方法)
Method for preparing thieno[3,2-c]pyridine derivative (噻吩
並 [3，2-c]吡啶衍生物的製備方法)
(S)-3-(1-dimethylaminoethyl)phenol preparing method ((S)3-(1-二甲氨基乙基) 苯酚的製備方法)
Method for preparing entecavir (一種恩替卡韋的製備方法)
Improved method for preparing 3.5g refined
menthocamphorate (一種改進的製備3.5克精裝清涼油的
方法)
Mixing equipment used in the process of preparing
menthocamphorate plant medicine composition (一種清
涼油植物藥組合物製備過程用混合設備)
Method for dry pill (一種乾燥藥丸的方法)
Risperidone sustained-release gel injection and preparing
method thereof (利培酮緩釋凝膠注射劑及其製備方法)
Patent
201010193842.5
200810110711.9
200810008419.6
200810123806.4
201010254655.3
201010234571.3
201010230687.X
200880020245.3
200910201121.1
200910055549.X
200910050594.6
201010197550.9
200910053425.8
201020239063.X
200910052738.1
Application No.
Remarks
APPENDIX X
115
114
113
Applicant
Serial
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
132
133
134
135
Chiatai Qingchunbao
128
131
Chiatai Qingchunbao
127
Chiatai Qingchunbao
Chiatai Qingchunbao
126
130
Chiatai Qingchunbao
125
Chiatai Qingchunbao
Changzhou Pharmaceutical Factory Co., Ltd
124
Method for improving resolution yield of Clopidogrel
camphorsulfonate (一種提高氯吡格雷樟腦磺酸鹽拆分收率
的方法)
Method for extracting salvianolic acid B (一種丹酚酸B的提
取方法)
Preparing method of injector using tween-80 as solubilizer
(一種以吐溫-80為增溶劑的注射液的製備方法)
Quantitative measuring method for 5-hydroxymethyl
furfural in shengmai injection (一種參麥注射液中5-羥甲基
糠醛的定量測定方法)
Compound in salvia miltiorrhiza bungered sage root
injection and application thereof in curing treating
cardiovascular disease (丹參注射液中的化合物及其在心血
管疾病治療中的應用)
Stable sitafloxacin medicinal composition and preparing
method thereof (一種穩定的西他沙星藥用組合物及其製備
方法)
Quality control method for Shenmai injection (一種參麥注
射液的品質量控制方法)
Quantitative measuring method for effective ingredient in
Salvia miltiorrhiza Bunge injection (一種丹參注射液中有
效成分的定量測定方法)
Salvianolic acid A injection and its preparing method (一種
丹參丹酚酸A的注射製劑及其製備方法)
Method of preparing red sage root injection and quality
control method thereof (一種丹參注射液的製備方法及其
質量控制方法)
Method for extracting effective part of Chinese traditional
medicine of red sage root and rhizome of Sichuan
lovage (丹參和川芎中藥有效部位的提取方法)
One-step granulation device (一種一步制粒裝置)
Patent
– X-54 –
200810163264.3
200710127787.8
200710143306.2
200710120048.6
201010117473.1
200910155685.6
200910155342.X
200910154841.7
200910100937.5
200910095951.0
200810061462.9
201010204576.1
Application No.
on examination
on examination
on examination
on examination
Remarks
APPENDIX X
129
Applicant
Serial
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Liaoning Herbapex Pharmaceutical (Group) Co., Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., Ltd.
145
146
Liaoning Herbapex Pharmaceutical (Group) Co., Ltd.
141
Liaoning Herbapex Pharmaceutical (Group) Co., Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., Ltd.
140
144
Liaoning Herbapex Pharmaceutical (Group) Co., Ltd.
139
Liaoning Herbapex Pharmaceutical (Group) Co., Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., Ltd.
138
143
Liaoning Herbapex Pharmaceutical (Group) Co., Ltd.
137
Liaoning Herbapex Pharmaceutical (Group) Co., Ltd.
Chiatai Qingchunbao
136
Method for extracting salvianolic acid B (一種丹酚酸B的提
取方法)
Chinese medicine for dissipating cold, clearing heat,
harmonizing nutrient and relieving pain and preparing
method thereof (一種散寒清熱、和營定痛的中藥及其製備
方法)
Sanitary hydrojet for cleaning vagina and preparing
method (一種潔陰衛生噴液及製備方法)
Sanitary moisture paper tissue and preparing method
thereof (一種衛生濕巾及其製備方法)
Sanitary moisture paper tissue capable of cleaning vaginal
and preparing method thereof (潔陰衛生濕巾及其製備
方法)
Method for preparing Chinese medicine preparation for
treating wind-heat symptoms type nephritis (治療風熱症
候型腎炎中藥製劑的製備方法)
Chinese medicine for treating children’s hyperkinetic
syndrome and its preparing method (一種治療兒童多動症
的中藥及製備方法)
Chinese medicine for treating neuorsis and its preparing
method (一種治療神經衰弱症的中藥及製備方法)
Chinese medicine for treating puerperal hypogalactia and
its preparing method (一種治療產後乳少、無乳、乳汁不
通的中藥及製備方法)
Traditional Chinese medicinal composition plaster for
curing rheumatism or rheumatoid diseases and its
preparing method (一種治療風濕或類風濕的中藥組合物貼
膏及其製備方法)
Traditional Chinese medicine for treating kidney yin
deficiency and deficiency of both yin and yang and its
preparing method (治療腎陰虛、陰陽兩虛證的中藥及製備
方法)
Patent
– X-55 –
200710157653.0
200710175896.7
200610046009.1
200610046033.5
200610046034.x
200810012479.5
200910010766.7
200910010764.8
200910010765.2
200810012478.0
200810061462.9
Application No.
on examination
Remarks
APPENDIX X
142
Applicant
Serial
No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai Sunway Biotech Co., Ltd.
Shanghai Medical Instruments Co., Ltd. No. 5 Medical
Instruments Plant (上海醫療器械股份有限公司醫療器械五
廠)
Qingdao Growful
Qingdao Growful
Qingdao Growful
147
148
150
151
149
Applicant
Serial
No.
Novel tumor target gene therapy system based on gland
virus replication and recombination (一種新的基於腺病毒
複製重組的腫瘤靶向基因治療系統)
Light bulb fixture mechanism of operation shadowless
lamp using two kinds light of light bulb as light source
(一種以兩種燈泡作為光源的手術無影燈的燈泡固定裝置)
A Chinese medicine composition for brain and its
preparing method and testing method (一種健腦中藥組
合物及其製備方法和檢測方法)
A pharmaceutical composition for treatment of cold and
its preparing method (一種治療感冒的藥物組合物及其製
備方法)
A Chinese medicine composition for treatment of gastritis,
gastric ulcer and duodenal ulcer and their identification
methods (一種治療胃炎、胃潰瘍及十二指腸潰瘍的中藥組
合物及其鑒別方法)
Patent
open stage
open stage
200910148324.9
APPENDIX X
200910087825.0
open stage
on examination
open stage
Remarks
200910152373.X
200610029558.8
200810200511.2
Application No.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-56 –
Registered trademarks:
(a)
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
7.
8.
9.
10.
11.
Sine Pharmaceutical
4.
6.
Shanghai Pharmaceuticals
3.
Sine Pharmaceutical
Shanghai Pharmaceuticals
2.
– X-57 –
936688
172087
381854
135107
1616520
1407500
212067
101282
4275003
Trademark
January 27, 2017
February 28, 2013
Class 5
Class 5
February 28, 2013
Class 5
February 28, 2013
August 13, 2011
Class 5
Class 5
June 13, 2020
Class 5
August 29, 2014
February 28, 2013
Class 5
Class 5
January 27, 2018
Class 5
October 13, 2017
September 27, 2017
Class 5
Class 5
Expiry date
Class
Remarks
APPENDIX X
5.
4275001
Shanghai Pharmaceuticals
1.
4275002
Registration
No.
Serial
No.
Registrant
As of the Latest Practicable Date, the following trademarks were registered in the name of the relevant member of our Company:
Trademarks
(ii)
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
22.
23.
24.
25.
26.
27.
Sine Pharmaceutical
18.
Sine Pharmaceutical
Sine Pharmaceutical
17.
21.
Sine Pharmaceutical
16.
Sine Pharmaceutical
Sine Pharmaceutical
15.
20.
Sine Pharmaceutical
14.
Sine Pharmaceutical
Sine Pharmaceutical
13.
– X-58 –
1246255
1210315
1118258
1050615
1050614
1044725
1044721
1032572
1032571
1032570
1032569
1032568
1032567
1032566
Trademark
Class 5
February 13, 2019
September 27, 2018
October 13, 2017
Class 5
Class 5
July 13, 2017
July 13, 2017
Class 5
Class 5
July 6, 2017
Class 5
July 6, 2017
June 20, 2017
Class 5
Class 5
June 20, 2017
June 20, 2017
Class 5
Class 5
June 20, 2017
June 20, 2017
Class 5
Class 5
June 20, 2017
June 20, 2017
Class 5
Class 5
June 20, 2017
May 13, 2017
Expiry date
Class 5
Class 5
Class
Remarks
APPENDIX X
19.
1002771
Sine Pharmaceutical
12.
1032565
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
38.
39.
40.
41.
42.
Sine Pharmaceutical
34.
Sine Pharmaceutical
Sine Pharmaceutical
33.
37.
Sine Pharmaceutical
32.
Sine Pharmaceutical
Sine Pharmaceutical
31.
36.
Sine Pharmaceutical
30.
Sine Pharmaceutical
Sine Pharmaceutical
29.
– X-59 –
3890500
3450537
3316369
3221906
3190082
3190081
3190080
3183135
3012396
3012381
1600498
147387
1365169
Trademark
October20, 2014
June 27, 2016
Class 5
Class 5
March 13, 2014
September 20, 2013
Class 5
Class 5
September 20, 2013
Class 5
September 20, 2013
September 20, 2013
Class 5
Class 5
August 13, 2013
Class 5
December 20, 2012
December 20, 2012
Class 5
Class 5
July 13, 2011
Class 5
February 28, 2013
February 20, 2020
Class 5
Class 5
January 13, 2020
January 13, 2020
Expiry date
Class 5
Class 5
Class
Remarks
APPENDIX X
35.
1352798
Sine Pharmaceutical
28.
1353335
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
53.
54.
55.
56.
57.
Sine Pharmaceutical
49.
Sine Pharmaceutical
Sine Pharmaceutical
48.
52.
Sine Pharmaceutical
47.
Sine Pharmaceutical
Sine Pharmaceutical
46.
51.
Sine Pharmaceutical
45.
Sine Pharmaceutical
Sine Pharmaceutical
44.
– X-60 –
4694751
4350363
4350362
4114546
4114524
4114522
4114519
4114518
4114517
4114516
3890509
3890507
3890505
Trademark
October 20, 2018
January 6, 2018
Class 5
Class 5
January 6, 2018
March 27, 2017
Class 5
Class 5
March 27, 2017
March 27, 2017
Class 5
Class 5
March 27, 2017
Class 5
March 27, 2017
March 27, 2017
Class 5
Class 5
March 27, 2017
June 13, 2016
Class 5
Class 5
June 27, 2016
Class 5
June 27, 2016
June 27, 2016
Class 5
Class 5
June 27, 2016
Expiry date
Class 5
Class
Remarks
APPENDIX X
50.
3890502
Sine Pharmaceutical
43.
3890503
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
68.
69.
70.
71.
72.
Sine Pharmaceutical
64.
Sine Pharmaceutical
Sine Pharmaceutical
63.
67.
Sine Pharmaceutical
62.
Sine Pharmaceutical
Sine Pharmaceutical
61.
66.
Sine Pharmaceutical
60.
Sine Pharmaceutical
Sine Pharmaceutical
59.
– X-61 –
705371
705370
699277
655158
655157
655156
619520
619519
607797
4870392
4843570
4843418
4797154
Trademark
July 27, 2014
Class 5
Class 5
September 13, 2014
September 13, 2014
August 27, 2013
Class 5
Class 5
August 27, 2013
Class 5
August 27, 2013
November 29, 2012
Class 5
Class 5
November 29, 2012
August 29, 2012
Class 5
Class 5
January 20, 2019
January 27, 2019
Class 5
Class 5
January 27, 2019
Class 5
February 27, 2019
February 27, 2019
Class 5
Class 5
February 27, 2019
Expiry date
Class 5
Class
Remarks
APPENDIX X
65.
4797152
Sine Pharmaceutical
58.
4797153
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
83.
84.
85.
86.
87.
Sine Pharmaceutical
79.
Sine Pharmaceutical
Sine Pharmaceutical
78.
82.
Sine Pharmaceutical
77.
Sine Pharmaceutical
Sine Pharmaceutical
76.
81.
Sine Pharmaceutical
75.
Sine Pharmaceutical
Sine Pharmaceutical
74.
– X-62 –
1444719
1432726
172875
978656
4388190
4388189
4364799
4364798
4114521
3012382
200575
1688475
1608532
Trademark
December 20, 2012
Class 5
April 13, 2017
Class 5
Class 30
Class 30
September 13, 2020
August 13, 2020
March 14, 2013
February 13, 2018
Class 5
Class 29
February 13, 2018
January 27, 2018
Class 5
Class 5
January 27, 2018
Class 5
March 27, 2017
October 29, 2013
Class 5
Class 5
December 27, 2011
July 27, 2011
Class 5
Class 5
April 13, 2017
February 13,2015
Expiry date
Class 5
Class 5
Class
Remarks
APPENDIX X
80.
729229
Sine Pharmaceutical
73.
978657
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
98.
99.
100.
101.
102.
Sine Pharmaceutical
94.
Sine Pharmaceutical
Sine Pharmaceutical
93.
97.
Sine Pharmaceutical
92.
Sine Pharmaceutical
Sine Pharmaceutical
91.
96.
Sine Pharmaceutical
90.
Sine Pharmaceutical
Sine Pharmaceutical
89.
– X-63 –
4557015
4557014
3890508
3206411
3206410
3012382
1728428
1624583
1389396
3221907
3480363
3480362
3480361
Trademark
July 27, 2018
July 6, 2018
Class 5
Class 5
June 27, 2016
August 27, 2013
Class 5
Class 5
August 27, 2013
Class 5
December 20, 2012
March 13, 2012
Class 5
Class 5
August 27, 2011
Class 5
April 27, 2020
January 6, 2014
Class 32
Class 5
August 20, 2014
August 20, 2014
Class 30
Class 30
April 27, 2015
April 13, 2014
Class 30
Class 30
March 27, 2013
Expiry date
Class 30
Class
Remarks
APPENDIX X
95.
3078589
Sine Pharmaceutical
88.
3390101
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
5393568
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Shanghai Sine Kangjie Pharmaceutical Co., Ltd. 3712504
(上海信誼康捷藥業有限公司)
103.
104.
105.
106.
107.
108.
109.
110.
– X-64 –
111.
112.
113.
114.
7492624
7492618
6895885
6347532
6347531
Trademark
December 20, 2020
January 27, 2016
Class 5
Class 5
December 20, 2020
July 13, 2020
Class 5
Class 5
March 27, 2020
March 27, 2020
Class 5
Class 5
March 27, 2020
Class 5
March 27, 2020
Class 5
December 13, 2019
Class 5
March 27, 2020
November 13, 2019
Class 5
Class 5
August 27, 2019
Expiry date
Class 5
Class
Remarks
APPENDIX X
6347530
6347529
6347528
5803657
5626355
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai Sine Kangjie Pharmaceutical
(上海信誼康捷藥業有限公司)
Shanghai Sine Kangjie Pharmaceutical
(上海信誼康捷藥業有限公司)
Shanghai Sine Kangjie Pharmaceutical
(上海信誼康捷藥業有限公司)
Shanghai Sine Kangjie Pharmaceutical
(上海信誼康捷藥業有限公司)
Shanghai Sine Kangjie Pharmaceutical
(上海信誼康捷藥業有限公司)
Shanghai Sine Kangjie Pharmaceutical
(上海信誼康捷藥業有限公司)
Shanghai Sine Kangjie Pharmaceutical
(上海信誼康捷藥業有限公司)
Shanghai Sine Kangjie Pharmaceutical
(上海信誼康捷藥業有限公司)
Shanghai Sine Kangjie Pharmaceutical
(上海信誼康捷藥業有限公司)
Shanghai Yanan Wanxiang Pharmaceutical
3382596
Co., Ltd. (上海延安萬象藥業有限公司)
(the predecessor of Shanghai Sine Wanxiang
Pharmaceutical Co., Ltd.)
Shanghai Yanan Wanxiang Pharmaceutical
3227231
Co., Ltd. (上海延安萬象藥業有限公司)
(the predecessor of Shanghai Sine Wanxiang
Pharmaceutical Co., Ltd.)
117.
– X-65 –
126.
127.
125.
124.
123.
122.
Co., Ltd. 4686982
Co., Ltd. 4557018
Co., Ltd. 4686981
Co., Ltd. 4686980
Co., Ltd. 4686979
Co., Ltd. 4662785
Co., Ltd. 4557017
Co., Ltd. 4557016
Trademark
Class 5
September 20, 2013
July 13, 2014
October 13, 2018
Class 5
Class 5
July 6, 2018
October 13, 2018
Class 5
Class 5
October 13, 2018
October 13, 2018
Class 5
Class 5
October 6, 2018
July 27, 2018
Class 5
Class 5
July 27, 2018
Class 5
March 27, 2017
March 27, 2017
Class 5
Class 5
June 27, 2016
Expiry date
Class 5
Class
Remarks
APPENDIX X
121.
120.
119.
118.
Shanghai Sine Kangjie Pharmaceutical Co., Ltd. 4115818
(上海信誼康捷藥業有限公司)
116.
Co., Ltd. 4114548
Shanghai Sine Kangjie Pharmaceutical Co., Ltd. 3890506
(上海信誼康捷藥業有限公司)
Registration
No.
115.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai Yanan Wanxiang Pharmaceutical
3794032
Co., Ltd. (上海延安萬象藥業有限公司)
(the predecessor of Shanghai Sine Wanxiang
Pharmaceutical Co., Ltd.)
Shanghai Sine Wanxiang Pharmaceutical Co.,
4650993
Ltd.
Shanghai Sine Wanxiang Pharmaceutical Co.,
4274998
Ltd.
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
133.
– X-66 –
136.
137.
135.
134.
132.
4863682
3411400
4890418
3155930
3158602
Trademark
September 27, 2014
Class 5
January 13, 2019
September 27, 2017
Class 5
Class 5
October 13, 2018
March 13, 2016
January 13, 2019
June 20, 2013
Class 5
Class 5
Class 5
Class 5
June 20, 2013
September 6, 2012
Class 5
Class 5
September 20, 2013
Expiry date
Class 5
Class
Remarks
APPENDIX X
131.
130.
1906876
3227230
Shanghai Yanan Wanxiang Pharmaceutical
Co., Ltd. (上海延安萬象藥業有限公司)
(the predecessor of Shanghai Sine Wanxiang
Pharmaceutical Co., Ltd.)
Shanghai Yanan Wanxiang Pharmaceutical
Co., Ltd. (上海延安萬象藥業有限公司)
(the predecessor of Shanghai Sine Wanxiang
Pharmaceutical Co., Ltd.)
Shanghai Yanan Wanxiang Pharmaceutical
Co., Ltd. (上海延安萬象藥業有限公司)
(the predecessor of Shanghai Sine Wanxiang
Pharmaceutical Co., Ltd.)
Shanghai Yanan Wanxiang Pharmaceutical
Co., Ltd. (上海延安萬象藥業有限公司)
(the predecessor of Shanghai Sine Wanxiang
Pharmaceutical Co., Ltd.)
Shanghai Sine Wanxiang Pharmaceutical Co.,
Ltd.
128.
129.
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
4913032
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
138.
139.
140.
141.
142.
143.
144.
145.
– X-67 –
146.
147.
148.
149.
150.
151.
3262996
3262994
3262993
3168812
1972098
1805638
1696489
1640583
Trademark
July 13, 2012
Class 5
Class 5
January 6, 2014
January 6, 2014
January 6, 2014
Class 5
Class 5
July 6, 2013
Class 5
November 13, 2012
January 13, 2012
Class 5
Class 5
September 27, 2011
February 27, 2020
June 6, 2011
February 28, 2013
Class 5
Class 5
Class 5
Class 5
February 28, 2013
August 13, 2019
Class 5
Class 5
March 13, 2019
Expiry date
Class 5
Class
Remarks
APPENDIX X
1367736
1580468
101287
101279
5260604
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
Shanghai Ziyuan Pharmaceutical Co., Ltd.
Shanghai Ziyuan Pharmaceutical Co., Ltd.
162.
163.
164.
165.
166.
Shanghai No. 1 Biochemical
158.
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
157.
161.
Shanghai No. 1 Biochemical
156.
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
155.
160.
Shanghai No. 1 Biochemical
154.
Shanghai No. 1 Biochemical
Shanghai No. 1 Biochemical
153.
– X-68 –
4427208
4459309
3411401
4377019
3692228
3518890
3168811
3020033
3928919
3915145
3822789
3677771
3677770
Trademark
May 20, 2018
April 13, 2018
Class 5
Class 5
September 20, 2014
May 13, 2018
Class 5
Class 5
January 6, 2016
February 13, 2018
Class 5
Class 5
July 6, 2013
December 20, 2012
August 27, 2016
Class 5
Class 5
Class 5
August 13, 2016
April 6, 2016
Class 5
Class 5
December 13, 2015
December 13, 2015
Class 5
Class 5
January 20, 2014
February 6, 2014
Expiry date
Class 5
Class 5
Class
Remarks
APPENDIX X
159.
3283238
Shanghai No. 1 Biochemical
152.
3290779
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai Shanglian Pharmaceutical Co., Ltd.
(上海上聯藥業有限公司)
Shanghai Industrial United Holdings
Pharmaceutical Co., Ltd.
Shanghai Industrial United Holdings
Pharmaceutical Co., Ltd.
169.
170.
171.
– X-69 –
175.
174.
173.
Shanghai Industrial United Holdings
Pharmaceutical Co., Ltd. (the predecessor of
Shanglian Pharmaceutical) (上海實業聯合集團
製藥有限公司（系上聯藥業前身）)
Shanghai Industrial United Holdings
Pharmaceutical Co., Ltd. (the predecessor of
Shanglian Pharmaceutical) (上海實業聯合集團
製藥有限公司（系上聯藥業前身）)
Shanghai Medical Instruments Co., Ltd., Dental
Material Factory (上海醫療器械股份有限公司
齒科材料廠)
Shanghai Medical Instruments Co., Ltd., Dental
Material Factory (上海醫療器械股份有限公司
齒科材料廠)
Hangzhou Huqingyutang Pharmaceutical
Co., Ltd.
168.
100489
381337
6058181
6058182
4502083
4487973
1770687
Trademark
February 28, 2013
February 28, 2013
Class 5
December 20, 2019
Class 30
Class 10
February 6, 2020
September 6, 2017
Class 30
Class 5
May 6, 2018
May 20, 2012
Class 5
Class 5
November 20, 2009
August 13, 2009
Expiry date
Class 5
Class 5
Class
This is a branch company
of Shanghai Medical
Instruments Co., Ltd.
This trademark has been
licensed to Shanglian
Pharmaceutical and the
license expires on May 6,
2018
This trademark has been
licensed to Shanglian
Pharmaceutical and the
license expires on Sep 6,
2017
Remarks
APPENDIX X
172.
1302735
Hangzhou Huqingyutang Pharmaceutical
Co., Ltd.
167.
1335251
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-70 –
185.
184
183.
182.
181.
1519436
1479098
1620503
1606563
1574107
1573923
3024400
381338
100491
Trademark
February 6, 2021
November 20, 2020
Class 10
Class 10
August 20, 2011
July 20, 2011
Class 5
Class 9
May 20, 2011
May 20, 2011
Class 7
Class 8
March 6, 2013
Class 10
February 28, 2013
February 28, 2013
Class 9
Class 8
February 28, 2013
Expiry date
Class 7
Class
Remarks
APPENDIX X
180.
179.
178.
177.
100490
176.
Shanghai Medical Instruments Co., Ltd., Dental
Material Factory(上海醫療器械股份有限公司齒
科材料廠)
Shanghai Medical Instruments Co., Ltd., Dental
Material Factory (上海醫療器械股份有限公司
齒科材料廠)
Shanghai Medical Instruments Co., Ltd., Dental
Material Factory (上海醫療器械股份有限公司
齒科材料廠)
Shanghai Medical Instruments Co., Ltd., Dental
Material Factory (上海醫療器械股份有限公司
齒科材料廠)
Shanghai Medical Instruments Co., Ltd., Dental
Material Factory (上海醫療器械股份有限公司
齒科材料廠)
Shanghai Medical Instruments Co., Ltd., Dental
Material Factory (上海醫療器械股份有限公司
齒科材料廠)
Shanghai Medical Instruments Co., Ltd., Dental
Material Factory (上海醫療器械股份有限公司
齒科材料廠)
Shanghai Medical Instruments Co., Ltd., Dental
Material Factory (上海醫療器械股份有限公司
齒科材料廠)
Shanghai Medical Instruments Co., Ltd. Dental
Material Factory (上海醫療器械股份有限公司
齒科機械廠)
Shanghai Kangge Special Medical Instruments
Factory (上海康鴿特種醫用器械廠) (the
predecessor of Shanghai Shengyi Kangge
Medical Equipment Co., Ltd.)
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-71 –
196.
195.
194.
193 .
192 .
191.
190.
1920595
1161204
Class 10
Class 10
December 6, 2012
March 20, 2018
February 28, 2013
Class 10
381628
October 27, 2020
Class 10
1467023
February 20, 2018
February 28, 2013
June 6, 2018
September 20, 2011
Class 10
Class 10
Class 10
Class 10
December 6, 2016
November 9, 2012
Class 10
Class 10
December 20, 2011
Expiry date
Class 10
Class
1153055
100485
1181568
1637566
Trademark
This is a branch company
of Shanghai Medical
Instruments Co., Ltd.
This is a branch company
of Shanghai Medical
Instruments Co., Ltd.
Remarks
APPENDIX X
Shanghai Medical Instruments Co., Ltd., the
Medical Equipment Factory (上海醫療器械股
份有限公司醫療設備廠)
Shanghai Medical Instruments Co., Ltd., the
Medical Equipment Factory (上海醫療器械股
份有限公司醫療設備廠)
Shanghai Medical Instruments Co., Ltd., the
Medical Equipment Factory (上海醫療器械股
份有限公司醫療設備廠)
Shanghai Medical Instruments Co., Ltd., the
Medical Equipment Factory (上海醫療器械股
份有限公司醫療設備廠)
Shanghai Medical Instruments Co., Ltd., the
Medical Equipment Factory (上海醫療器械股
份有限公司醫療設備廠)
Shanghai Medical Instruments Co., Ltd. Dental
Medical Instruments Factory (上海醫療器械股
份有限公司齒科醫械廠)
Shanghai Medical Instruments Co., Ltd., the
Medical Optical Instruments Factory (上海醫
療器械股份有限公司醫用光學儀器廠)
Shanghai Medical Optical Instruments Factory
(上海醫用光學儀器廠)
Shanghai Medical Optical Instruments Factory
(上海醫用光學儀器廠)
188.
189.
Shanghai Shengli Medical Instruments Co., Ltd. 617516
(上海勝利醫療器械有限公司)
187.
910168
Shanghai Shengli Medical Instruments Co., Ltd. 1685537
(上海勝利醫療器械有限公司)
Registration
No.
186.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai Medical Instruments Co., Ltd., the
135958
Medical Equipment Factory (上海醫療器械股
份有限公司醫療設備廠)
Shanghai Medical Instruments Co., Ltd. the
216584
Fifth Medical Instrument Factory (上海醫療器
械股份有限公司醫療器械五廠)
Shanghai Medical Instruments Co., Ltd. the
4131189
Fifth Medical Instrument Factory (上海醫療器
械股份有限公司醫療器械五廠)
Shanghai Dental Medical Instruments Factory
(上海齒科醫械廠)
Shanghai Dental Medical Instruments Factory
(上海齒科醫械廠)
Shanghai Dental Medical Instruments Factory
(上海齒科醫械廠)
199.
201.
202.
203.
204.
200.
– X-72 –
898104
898079
Trademark
November 13, 2016
November 13, 2016
November 13, 2016
Class 10
Class 10
Class 10
January 20, 2017
December 24, 2014
Class 10
Class 10
February 28, 2013
April 19, 2017
Class 10
Class 10
January 20, 2013
Expiry date
Class 10
Class
This is a branch company
of Shanghai Medical
Instruments Co., Ltd.
Remarks
APPENDIX X
898068
284214
1920121
Shanghai Medical Instruments Co., Ltd., the
Medical Equipment Factory (上海醫療器械股
份有限公司醫療設備廠)
Shanghai Medical Instruments Co., Ltd., the
Medical Equipment Factory (上海醫療器械股
份有限公司醫療設備廠)
197.
198.
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
211.
212.
213.
214.
215.
Shanghai Pharmaceutical Distribution Co.
208.
210.
Shanghai Pharmaceutical Distribution Co.
207.
Shanghai Pharmaceutical Distribution Co.
Shanghai Medical Instruments Co., Ltd
206.
– X-73 –
1020850
820401
798252
5673710
5673709
5011145
5011144
808051
151178
Trademark
February 28, 2013
Class 5
March 6, 2016
June 6, 2017
Class 5
December 13, 2015
Class 5
Class 10
October 27, 2019
October 27, 2019
Class 39
Class 39
April 20, 2019
April 20, 2019
Class 5
Class 5
January 20, 2016
December 20, 2019
Class 10
Class 5
December 6, 2016
Expiry date
Class 10
Class
Remarks
APPENDIX X
209.
910168
Shanghai Dental Medical Instruments Factory
(上海齒科醫械廠)
205.
6140852
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
226.
227.
228.
229.
230.
231.
Shanghai Pharmaceutical Distribution Co.
222.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
221.
225.
Shanghai Pharmaceutical Distribution Co.
220.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
219.
224.
Shanghai Pharmaceutical Distribution Co.
218.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
217.
– X-74 –
4530872
4530871
4530870
4530869
4530868
4530867
4530863
4530861
4530860
4530859
4530858
4530857
4530856
4530855
Trademark
Class 5
May 13, 2018
May 13, 2018
May 13, 2018
Class 5
Class 5
May 13, 2018
Class 5
May 13, 2018
Class 5
May 13, 2018
Class 5
May 13, 2018
May 13, 2018
Class 5
Class 5
May 13, 2018
Class 5
May 13, 2018
Class 5
May 13, 2018
Class 5
May 13, 2018
May 13, 2018
Class 5
Class 5
May 20, 2018
May 20, 2018
Class 5
Class 5
November 27, 2018
Expiry date
Class 5
Class
Remarks
APPENDIX X
223.
1226146
Shanghai Pharmaceutical Distribution Co.
216.
4530854
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
242.
243.
244.
245.
246.
247.
Shanghai Pharmaceutical Distribution Co.
238.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
237.
241.
Shanghai Pharmaceutical Distribution Co.
236.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
235.
240.
Shanghai Pharmaceutical Distribution Co.
234.
Shanghai Pharmaceutical Distribution Co.
Shanghai Pharmaceutical Distribution Co.
233.
– X-75 –
4215374
4215373
3546062
3546061
3546060
4530893
4530892
4530891
4530890
4530889
4530888
4530887
4530886
4530885
Trademark
Class 7
January 6, 2017
December 27, 2016
December 13, 2014
Class 12
Class 7
December 13, 2014
June 27, 2015
Class 18
Class 12
May 13, 2018
Class 5
May 13, 2018
May 13, 2018
Class 5
Class 5
May 13, 2018
May 13, 2018
Class 5
Class 5
May 13, 2018
May 13, 2018
Class 5
Class 5
May 13, 2018
May 13, 2018
Class 5
Class 5
May 13, 2018
May 13, 2018
Expiry date
Class 5
Class 5
Class
Remarks
APPENDIX X
239.
4530873
Shanghai Pharmaceutical Distribution Co.
232.
4530874
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
4215376
Shanghai Pharmaceutical Distribution Co.
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
248.
249.
250.
251.
252.
253.
254.
255.
256.
– X-76 –
257.
258.
259.
260.
261.
262.
4852520
4852507
4852506
4852505
4852504
4852503
4852521
4852511
Trademark
Class 44
April 20, 2019
May 13, 2018
May 13, 2018
Class 32
Class 33
January 20, 2019
January 20, 2019
Class 16
Class 21
March 6, 2019
Class 35
January 6, 2020
July 20, 2018
Class 10
Class 5
February 20, 2019
Class 5
May 6, 2019
Class 5
June 20, 2019
April 6, 2019
Class 21
Class 3
July 6, 2019
February 13, 2021
Class 35
Class 39
January 27, 2017
Expiry date
Class 7
Class
Remarks
APPENDIX X
4852510
4852509
4794436
4848555
4848554
1523801
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
273.
274.
275.
Huashi Pharmacy
269.
Huashi Pharmacy
Huashi Pharmacy
268.
272.
Huashi Pharmacy
267.
Huashi Pharmacy
Huashi Pharmacy
266.
271.
Huashi Pharmacy
265.
Huashi Pharmacy
Huashi Pharmacy
264.
– X-77 –
4794446
4794437
4794435
4794434
4794433
4794432
4794431
1588373
3737786
4852508
4848520
Trademark
Class 39
January 27, 2019
March 6, 2019
June 6, 2018
Class 10
Class 3
April 6, 2018
January 27, 2019
Class 35
Class 30
February 27, 2019
February 20, 2019
Class 44
Class 16
June 20, 2011
April 13, 2016
Class 5
Class 5
March 6, 2019
May 13, 2018
Class 30
Class 39
July 27, 2018
March 6, 2019
Expiry date
Class 10
Class 3
Class
Remarks
APPENDIX X
270.
4852521
Huashi Pharmacy
263.
4852502
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
285.
286.
287.
288.
289.
Chiatai Qingchunbao
281.
284.
Huashi Pharmacy
280.
Chiatai Qingchunbao
Huashi Pharmacy
279.
283.
Huashi Pharmacy
278.
Chiatai Qingchunbao
Huashi Pharmacy
277.
– X-78 –
726832
715082
866095
1087276
1265252
1352739
1906175
3527279
3527278
7059868
3763251
4794449
Trademark
November 13, 2014
Class 32
January 27, 2015
August 27, 2016
Class 5
Class 29
August 27, 2017
April 20, 2019
Class 5
Class 5
January 13, 2020
October 20, 2012
Class 5
Class 5
February 20, 2015
October 6, 2014
Class 30
Class 5
August 27, 2020
May 27, 2015
Class 35
Class 10
February 20, 2019
April 6, 2018
Class 32
Class 21
April 6, 2018
Expiry date
Class 33
Class
Remarks
APPENDIX X
282.
4794447
Huashi Pharmacy
276.
4794448
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
300.
301.
302.
303.
304.
305.
Chiatai Qingchunbao
296.
Chiatai Qingchunbao
Chiatai Qingchunbao
295.
299.
Chiatai Qingchunbao
294.
Chiatai Qingchunbao
Chiatai Qingchunbao
293.
298.
Chiatai Qingchunbao
292.
Chiatai Qingchunbao
Chiatai Qingchunbao
291.
– X-79 –
771707
771305
770468
770509
770564
770344
769703
1352740
686030
687338
712667
712548
715081
726831
Trademark
Class 41
November 13, 2014
November 6, 2014
October 20, 2014
Class 42
Class 39
October 27, 2014
October 27, 2014
Class 36
Class 35
October 20, 2014
Class 37
October 13, 2014
January 13, 2020
Class 5
Class 40
April 20, 2014
April 27, 2014
Class 32
Class 5
October 27, 2014
October 27, 2014
Class 5
Class 33
November 13, 2014
January 27, 2015
Class 29
Class 32
October 20, 2014
October 27, 2014
Expiry date
Class 30
Class 30
Class
Remarks
APPENDIX X
297.
712209
Chiatai Qingchunbao
290.
711475
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
316.
317.
318.
319.
Chiatai Qingchunbao
312.
Chiatai Qingchunbao
Chiatai Qingchunbao
311.
315.
Chiatai Qingchunbao
310.
Chiatai Qingchunbao
Chiatai Qingchunbao
309.
314.
Chiatai Qingchunbao
308.
Chiatai Qingchunbao
Chiatai Qingchunbao
307.
– X-80 –
770815
709096
707232
711936
860622
875044
861429
859502
858930
857398
858743
770208
Trademark
October 27, 2014
October 6, 2014
Class 30
Class 37
September 20, 2014
October 20, 2014
Class 28
Class 24
August 6, 2016
September 27, 2016
Class 18
Class 12
August 6, 2016
July 27, 2016
Class 21
Class 20
July 27, 2016
July 20, 2016
Class 28
Class 10
July 27, 2016
October 20, 2014
Class 38
Class 9
July 27, 2016
May 20, 2016
Expiry date
Class 11
Class 31
Class
Remarks
APPENDIX X
313.
841123
Chiatai Qingchunbao
306.
858312
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
327.
328.
329.
330.
Chiatai Qingchunbao
324.
Chiatai Qingchunbao
Chiatai Qingchunbao
323.
326.
Chiatai Qingchunbao
322.
Chiatai Qingchunbao
Chiatai Qingchunbao
321.
– X-81 –
769149
690563
689276
769172
769490
770207
770259
771154
779366
Trademark
May 20, 2014
October 6, 2014
Class 36
May 13, 2014
Class 3
Class 10
October 6, 2014
October 6, 2014
Class 42
Class 40
October 20, 2014
October 20, 2014
November 6, 2014
Class 38
Class 39
Class 41
March 13, 2015
April 13, 2014
Class 7
Class 35
February 20, 2013
Expiry date
Class 30
Class
Remarks
APPENDIX X
325.
3020698
Chiatai Qingchunbao
320.
685541
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
338.
339.
340.
341.
342.
Chiatai Qingchunbao
335.
Chiatai Qingchunbao
Chiatai Qingchunbao
334.
337.
Chiatai Qingchunbao
333.
Chiatai Qingchunbao
Chiatai Qingchunbao
332.
– X-82 –
4116828
4116829
4050036
4050032
4050035
4050033
756522
704181
686027
687339
Trademark
February 6, 2017
Class 5
September 6, 2016
April 6, 2017
Class 30
Class 5
May 20, 2016
May 20, 2016
Class 30
Class 30
February 6, 2017
July 20, 2015
September 6, 2014
April 20, 2014
Class 5
Class 5
Class 5
Class 32
April 27, 2014
May 6, 2014
Class 29
Class 5
May 6, 2014
Expiry date
Class 30
Class
Remarks
APPENDIX X
336.
688103
Chiatai Qingchunbao
331.
688274
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
353.
354.
355.
356.
Chiatai Qingchunbao
349.
Chiatai Qingchunbao
Chiatai Qingchunbao
348.
352.
Chiatai Qingchunbao
347.
Chiatai Qingchunbao
Chiatai Qingchunbao
346.
351.
Chiatai Qingchunbao
345.
Chiatai Qingchunbao
Chiatai Qingchunbao
344.
– X-83 –
5246484
5246483
5742484
4625795
6598450
6428084
6598451
6428083
6807944
5232058
5901250
5901252
Trademark
Class 5
Class 30
October 6, 2019
April 6, 2019
October 6, 2019
December 20, 2017
Class 30
Class 30
March 6, 2020
March 6, 2020
Class 10
Class 29
March 27, 2020
Class 7
March 27, 2020
April 13, 2020
Class 31
Class 1
July 13, 2019
Class 5
December 27, 2019
December 27, 2019
Class 30
Class 30
July 6, 2020
March 27, 2019
Expiry date
Class 40
Class 30
Class
Remarks
APPENDIX X
350.
5232057
Chiatai Qingchunbao
343.
6428086
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
5246486
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
357.
358.
359.
360.
361.
362.
– X-84 –
363.
364.
5089660
4625794
4506018
Trademark
November 13, 2018
July 27, 2019
Class 5
Class 30
June 6, 2020
Class 5
June 6, 2020
January 20, 2020
Class 30
Class 5
January 20, 2020
July 13, 2019
Class 5
Class 30
April 6, 2019
Expiry date
Class 30
Class
Remarks
APPENDIX X
4506017
4506016
4506015
5246487
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
5089661
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
365.
366.
367.
368.
369.
370.
– X-85 –
371.
372.
373.
5102458
5102457
5102456
5102455
Trademark
August 13, 2019
Class 5
Class 30
November 13, 2018
November 13, 2018
November 13, 2018
Class 30
Class 30
May 20, 2019
May 20, 2019
Class 5
Class 5
May 20, 2019
August 13, 2019
Class 5
Class 5
August 13, 2019
Expiry date
Class 5
Class
Remarks
APPENDIX X
5102454
5102453
5102452
5102444
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
381.
382.
383.
Chiatai Qingchunbao
378.
Chiatai Qingchunbao
Chiatai Qingchunbao
377.
380.
Chiatai Qingchunbao
376.
Chiatai Qingchunbao
Chiatai Qingchunbao
375.
– X-86 –
6807943
6807942
6807941
6598452
6428085
5742486
5742485
5742483
Trademark
Class 35
September 20, 2020
September 20, 2020
September 27, 2020
Class 44
Class 43
August 27, 2020
September 27, 2020
April 13, 2020
December 20, 2019
Class 42
Class 32
Class 5
Class 5
December 6, 2019
November 13, 2018
Class 30
Class 5
November 13, 2018
Expiry date
Class 30
Class
Remarks
APPENDIX X
379.
5102459
Chiatai Qingchunbao
374.
5102460
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Sunve Pharmaceutical
Sunve Pharmaceutical
Sunve Pharmaceutical
Sunve Pharmaceutical
Sunve Pharmaceutical
Sunve Pharmaceutical
Sunve Pharmaceutical
393.
394.
395.
396.
397.
398.
Sunve Pharmaceutical
389.
392.
Sunve Pharmaceutical
388.
Sunve Pharmaceutical
Sunve Pharmaceutical
387.
391.
Sunve Pharmaceutical
386.
Sunve Pharmaceutical
Sunve Pharmaceutical
385.
– X-87 –
721025
721002
720703
720673
719523
719521
4567508
4567507
4567506
3715742
3642378
1745542
1644403
Trademark
December 20, 2014
Class 3
Class 5
December 20, 2014
December 20, 2014
December 20, 2014
Class 31
Class 5
December 13, 2014
December 13, 2014
Class 30
Class 30
August 6, 2018
August 6, 2018
August 6, 2019
Class 5
Class 5
Class 5
February 13, 2016
October 27, 2015
Class 5
Class 5
April 13, 2012
Class 5
October 6, 2011
February 28, 2013
Class 5
Class 5
August 13, 2020
Expiry date
Class 5
Class
Under modification
application
Under modification
application
Under modification
application
Under modification
application
Under modification
application
Under modification
application
Under modification
application
Under modification
application
Under modification
application
Under modification
application
Under modification
application
Under modification
application
Under modification
application
Under modification
application
Remarks
APPENDIX X
390.
7174564
Chiatai Qingchunbao
384.
101280
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
408.
409.
410.
Zhonghua Pharmaceutical
404.
407.
Zhonghua Pharmaceutical
403.
Zhonghua Pharmaceutical
Sunve Pharmaceutical
402.
406.
Sunve Pharmaceutical
401.
Zhonghua Pharmaceutical
Sunve Pharmaceutical
400.
– X-88 –
1447692
3583287
3045487
936703
306133
266342
3045483
944551
964176
722509
Trademark
September 20, 2020
July 20, 2015
Class 5
Class 30
February 27, 2013
January 27, 2017
Class 5
Class 5
December 29, 2017
October 19, 2016
June 6, 2013
Class 5
Class 5
Class 3
February 13, 2017
Class 3
December 27, 2014
Class 7
March 20, 2017
December 27, 2014
Class 3
Class 5
December 20, 2014
Expiry date
Class 7
Class
Under modification
application
Under modification
application
Under modification
application
Under modification
application
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Remarks
to
to
to
to
to
to
to
to
APPENDIX X
405.
721282
Sunve Pharmaceutical
399.
722110
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
418.
419.
420.
Zhonghua Pharmaceutical
415.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
414.
417.
Zhonghua Pharmaceutical
413.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
412.
– X-89 –
1780366
3045482
3045481
3583286
22080
3583288
3045488
756560
Trademark
June 6, 2012
February 27, 2013
Class 5
Class 3
May 13, 2014
October 20, 2015
February 28, 2013
Class 30
Class 5
Class 5
June 20, 2015
January 20, 2014
Class 5
Class 5
July 20, 2015
May 20, 2014
Class 3
Class 5
March 13, 2013
Expiry date
Class 30
Class
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Remarks
to
to
to
to
to
to
to
to
to
to
APPENDIX X
416.
3045485
Zhonghua Pharmaceutical
411.
3045484
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
756561
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
421.
422.
423.
424.
425.
426.
427.
– X-90 –
428.
429.
430.
3451574
101288
3583284
3583283
3583289
Trademark
October 20, 2015
Class 3
Class 5
October 20, 2014
February 28, 2013
October 6, 2015
Class 5
Class 5
October 20, 2015
Class 3
October 6, 2015
October 6, 2015
Class 5
Class 5
October 20, 2015
September 20, 2020
Class 30
Class 3
July 20, 2015
Expiry date
Class 5
Class
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
Has been transfered
Zhonghua
Pharmaceutical
to
to
to
to
to
to
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Remarks
APPENDIX X
3583271
3583285
3583282
1447690
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
437.
438.
439.
Zhonghua Pharmaceutical
434.
436.
Zhonghua Pharmaceutical
433.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
432.
– X-91 –
1008897
1008861
978763
3451577
3451576
5083366
960722
Trademark
May 20, 2017
May 20, 2017
Class 5
Class 5
April 13, 2017
October 20, 2014
October 20, 2014
Class 5
Class 5
Class 5
May 13, 2019
March 13, 2017
Class 5
Class 5
January 27, 2017
October 20, 2014
Expiry date
Class 5
Class 5
Class
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Remarks
APPENDIX X
435.
3451575
Zhonghua Pharmaceutical
431.
936613
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
447.
448.
449.
450.
451.
Zhonghua Pharmaceutical
444.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
443.
446.
Zhonghua Pharmaceutical
442.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
441.
– X-92 –
4703612
5125428
5125429
5125430
5125431
5125432
3322836
635065
5083365
4413973
Trademark
March 29, 2013
Class 5
May 27, 2019
May 27, 2019
Class 5
Class 5
August 22, 2013
May 27, 2019
Class 5
–
May 27, 2019
May 27, 2019
Class 5
Class 5
March 13, 2014
May 13, 2019
Class 5
Class 5
March 13, 2019
December 27, 2012
Class 5
Class 3
June 27, 2015
Expiry date
Class 5
Class
Registered in Japan
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Has been transfered to
Zhonghua
Pharmaceutical
Remarks
APPENDIX X
445.
3590941
Zhonghua Pharmaceutical
440.
3035673
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
461.
462.
463.
Zhonghua Pharmaceutical
457.
460.
Zhonghua Pharmaceutical
456.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
455.
459.
Zhonghua Pharmaceutical
454.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
453.
– X-93 –
6067158
3045480
5154683
6067148
6067144
6067143
6067153
4353188
5154684
6766657
Trademark
December 27, 2019
March 13, 2014
Class 3
Class 30
June 13, 2019
Class 5
March 20, 2021
January 20, 2020
Class 3
Class 5
January 20, 2020
February 13, 2020
Class 5
Class 3
December 27, 2017
June 13, 2019
Class 5
Class 5
May 27, 2020
August 26, 2013
August 26, 2013
Expiry date
Class 5
–
–
Class
Registered in United States
Registered in United States
Remarks
APPENDIX X
458.
2755373
Zhonghua Pharmaceutical
452.
2991222
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
471.
472.
473.
474.
475.
Zhonghua Pharmaceutical
468.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
467.
470.
Zhonghua Pharmaceutical
466.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
465.
– X-94 –
126747
825512
IDM000006016
Kor194311
49018
48472
16057/02
16058/02
6067147
6067152
Trademark
November 1, 2018
September 1, 2013
Class 5
Class 5
January 23, 2013
November 14, 2012
–
Class 5
December 27, 2011
Class 5
December 27, 2011
Class 5
December 27, 2011
–
December 27, 2011
January 20, 2020
Class 3
–
February 13, 2020
February 13, 2020
Class 5
Class 5
December 27, 2019
Expiry date
Class 30
Class
Registered in Russia
Registered in India
Registered in Indonesia
Registered in Thailand
Registered in Vietnam
Registered in Vietnam
Registered in Cambodia
Registered in Cambodia
Remarks
APPENDIX X
469.
6067160
Zhonghua Pharmaceutical
464.
6067149
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
483.
484.
485.
486.
Zhonghua Pharmaceutical
480.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
479.
482.
Zhonghua Pharmaceutical
478.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
477.
– X-95 –
731713
Kor219344
16059/02
14487
1141 OF 2002
4875/95
19352
23194
28283
Trademark
–
August 13, 2012
November 14, 2012
December 27, 2011
–
–
April 28, 2012
August 30, 2011
February 17, 2015
–
Class 5
Class 5
February 6, 2016
February 2, 2012
Class 5
Class 5
October 28, 2016
September 21, 2013
–
Class 5
September 10, 2013
Expiry date
–
Class
Registered in Benelux
Registered in Thailand
Registered in Cambodia
Registered in Syria
Registered in Burma
Registered in Democratic
Republic of Congo
Registered in Uganda
Registered in Tanzania
Registered in Romania
Registered in Poland
Registered in Hungary
Remarks
APPENDIX X
481.
140851
Zhonghua Pharmaceutical
476.
87302
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
494.
495.
496.
497.
Zhonghua Pharmaceutical
491.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
490.
493.
Zhonghua Pharmaceutical
489.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
488.
– X-96 –
A 551897
821079034
821079042
1385/90
493562
22428
341
22326
37544
Trademark
Class 5
March 12, 2018
May 31, 2015
May 31, 2015
Class 5
Class 3
May 16, 2015
September 20, 2014
Class 5
Class 5
February 6, 2012
December 22, 2011
Class 5
Class 5
October 14, 2017
August 7, 2015
–
–
June 23, 2014
January 13, 2019
Expiry date
Class 5
Class 5
Class
Registered in Australia
Registered in Brazil
Registered in Brazil
Registered in Ecuador
Registered in Organisation
Africaine de la Propriété
Intellectuelle
Registered in Mexico
Registered in Tunisia
Registered in Ghana
Registered in Nigeria
Registered in Kenya
Registered in Cyprus
Remarks
APPENDIX X
492.
24480
Zhonghua Pharmaceutical
487.
46018 B
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Shanghai Huayu Pharmaceutical Co., Ltd.
504.
505.
506.
Zhonghua Pharmaceutical
501.
503.
Zhonghua Pharmaceutical
500.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
499.
– X-97 –
305179
3583270
6067146
6067145
6067142
6067157
3583279
Trademark
December 19, 2017
February 20, 2021
Class 30
Class 5
February 13, 2021
February 13, 2021
February 13, 2021
Class 3
Class 3
Class 3
December 27, 2019
February 20, 2021
Class 30
Class 30
June 9, 2013
April 23, 2019
Expiry date
–
Class 5
Class
Registered in European
Union
Registered in Fiji
Remarks
APPENDIX X
502.
22209
Zhonghua Pharmaceutical
498.
3218757
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai Xingling Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling Pharmaceutical Technology
Co., Ltd.
Shanghai Xingling Pharmaceutical Technology
Co., Ltd.
508.
510.
511.
513.
– X-98 –
514.
515.
516.
4098401
4098403
2674579
2677269
1556504
1556505
802249
1416354
Trademark
October 6, 2016
October 20, 2016
Class 30
January 13, 2013
Class 5
Class 30
January 13, 2013
Class 5
April 20, 2011
April 20, 2011
Class 5
Class 5
December 27, 2015
July 6, 2020
Class 5
Class 5
October 6, 2015
October 6, 2015
Expiry date
Class 5
Class 5
Class
Registered in United States
Registered in United States
Remarks
APPENDIX X
512.
509.
780155
Shanghai Xingling Pharmaceutical Technology
Co., Ltd.
507.
780154
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai Xinde Traditional Chinese Medicines
Co., Ltd.(上海信德中藥公司)
Liaoning
Ltd.
Liaoning
Ltd.
Liaoning
Ltd.
Liaoning
Ltd.
Liaoning
Ltd.
Liaoning
Ltd.
Liaoning
Ltd.
Liaoning
Ltd.
Liaoning
Ltd.
Liaoning
Ltd.
Liaoning Huanhong Pharmaceutical Co., Ltd.
(遼寧省桓紅藥業有限公司)
518.
519.
– X-99 –
529.
528.
527.
526.
525.
524.
523.
2008087
Herbapex Pharmaceutical (Group) Co., 1974399
Herbapex Pharmaceutical (Group) Co., 1974387
Herbapex Pharmaceutical (Group) Co., 3674083
Herbapex Pharmaceutical (Group) Co., 3674085
Herbapex Pharmaceutical (Group) Co., 3674086
Herbapex Pharmaceutical (Group) Co., 3674082
Herbapex Pharmaceutical (Group) Co., 3707523
Herbapex Pharmaceutical (Group) Co., 3674084
Herbapex Pharmaceutical (Group) Co., 3674080
Herbapex Pharmaceutical (Group) Co., 3674081
Trademark
March 27, 2013
December 13, 2012
Class 5
Class 40
November 20, 2012
August 6, 2015
Class 40
Class 5
January 13, 2016
November 13, 2015
Class 43
Class 14
June 13, 2015
April 27, 2015
Class 29
Class 7
August 13, 2015
January 6, 2016
Class 28
Class 41
August 13, 2015
May 9, 2012
Class 5
Class 39
October 20, 2016
Expiry date
Class 30
Class
Remarks
APPENDIX X
522.
521.
520.
4098402
Shanghai Xingling Pharmaceutical Technology
Co., Ltd.
517.
593675
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Liaoning Herbapex Pharmaceutical (Group) Co., 3772858
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 3707524
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 3668732
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 3772857
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 3552799
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 3552800
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 1969709
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 1906018
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 1974396
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 1974394
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 3354475
Ltd.
531.
532.
533.
534.
535.
536.
537.
538.
539.
540.
Registration
No.
530.
Serial
No.
Registrant
Trademark
– X-100 –
January 20, 2014
January 20, 2014
June 13, 2014
Class 5
Class 5
January 20, 2014
Class 5
Class 5
March 27, 2013
April 20, 2015
Class 5
Remarks
APPENDIX X
Class 35
June 27, 2015
Class 5
March 6, 2016
Class 5
November 20, 2015
January 20, 2016
Class 5
Class 10
October 20, 2015
Expiry date
Class 30
Class
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Liaoning Herbapex Pharmaceutical (Group) Co., 3881604
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 3945063
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 3938140
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 866126
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 4548968
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 3831137
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 4057352
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 3772859
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 4268305
Ltd.
542.
543.
545.
546.
547.
548.
549.
Trademark
November 6, 2016
October 27, 2016
Class 5
Class 5
– X-101 –
July 27, 2017
Class 5
Class 5
October 13, 2017
June 6, 2016
July 20, 2018
Class 5
Class 5
June 27, 2018
Class 5
August 27, 2016
June 13, 2016
Class 5
Class 5
June 13, 2016
Expiry date
Class 5
Class
Remarks
APPENDIX X
550.
544.
Liaoning Herbapex Pharmaceutical (Group) Co., 3881603
Ltd.
Registration
No.
541.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Liaoning Herbapex Pharmaceutical (Group) Co., 1170264
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 1722728
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 4079350
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 5005580
Ltd.
552.
554.
555.
Liaoning Herbapex Pharmaceutical (Group) Co., 5005581
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 5005583
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 7365145
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 7365222
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 7365257
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 7365420
Ltd.
557.
558.
559.
560.
561.
Trademark
– X-102 –
Class 29
Class 32
October 20, 2020
August 27, 2020
August 27, 2020
September 20, 2020
Class 5
Class 30
May 27, 2019
Class 21
June 20, 2019
June 20, 2019
Class 5
Class 5
May 20, 2017
Class 5
February 27, 2012
April 27, 2018
Class 5
Class 30
March 20, 2019
Expiry date
Class 10
Class
Remarks
APPENDIX X
556.
553.
Liaoning Herbapex Pharmaceutical (Group) Co., 5005582
Ltd.
Registration
No.
551.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
568.
569.
Leiyunshang Pharmaceutical
565.
567.
Leiyunshang Pharmaceutical
564.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
563.
– X-103 –
322774
278587
1056712
1714792
1234282
1567240
Trademark
Class 32
Class 5
Class 5
Class 30
Class 5
August 29, 2018
February 19, 2017
July 20, 2017
February 13, 2012
December 27, 2018
May 6, 2011
March 6, 2012
Class 5
Class 30
October 27, 2012
Expiry date
Class 5
Class
Remarks
APPENDIX X
566.
1908630
Leiyunshang Pharmaceutical
562.
1724587
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
576.
577.
Leiyunshang Pharmaceutical
573.
575.
Leiyunshang Pharmaceutical
572.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
571.
– X-104 –
314445
308715
681031
681033
681032
333104
Trademark
May 19, 2018
February 19, 2018
Class 29
Class 33
March 13, 2014
March 13, 2014
March 13, 2014
Class 5
Class 5
Class 5
December 19, 2018
December 19, 2018
Class 5
Class 5
September 19, 2018
Expiry date
Class 3
Class
Remarks
APPENDIX X
574.
324082
Leiyunshang Pharmaceutical
570.
333106
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
584.
585.
Leiyunshang Pharmaceutical
581.
583.
Leiyunshang Pharmaceutical
580.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
579.
– X-105 –
3449112
1367750
1016665
1023485
612992
1104458
Trademark
July 6, 2014
February 27, 2020
Class 5
Class 30
May 27, 2017
Class 32
June 6, 2017
October 9, 2012
Class 5
Class 30
September 20, 2017
February 28, 2013
November 9, 2018
Expiry date
Class 5
Class 5
Class 32
Class
Remarks
APPENDIX X
582.
329397
Leiyunshang Pharmaceutical
578.
150118
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
593.
594.
Leiyunshang Pharmaceutical
590.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
589.
592.
Shanghai Leiyunshang Pharmaceutical Factory
(上海雷允上製藥廠)
588.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
587.
– X-106 –
3508109
3508112
3508111
3508075
528250
384749
693369
Trademark
September 9, 2020
Class 5
October 6, 2014
August 6, 2014
Class 32
October 6, 2014
October 6, 2014
Class 33
Class 33
Class 33
September 9, 2020
June 13, 2014
Class 30
Class 5
November 13, 2019
September 19, 2018
Expiry date
Class 30
Class 5
Class
Remarks
APPENDIX X
591.
323984
Leiyunshang Pharmaceutical
586.
1334204
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
602.
603.
604.
Leiyunshang Pharmaceutical
599.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
598.
601.
Leiyunshang Pharmaceutical
597.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
596.
– X-107 –
1055772
339054
972705
972706
3508074
3515471
3508108
3449121
Trademark
July 13, 2017
Class 36
April 6, 2017
Class 5
February 9, 2019
April 6, 2017
Class 5
Class 5
March 6, 2015
February 6, 2015
February 20, 2015
Class 3
Class 5
Class 3
October 20, 2014
October 20, 2014
Class 5
Class 5
August 6, 2014
Expiry date
Class 32
Class
Remarks
APPENDIX X
600.
3508110
Leiyunshang Pharmaceutical
595.
3449122
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
612.
613.
614.
Leiyunshang Pharmaceutical
609.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
608.
611.
Leiyunshang Pharmaceutical
607.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
606.
– X-108 –
1198371
1194961
1194960
1216110
1196150
1197456
1197491
1642992
Trademark
Class 20
August 6, 2018
July 27, 2018
July 27, 2018
Class 10
Class 10
October 20, 2018
August 6, 2018
Class 3
Class 3
August 6, 2018
August 6, 2018
Class 32
Class 32
September 27, 2011
September 27, 2011
Class 30
Class 30
September 27, 2011
Expiry date
Class 30
Class
Remarks
APPENDIX X
610.
1643008
Leiyunshang Pharmaceutical
605.
1642991
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
1196400
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
615.
616.
617.
618.
619.
620.
621.
– X-109 –
622.
623.
3357989
1067813
1049650
1049899
Trademark
May 27, 2014
July 27, 2017
Class 42
Class 5
July 6, 2017
July 6, 2017
Class 39
Class 41
August 6, 2017
August 13, 2017
Class 35
Class 37
August 13, 2018
August 13, 2018
Class 7
Class 7
August 13, 2018
Expiry date
Class 20
Class
Remarks
APPENDIX X
1073854
1079518
1199352
1199394
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
628.
629.
630.
631.
632.
Leiyunshang Pharmaceutical
626.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
625.
– X-110 –
4254304
4254303
3726986
3256338
3256337
3256336
3256335
Trademark
April 13, 2016
February 13, 2017
Class 5
Class 29
February 13, 2017
September 20, 2013
Class 30
Class 30
January 6, 2014
September 20, 2013
Class 5
Class 30
January 6, 2014
November 6, 2012
Class 30
Class 5
September 20, 2012
Expiry date
Class 5
Class
Remarks
APPENDIX X
627.
1905821
Leiyunshang Pharmaceutical
624.
1954318
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
639.
640.
641.
642.
643.
Leiyunshang Pharmaceutical
636.
638.
Leiyunshang Pharmaceutical
635.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
634.
– X-111 –
3508113
4254949
4254953
4254299
4254950
4254951
4254952
4254305
4254301
Trademark
Class 3
February 20, 2015
February 6, 2018
September 6, 2017
Class 5
Class 44
August 27, 2017
February 13, 2017
Class 30
Class 3
February 13, 2017
Class 29
February 13, 2017
February 6, 2018
Class 44
Class 10
August 27, 2017
August 27, 2017
Class 3
Class 5
March 20, 2017
Expiry date
Class 10
Class
Remarks
APPENDIX X
637.
4254302
Leiyunshang Pharmaceutical
633.
4254300
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
650.
651.
Leiyunshang Pharmaceutical
647.
649.
Leiyunshang Pharmaceutical
646.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
645.
– X-112 –
3956809
3956799
3956803
3956804
3956806
3956732
Trademark
April 20, 2016
Class 9
March 13, 2015
November 27, 2017
July 20, 2017
Class 18
Class 22
April 20, 2016
Class 13
Class 12
December 20, 2015
April 20, 2016
Class 7
Class 10
April 20, 2016
Expiry date
Class 6
Class
Remarks
APPENDIX X
648.
3956734
Leiyunshang Pharmaceutical
644.
3956733
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
658.
659.
Leiyunshang Pharmaceutical
655.
657.
Leiyunshang Pharmaceutical
654.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
653.
– X-113 –
3956817
3956820
3956815
3956814
3956813
3956812
Trademark
August 20, 2017
Class 25
November 27, 2017
October 6, 2016
February 13, 2016
Class 29
Class 30
July 20, 2017
Class 28
Class 27
July 20, 2017
July 20, 2017
Class 24
Class 26
July 20, 2017
Expiry date
Class 23
Class
Remarks
APPENDIX X
656.
3956810
Leiyunshang Pharmaceutical
652.
3956811
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
666.
667.
Leiyunshang Pharmaceutical
663.
665.
Leiyunshang Pharmaceutical
662.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
661.
– X-114 –
3956828
3956827
3956826
3956825
3956821
3956823
Trademark
December 20, 2016
Class 36
December 6, 2016
December 6, 2016
February 27, 2017
Class 41
Class 42
December 20, 2016
Class 40
Class 39
December 20, 2016
February 13, 2016
Class 34
Class 38
February 13, 2016
Expiry date
Class 31
Class
Remarks
APPENDIX X
664.
3956819
Leiyunshang Pharmaceutical
660.
3956818
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
675.
676.
677.
678.
679.
680.
Leiyunshang Pharmaceutical
672.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
671.
674.
Leiyunshang Pharmaceutical
670.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
669.
– X-115 –
4295586
4295587
4295588
4295589
4295610
4295608
4295609
4115697
4148182
4149335
4149334
Trademark
December 27, 2016
Class 30
December 20, 2017
March 6, 2017
Class 5
Class 29
December 6, 2017
December 6, 2017
March 6, 2017
Class 3
Class 5
Class 29
March 20, 2018
December 20, 2017
Class 3
Class 44
March 27, 2017
September 27, 2017
Class 5
Class 5
September 13, 2017
May 20, 2017
Class 44
Class 44
January 6, 2017
Expiry date
Class 43
Class
Remarks
APPENDIX X
673.
3956729
Leiyunshang Pharmaceutical
668.
3956730
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
4295585
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
681.
682.
683.
684.
685.
686.
687.
688.
689.
– X-116 –
690.
691.
692.
693.
694.
4295594
4295595
4295596
4295602
4295574
4295575
4295576
Trademark
December 6, 2017
April 6, 2017
Class 29
December 6, 2017
March 20, 2018
March 6, 2017
Class 5
Class 3
Class 44
Class 29
December 6, 2017
December 6, 2017
Class 3
Class 5
June 13, 2018
April 6, 2017
Class 44
Class 30
March 6, 2017
Class 29
December 6, 2017
Class 3
December 6, 2017
June 13, 2018
Class 44
Class 5
April 6, 2017
Expiry date
Class 30
Class
Remarks
APPENDIX X
4295612
4295605
4295604
4295603
4295601
4285583
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical Shenxiang
Ginseng Branch Company（神象參茸分公
司）
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
696.
697.
698.
699.
700.
702.
703.
– X-117 –
704.
705.
4592274
4592271
4566325
4566323
4566322
4223045
4265911
4381408
4381411
Trademark
August 13, 2018
December 20, 2017
Class 3
Class 33
July 27, 2018
February 6, 2018
Class 29
Class 3
November 20, 2017
Class 31
September 13, 2017
October 13, 2017
Class 5
Class 5
July 13, 2017
July 13, 2017
Class 30
Class 30
July 13, 2017
March 20, 2018
Expiry date
Class 30
Class 44
Class
Remarks
APPENDIX X
701.
4295597
Leiyunshang Pharmaceutical
695.
4381413
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
713.
714.
715.
716.
Leiyunshang Pharmaceutical
710.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
709.
712.
Leiyunshang Pharmaceutical
708.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
707.
– X-118 –
4780307
4948324
4901052
4901050
4901048
4589418
4589417
4409827
4409826
Trademark
September 27, 2018
Class 30
Class 30
June 6, 2018
October 13, 2018
September 27, 2018
Class 30
Class 30
September 13, 2018
Class 30
August 27, 2018
July 27, 2018
Class 5
Class 5
February 13, 2018
Class 5
February 13, 2018
October 13, 2018
Class 44
Class 5
May 20, 2018
Expiry date
Class 5
Class
Remarks
APPENDIX X
711.
4527446
Leiyunshang Pharmaceutical
706.
4566321
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
5154919
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
717.
718.
719.
720.
721.
722.
723.
– X-119 –
724.
725.
3956738
3956737
3956736
Trademark
Class 1
Class 2
February 6, 2017
February 6, 2017
February 6, 2017
February 6, 2017
Class 4
Class 3
February 27, 2017
May 6, 2019
Class 5
Class 45
January 13, 2019
January 13, 2019
Class 5
Class 5
December 13, 2018
Expiry date
Class 30
Class
Remarks
APPENDIX X
3956735
3956731
4948323
4901051
4901047
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
732.
Leiyunshang Pharmaceutical
729.
731.
Leiyunshang Pharmaceutical
728.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
727.
– X-120 –
3956805
3956802
3956801
3956800
3956796
Trademark
Class 11
Class 14
Class 15
Class 16
January 27, 2016
February 6, 2017
February 6, 2017
February 6, 2017
February 6, 2017
February 6, 2017
Class 5
Class 19
January 13, 2016
Expiry date
Class 8
Class
Remarks
APPENDIX X
730.
3956794
Leiyunshang Pharmaceutical
726.
3956795
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
739.
740.
741.
742.
Leiyunshang Pharmaceutical
736.
738.
Leiyunshang Pharmaceutical
735.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
734.
– X-121 –
4149336
4149335
4149334
4148182
4148181
4115697
3956822
3956821
Trademark
February 6, 2018
September 13, 2017
Class 44
Class 44
December 27, 2016
September 27, 2017
February 20, 2018
March 27, 2017
February 27, 2017
Class 30
Class 5
Class 44
Class 5
Class 37
December 20, 2016
February 6, 2017
Class 17
Class 38
February 6, 2017
Expiry date
Class 21
Class
Remarks
APPENDIX X
737.
3956808
Leiyunshang Pharmaceutical
733.
3956816
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
4149337
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
743.
744.
745.
746.
747.
748.
749.
750.
751.
– X-122 –
752.
753.
754.
755.
756.
4295606
4295603
4295600
4295599
4295598
4295593
4295592
Trademark
March 6, 2017
Class 30
Class 33
March 6, 2017
December 6, 2017
March 6, 2017
Class 30
Class 5
March 6, 2017
March 6, 2017
March 6, 2017
Class 32
Class 33
Class 30
March 6, 2017
March 6, 2017
Class 33
Class 32
March 6, 2017
June 13, 2018
Class 32
Class 44
March 6, 2017
March 6, 2017
Class 32
Class 33
January 20, 2017
Expiry date
Class 30
Class
Remarks
APPENDIX X
4295591
4295590
4295584
4295583
4295577
4295573
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
766.
767.
Leiyunshang Pharmaceutical
762.
765.
Leiyunshang Pharmaceutical
761.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
760.
764.
Leiyunshang Pharmaceutical
759.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
758.
– X-123 –
4948324
4917696
4917695
4780307
4592275
4592273
4566324
4566321
4381411
Trademark
July 13, 2017
Class 30
March 27, 2019
October 13, 2018
Class 5
Class 30
March 13, 2019
June 6, 2018
Class 30
Class 5
December 20, 2017
October 20, 2018
Class 44
Class 30
September 27, 2018
Class 5
October 13, 2018
March 6, 2017
Class 33
Class 44
March 6, 2017
Expiry date
Class 32
Class
Remarks
APPENDIX X
763.
4295607
Leiyunshang Pharmaceutical
757.
4295611
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
775.
776.
Leiyunshang Pharmaceutical
772.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
771.
774.
Leiyunshang Pharmaceutical
770.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
769.
– X-124 –
5108848
5108847
5108846
5108845
5108844
5108843
4989208
Trademark
November 13, 2018
November 13, 2018
Class 32
November 13, 2018
Class 33
Class 30
May 27, 2019
October 27, 2019
Class 44
Class 5
June 13, 2019
Class 3
March 13, 2019
May 27, 2019
Class 5
Class 5
June 27, 2019
Expiry date
Class 5
Class
Remarks
APPENDIX X
773.
4989206
Leiyunshang Pharmaceutical
768.
4989207
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
786.
787.
Leiyunshang Pharmaceutical
782.
785.
Leiyunshang Pharmaceutical
781.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
780.
784.
Leiyunshang Pharmaceutical
779.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
778.
– X-125 –
6069616
5764252
5764251
5555503
5354863
5220583
5159615
5159614
5159613
Trademark
July 6, 2020
January 20, 2020
Class 44
Class 44
May 27, 2020
October 6, 2019
Class 41
Class 35
July 20, 2019
March 27, 2019
Class 30
Class 30
October 27, 2019
June 13, 2019
Class 5
Class 5
June 13, 2019
June 13, 2019
April 6, 2019
Expiry date
Class 5
Class 5
Class 30
Class
Remarks
APPENDIX X
783.
5154918
Leiyunshang Pharmaceutical
777.
5159612
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai Hutchison
Shanghai Hutchison
Shanghai Hutchison
797.
798.
Leiyunshang Pharmaceutical
793.
796.
Leiyunshang Pharmaceutical
792.
Shanghai Hutchison
Leiyunshang Pharmaceutical
791.
795.
Leiyunshang Pharmaceutical
790.
Leiyunshang Pharmaceutical
Leiyunshang Pharmaceutical
789.
– X-126 –
337851
336999
205426
101150
7922466
7922456
7922443
7922439
7922432
Trademark
January 19, 2019
Class 32
January 29, 2019
March 14, 2014
Class 5
Class 5
February 28, 2013
Class 5
January 20, 2021
January 27, 2021
Class 5
Class 5
January 20, 2021
Class 5
January 20, 2021
January 20, 2021
Class 5
Class 5
January 20, 2021
February 20, 2001
Expiry date
Class 5
Class 35
Class
Remarks
APPENDIX X
794.
6069615
Leiyunshang Pharmaceutical
788.
7922427
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Shanghai Hutchison
Shanghai Sine Kangjie Pharmaceutical Co., Ltd. 7999666
(上海信誼康捷藥業有限公司)
Shanghai Shanglian Pharmaceutical Co., Ltd.
8075128
(上海上聯藥業有限公司)
Zhonghua Pharmaceutical
800.
801.
803.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
805.
– X-127 –
806.
807.
808.
2002-0488
19570616
11172 OF 2002
613.742
4-2003-003725
4-2003-003723
Trademark
May 30, 2012
March 12, 2016
Class 5
Class 5
July 2, 2018
Class 5
September 20, 2014
Class 5
January 8, 2017
Class 5
September 3, 2016
February 27, 2021
Class 5
Class 5
February 6, 2021
September 29, 2019
July 9, 2019
Expiry date
Class 5
Class 5
Class 3
Class
Registered in Cuba
Registered in Hong Kong
Registered in Hong Kong
Registered in Chile
Registered in the
Philippines
Registered in the
Philippines
Remarks
APPENDIX X
804.
802.
353817
Shanghai Hutchison
799.
363038
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
783508
809.
Trademark
Class 5
Class
December 2, 2012
Expiry date
Registered in Mexico
Remarks
Our Company is applying for renewal of some of above trademarks which have expired or are about to expire in accordance with the relevant
PRC laws and regulations, and such trademarks will be renewed upon the approval of the Trademark Office. As confirmed by Grandall Legal
Group, Shanghai Office, the PRC legal adviser of the Company, there is no legal impediment for the renewal of the trademark registrations. The
Directors are of the view that there will not be any material adverse impact on our Company if such trademark registrations expire.
Zhonghua Pharmaceutical
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
APPENDIX X
STATUTORY AND GENERAL INFORMATION
– X-128 –
Trademarks under application:
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
7.
8.
Zhonghua Pharmaceutical
4.
6.
Zhonghua Pharmaceutical
3.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
2.
– X-129 –
3583260
6067156
6067155
6067154
6067150
6067151
Trademark
Class 30
Class 30
Class 5
Class 5
June 6, 2003
May 24, 2007
May 24, 2007
May 24, 2007
May 24, 2007
May 24, 2007
Class 5
Class 5
May 24, 2007
December 20, 2001
Class 30
Class 30
Application date
Class
Remarks
APPENDIX X
5.
3045486
Zhonghua Pharmaceutical
1.
6067159
Registration
No.
Serial
No.
Registrant
As of the Latest Practicable Date, the relevant member of our Company had applied for the registration of the following trademarks:
(b)
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
15.
16.
Zhonghua Pharmaceutical
12.
14.
Zhonghua Pharmaceutical
11.
Zhonghua Pharmaceutical
Zhonghua Pharmaceutical
10.
– X-130 –
8630978
8630966
8630956
8076841
7985295
7985277
Trademark
September 1, 2010
September 1, 2010
Class 5
September 1, 2010
February 20, 2010
Class 3
Class 3
Class 3
January 11, 2010
January 11, 2010
Class 5
Class 3
January 8, 2010
May 24, 2007
Application date
Class 3
Class 30
Class
Remarks
APPENDIX X
13.
6067161
Zhonghua Pharmaceutical
9.
7981019
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
Sine Pharmaceutical
23.
24.
25.
Leiyunshang Pharmaceutical
20.
22.
Leiyunshang Pharmaceutical
19.
Sine Pharmaceutical
Leiyunshang Pharmaceutical
18.
– X-131 –
8436608
8436604
8436591
8435791
7499168
8360629
8290503
Trademark
June 3, 2010
Class 33
Class 5
June 29, 2010
June 29, 2010
June 29, 2010
Class 5
Class 5
June 29, 2010
Class 5
June 25, 2009
May 12, 2010
Class 30
Class 5
Novembver 8, 2005
September 1, 2010
Application date
Class 5
Class 5
Class
Remarks
APPENDIX X
21.
8631018
Zhonghua Pharmaceutical
17.
4989209
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
Huashi Pharmacy
33.
34.
35.
36.
37.
Huashi Pharmacy
30.
Huashi Pharmacy
Huashi Pharmacy
29.
32.
Huashi Pharmacy
28.
Huashi Pharmacy
Sine Pharmaceutical
27.
– X-132 –
8221657
8221651
8221636
8221632
8173322
8173321
8173320
8173319
8173318
8173304
Trademark
Class 5
Class 5
April 19, 2010
April 19, 2010
April 19, 2010
April 19, 2010
Class 35
Class 35
April 2, 2010
April 2, 2010
April 2, 2010
April 2, 2010
Class 3
Class 5
Class 8
Class 21
April 2, 2010
April 2, 2010
Class 44
Class 30
June 29, 2010
June 29, 2010
Application date
Class 5
Class 5
Class
Remarks
APPENDIX X
31.
8436610
Sine Pharmaceutical
26.
8436617
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
5901249
Chiatai Qingchunbao
Chiatai Qingchunbao
Chiatai Qingchunbao
Liaoning Herbapex Pharmaceutical (Group) Co., 8425766
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 8425804
Ltd.
Liaoning Herbapex Pharmaceutical (Group) Co., 8431332
Ltd.
Shanghai Hutchison
Shanghai Hutchison
Shanghai Hutchison
38.
39.
40.
41.
42.
43.
44.
45.
– X-133 –
46.
8153969
8153945
Trademark
March 26, 2010
March 26, 2010
Class 5
March 26, 2010
June 28, 2010
June 25, 2010
Class 5
Class 5
Class 5
Class 5
June 25, 2010
January 20, 2009
Class 5
Class 30
February 9, 2007
February 9, 2007
Application date
Class 5
Class 5
Class
Remarks
APPENDIX X
8153939
7174563
5901251
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
8153972
47.
Trademark
Class 5
Class
March 26, 2010
Application date
Remarks
Class 6: Common metals and their alloys; metal building materials; transportable buildings of metal; materials of metal for railway tracks; non-electric cables and wires of
common metal; ironmongery, small items of metal hardware; pipes and tubes of metal; safes; goods of common metal not included in other classes; ores.
Class 7: Machines and machine tools; motors and engines (except for land vehicles); machine coupling and transmission components (except for land vehicles); agricultural
implements other than hand-operated; incubators for eggs.
Class 8: Hand tools and implements (hand-operated); cutlery; side arms; razors.
Class 9: Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and
instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or
reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin-operated apparatus; cash registers, calculating
machines, data processing equipment and computers; fire-extinguishing apparatus.
Class 10: Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
Class 11: Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying, ventilating, water supply and sanitary purposes.
Class 12: Vehicles; apparatus for locomotion by land, air or water.
Class 13: Firearms; ammunition and projectiles; explosives; fireworks.
Class 14: Precious metals and their alloys and goods in precious metals or coated therewith, not included in other classes; jewellery, precious stones; horological and
chronometric instruments.
Class 15: Musical instruments.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
Class 4: Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions; fuels (including motor spirit) and illuminants; candles and wicks for lighting.
4.
Class 5: Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters,
materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Class 3: Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair
lotions; dentifrices.
3.
APPENDIX X
5.
Class 2: Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood; colorants; mordants; raw natural resins; metals in foil and powder form for
painters, decorators, printers and artists.
2.
Note:
1.
Class 1: Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures;
fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
Shanghai Hutchison
Registration
No.
Serial
No.
Registrant
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-134 –
Class 27: Carpets, rugs, mats and matting, linoleum and other materials for covering existing floors; wall hangings (non-textile).
Class 28: Games and playthings; gymnastic and sporting articles not included in other classes; decorations for Christmas trees.
Class 29: Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits and vegetables; jellies, jams, compotes; eggs, milk and milk products; edible
oils and fats.
Class 30: Coffee, tea, cocoa, sugar, rice, tapioca, sago, artificial coffee; flour and preparations made from cereals, bread, pastry and confectionery, ices; honey, treacle; yeast,
baking-powder; salt, mustard; vinegar, sauces (condiments); spices; ice.
Class 31: Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers;
foodstuffs for animals; malt.
Class 32: Beers; mineral and aerated waters and other non-alcoholic drinks; fruit drinks and fruit juices; syrups and other preparations for making beverages.
Class 33: Alcoholic beverages (except beers).
Class 34: Tobacco; smokers’ articles; matches.
Class 35: Advertising; business management; business administration; office functions.
28.
29.
30.
31.
32.
33.
34.
35.
Class 23: Yarns and threads, for textile use.
23.
27.
Class 22: Ropes, string, nets, tents, awnings, tarpaulins, sails, sacks and bags (not included in other classes); padding and stuffing materials (except of rubber or plastics); raw
fibrous textile materials.
22.
Class 26: Lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles; artificial flowers.
Class 21: Household or kitchen utensils and containers; combs and sponges; brushes (except paint brushes); brush-making materials; articles for cleaning purposes; steelwool;
unworked or semi-worked glass (except glass used in building); glassware, porcelain and earthenware not included in other classes.
21.
26.
Class 20: Furniture, mirrors, picture frames; goods (not included in other classes) of wood, cork, reed, cane, wicker, horn, bone, ivory, whalebone, shell, amber, mother-of-pearl,
meerschaum and substitutes for all these materials, or of plastics.
20.
Class 25: Clothing, footwear, headgear.
Class 19: Building materials (non-metallic); non-metallic rigid pipes for building; asphalt, pitch and bitumen; non-metallic transportable buildings; monuments, not of metal.
19.
25.
Class 18: Leather and imitations of leather, and goods made of these materials and not included in other classes; animal skins, hides; trunks and travelling bags; umbrellas,
parasols and walking sticks; whips, harness and saddlery.
18.
Class 24: Textiles and textile goods, not included in other classes; bed and table covers.
Class 17: Rubber, gutta-percha, gum, asbestos, mica and goods made from these materials and not included in other classes; plastics in extruded form for use in manufacture;
packing, stopping and insulating materials; flexible pipes, not of metal.
17.
APPENDIX X
24.
Class 16: Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for
stationery or household purposes; artists’ materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus);
plastic materials for packaging (not included in other classes); printers’ type; printing blocks.
16.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
STATUTORY AND GENERAL INFORMATION
– X-135 –
Class 36: Insurance; financial affairs; monetary affairs; real estate affairs.
Class 37: Building construction; repair; installation services.
Class 38: Telecommunications.
Class 39: Transport; packaging and storage of goods; travel arrangement.
Class 40: Treatment of materials.
Class 41: Education; providing of training; entertainment; sporting and cultural activities.
Class 42: Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware
and software.
Class 43: Services for providing food and drink; temporary accommodation.
Class 44: Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
Class 45: Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
APPENDIX X
STATUTORY AND GENERAL INFORMATION
– X-136 –
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
APPENDIX X
STATUTORY AND GENERAL INFORMATION
(iii) Domain Name
As of the Latest Practical Date,the Company had obtained registration of the following material
domain names:
Entity name
The Company
Shanghai Pharmaceutical
Distribution Co.
Huashi Pharmacy
Changzhou Pharmaceutical
Changzhou Pharmaceutical Factory
Co., Ltd.
Shanghai Medical Instruments Co. Ltd.
Chiatai Qingchunbao
Hangzhou Huqingyutang
Pharmaceutical Co., Ltd
Xiamen Traditional Chinese Medicine
Co., Ltd.
Liaoning Herbapex Pharmaceutical
(Group) Co., Ltd.
Hangzhou Huqingyutang Guohao
Pharmaceutical Co., Ltd.
Shanghai Sine Pharmaceutical
Laboratories Co., Ltd
Shanghai No. 1 Biochemical
Shanghai Sine Wanxiang
Pharmaceutical Co., Ltd.
Shanghai Sine Kangjie Pharmaceutical
Co., Ltd.
Shanghai Asia Pioneer
Shanghai New Asiatic
Leiyunshang Pharmaceutical
Domain name or
internet keywords
Expiry date
pharm-sh.com.cn
pharmhealth.com.cn
November 12, 2011
February 7, 2013
newpharm.com.cn
February 7, 2013
firsthealth.com.cn
February 7, 2013
spharm.com.cn
March 25, 2013
spharm.cn
shpgh.com
shpgh.com.cn
March 25, 2013
February 26, 2012
February 27, 2012
sphweb.com.cn
February 27, 2012
shpharma.com.cn
February 27, 2012
shaphar.com.cn
August 30, 2012
yplsw.com
czyy.com.cn
czzyc.com
May 27, 2020
December 23, 2014
August 15, 2011
smicc.com
cnqcb.com
hqyt.com
October 31, 2013
May 21, 2014
April 26, 2011
dinglu.com
April 11, 2012
herbapex.com.cn
August 4, 2012
hqytgyh.com
August 28, 2011
sinepharm.com
May 6, 2018
sbpc.com.cn
sine-wx.com
March 8, 2016
April 29, 2013
sinekj.com
October 8, 2011
asiapioneer.com.cn
xinyapharm.com
shlys.com
November 11, 2012
June 14, 2013
February 12, 2012
– X-137 –
Remarks
This domain name
by the registrar.
This domain name
by the registrar.
This domain name
by the registrar.
This domain name
by the registrar.
is suspended
is suspended
is suspended
is suspended
This domain name is suspended
by the registrar.
This domain name is suspended
by the registrar.
This domain name is suspended
by the registrar.
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
APPENDIX X
Entity name
Shanghai Huayu Pharmaceutical Co.,
Ltd.
Shanghai Sunway Biotech Co., Ltd.
Zhongxi Sunve
Zhonghua Pharmaceutical
Qingdao Growful
SPIE
Shanghai Far-East Pharmaceutical
Machinery Co., Ltd
Shanghai Squibb
Shanghai Roche
Shanghai Hutchison
Shanghai Tsumura Pharmaceutical Co.,
Ltd.
Shanghai Harvest Pharmaceutical Co.,
Ltd.
5.
STATUTORY AND GENERAL INFORMATION
Domain name or
internet keywords
Expiry date
hyherbs.com
February 18, 2012
sunwaybio.com.cn
sunve.com
zhpharm-sh.com
growful.com
shpiec.com
shyd.cn
May 12, 2011
May 31, 2017
March 17, 2012
May 25, 2013
May 28, 2012
December 10, 2011
bms.com.cn
roche.com.cn
shpl.com.cn
shtsumura-p.com
June 4, 2020
April 12, 2012
July 10, 2021
June 18, 2011
shharvest.com
March 11, 2011
Remarks
FURTHER INFORMATION ABOUT DIRECTORS, SUPERVISORS, MANAGEMENT AND
STAFF
A. Particulars of Directors’ and Supervisors’ service agreements
None of our Directors, except for Mr. XU Guoxiong (徐國雄), has or is proposed to have a service
contract with any member of our Group, other than contracts expiring or determinable by the
employer within one year without the payment of compensation other than the statutory
compensation.
Mr. Xu has entered into a service contract with the Company for an indefinite term commencing on
May 1, 2010 (subject to termination in certain circumstances as stipulated in the relevant agreement).
His salary will be determined by the Company according to Company’s internal salary management
system and his appointment contract. His salary is adjustable according to relevant PRC laws and
regulations, Company’s condition and Mr. Xu’s performance.
B. Directors’ and Supervisors’ remuneration
The remuneration our Directors have received (including fees, salaries, discretionary bonus,
contributions to defined contribution benefit plans (including pension), housing and other
allowances, and other benefits in kind) for the three years ended December 31, 2008, 2009 and 2010
were approximately RMB801,000, RMB934,000 and RMB1,482,000, respectively.
The aggregate amount of fees, salaries, discretionary bonus, defined contribution benefit plans
(including pension), housing and other allowances, and other benefits in kind paid to our five highest
paid individuals of our Company, including Directors, during each of 2008 and 2009 as well as 2010
were approximately RMB3,000,000, RMB3,900,000 and RMB4,189,000 respectively.
We have not paid any remuneration to our Directors or the five highest paid individuals as an
inducement to join or upon joining us or as a compensation for loss of office in respect of the two
years ended December 31, 2008 and December 31, 2009 and the nine months ended September 30,
2010. Further, none of our Directors had waived any remuneration during the same period.
Save as disclosed above, no other payments have been paid or are payable, in 2008, 2009 and 2010,
by us or any of our subsidiaries to our Directors. Under the arrangement currently in force, the
aggregate amount of remuneration of our Directors for the year ending December 31, 2011
(excluding discretionary bonuses for our Directors who are also members of the senior management)
is estimated to be approximately RMB1,220,000.]
– X-138 –
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
APPENDIX X
6.
STATUTORY AND GENERAL INFORMATION
DISCLOSURE OF INTERESTS
A. Disclaimers
Save as disclosed in this Document:
(i)
none of the Directors, Supervisors nor any of the parties listed in paragraph 7I of this appendix
is interested, directly or indirectly, in the promotion of, or in any assets which have, within the
two years immediately preceding the issue of this Document, been acquired or disposed of by
or leased to any member of our Company, or are proposed to be acquired or disposed of by or
leased to any member of our Company;
(ii)
none of the Directors or Supervisors is materially interested in any contract or arrangement
subsisting at the date of this Document which is significant in relation to the business of our
Company;
(iii)
save in connection with the [●], none of the parties listed in paragraph 7I of this appendix:
(a)
is interested legally or beneficially in any shares in any member of our Company; or
(b)
has any right (whether legally enforceable or not) to subscribe for or to nominate persons
to subscribe for securities in any member of our Company;
(iv)
save as referred to above, there are no existing or proposed service contracts (excluding
contracts expiring or determinable by the employer within one year without payment of
compensation other than statutory compensation) between any member of our Company and
any of the Directors or Supervisors; and
(v)
no cash, securities or other benefit has been paid, allotted or given within the two years
immediately preceding the date of this Document to Shanghai Pharma Group (上海醫藥(集團)總
公司) nor is any such cash, securities or other benefit proposed to be paid, allotted or given.
7.
OTHER INFORMATION
A. Tax and estate duty
The Directors have been advised that no material liability for estate duty under the laws of the PRC,
where substantially all of the assets and businesses of the Company are situated, would be likely to
fall upon the Company or any member of our Company.
B. Litigation
Neither the Company nor any of its subsidiaries is engaged in any litigation or claim of material
importance, and no litigation or claim of material importance is known to the Directors to be pending
or threatened against the Company that would have material effect on the Company’s results of
operations or financial condition.
C. Agency fees or commissions
Save as disclosed in this Document, no commissions, discounts, brokerages or other special terms
have been granted in connection with the issue or sale of any capital of any member of our Company
within the two years immediately preceding the issue of this Document.
D. Preliminary expenses
The preliminary expenses of the Company are estimated to be about RMB[●] and are payable by the
Company.
– X-139 –
THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained herein is incomplete and subject to change and
it must be read in conjunction with the section headed “Warning” on the cover of this Web Proof Information Pack.
APPENDIX X
E.
STATUTORY AND GENERAL INFORMATION
Promoters
Shanghai Pharma Group (上海醫藥(集團)總公司) is the sole promoter of the Company. Save as
disclosed in this Document, within the two years immediately preceding the date of this Document,
no cash, securities or other benefit has been paid, allotted or given or is proposed to be paid, allotted
or given to the promoters or the related transactions described in this Document.
H.
No material adverse change
There has been no material adverse change in the financial or trading position of our Company since
December 31, 2010.
K.
Miscellaneous
(a)
Save as disclosed in this Document:
(i)
within the two years preceding the date of this Document, no share or loan capital of any
member of our Company has been issued or agreed to be issued fully or partly paid either
for cash or for a consideration other than cash;
(ii)
no share or loan capital of any member of our Company is under option or is agreed
conditionally or unconditionally to be put under option;
(iii)
no commission has been paid or is payable for subscription, agreeing to subscribe,
procuring subscription or agreeing to procure subscription of any share in the Company or
any of its subsidiaries; and
(iv)
neither the Company nor any of its subsidiaries has issued or agreed to issue any founder
shares, management shares or deferred shares.
(b)
there has been no interruption in our business which may have or have had a significant effect
on the financial position in the last 12 months.
(c)
The Company currently does not intend to apply for the status of a Sino-foreign investment joint
stock limited company and does not expect to be subject to the PRC Sino-foreign Joint Venture
Law.
(d)
Save as disclosed in this Document, none of the equity and debt securities of our Company is
listed or dealt in any other stock exchange or trading system nor is any listing or permission to
deal in such securities being or proposed to be sought.
(e)
No member of our Company has any outstanding debenture or other debt securities.
– X-140 –